DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
up	MT2A; MT1A; MT1E; MT1F; MT1G; MT1H; MT1X; MT1M; MT1L;	GO:0045926~negative regulation of growth	9	18	50	0	0	0	0	0	0	0
down	CDC45; ZNF324; POLA1; CDK4; RCC1; MCM3; RPA1; MCM4; MCM5; MCM7; ACVR1B; CDKN1A; CDKN2C; NASP; PRIM1; MCM2; CDKN2D; ACVR1; KHDRBS1; POLE; ORC1; EIF4EBP1; CUL1; POLA2; MCM6; IQGAP3; CDC6; HINFP; CDT1; PIM2; MCM8; PHF8; CAMK2A; GPR132;	GO:0000082~G1/S transition of mitotic cell cycle	34	100	34	0	0	0	0	0	0	0
down	TMEM129; PSMD3; SPOP; UBOX5; FBXO21; UBR5; ARIH2; TRIM21; TAF1; CBL; PSMB9; PSMB10; CCNF; PSMD4; UBE2L3; PSMD2; PPIL2; CUL1; BLMH; NFE2L1; PSME4; UBE3C; FBXO31; RNF213; DCAF15; LRSAM1; RNF165; HUWE1; IRF2BP1; FBXL14; DDB2; PSMF1; MIB2; SPSB1; FBXO17; RNF31; RUSC1; RBCK1; RNF41; RNF167; FBXL12; DTL; BFAR; KLHL42; HDAC6; FBXO2; FBXW2; PRPF19; BTRC; FBXO7; RNF115; RNF144A; UBE2J2; UBE4B; RNF166; PELI3; TRIM3; UBE3B;	GO:0000209~protein polyubiquitination	58	245	23.6734693877551	0	0	0	0	0	0	0
down	CASC3; PRPF4; PRPF3; HTATSF1; DHX16; SNRNP200; PRPF6; CD2BP2; CPSF4; SNRNP70; HNRNPL; POLR2E; POLR2A; U2AF2; PTBP1; GTF2F1; FUS; RBMX; POLR2H; POLR2J; SNRPD3; SF3B2; SNW1; DDX39B; DHX8; SART3; EFTUD2; RNPS1; PCBP2; SF3B3; SF3B4; SF3A2; SF3A1; SF1; ELAVL1; SNRNP35; USP39; ZCCHC8; PRPF8; DDX46; METTL3; CHERP; SUGP1; CPSF7; CACTIN; PRPF31; CTNNBL1; DHX38; PRCC; SYMPK; GPKOW; BUD13; GPATCH1; HNRNPUL1; DDX23; SRRT; WDR33; XAB2; RBM22; CWC25; TFIP11; PRPF19; NOVA2; SRRM2; WBP11; SNRPGP15; CWF19L2; RAVER1; PRPF40B; NONO;	GO:0000398~mRNA splicing, via spliceosome	70	246	28.4552845528455	0	0	0	0	0	0	0
down	MEIS1; NRP1; TNFSF12; HS6ST1; NRP2; DYSF; APOD; FGF1; COL4A2; PECAM1; TAL1; NCL; EFNA1; FGFR2; PTPRB; SHC1; SOX18; KDR; GJA5; ACVRL1; MCAM; MMP14; PLCD1; PRKX; EPHB3; RHOB; TEK; CAV1; MFGE8; ADAM15; FZD5; AAMP; VEZF1; MED1; DAB2IP; RNF213; VASH1; ARHGAP22; PLXDC1; FMNL3; UNC5B; NDNF; STAB2; ROBO4; SETD2; PRKD2; POFUT1; RHOJ; CCDC134; DLL4; TMEM100; APLN; PLXND1; HEY1; ADGRG1; WASF2; AMOTL1; COL18A1; TIE1; ACVR1;	GO:0001525~angiogenesis	60	230	26.0869565217391	0	0	0	0	0	0	0
down	ARID1A; DVL2; APAF1; TULP3; ABL1; MTHFD1; BMP4; SKI; RARG; PRKACA; BRD2; MTHFR; TSC2; SCRIB; TEAD2; GRHL2; MTHFD1L; TSC1; KAT2A; MED12; DLC1; FUZ; SETD2; SEMA4C; IFT122; ARHGAP35; MKS1; IFT172; VANGL2; SUFU; ST14; LRP6;	GO:0001843~neural tube closure	32	78	41.025641025641	0	0	0	0	0	0	0
down	DVL2; AXIN1; HDAC3; PDE8A; PLA2G6; CHEK2; ABL1; EGFR; HRAS; CD4; HLA-DRB1; CD74; ERBB2; APP; CSF1R; BMP2; BMP4; PECAM1; ENG; EFNA1; CD40; CCND2; AKT1; AKT2; FLT4; KDR; MTOR; CSNK1D; FLT3LG; WNT3A; TEK; RIPK1; GAS6; GPNMB; AGER; PRR5L; BRAT1; MAVS; PROM2; FLCN; DVL3; FAXDC2; CAMKK2; FIZ1; CARD14; DAXX; SLCO3A1; FXR2;	GO:0001934~positive regulation of protein phosphorylation	48	161	29.8136645962733	0	0	0	0	0	0	0
down	CDC45; KAT7; NFIC; POLA1; MCM3; RPA1; POLD1; MCM4; MCM5; MCM7; RFC4; RFC2; BRCA1; RFC5; NASP; MCM2; POLE; SSRP1; RBBP4; CHAF1A; CHAF1B; ORC1; TOP3A; TNFAIP1; POLA2; MCM6; NFIX; RBBP7; TBRG1; E4F1; TICRR; SLX4; ATRIP; ING5; KCTD13; TOPBP1; UPF1; KAT5; RMI2; SIN3A; RAD9A; CDC6; REPIN1; NT5M; DTL; POLL; MCM8; TIMELESS; POLH; SUPT16H; CDT1; TOP1MT;	GO:0006260~DNA replication	52	132	39.3939393939394	0	0	0	0	0	0	0
down	MEN1; FANCG; FANCA; POLQ; RAD51D; UBR5; ERCC1; PARP1; POLA1; UNG; ERCC3; RPA1; POLD1; RFC5; CDK9; MSH6; PPP5C; BTG2; FANCC; HSF1; XPC; RAD51; FOXM1; SSRP1; CHAF1A; CHAF1B; TRIM28; SMC1A; KIF22; PSME4; NONO; DDB1; INTS3; NFRKB; TICRR; RPAIN; KMT5C; SLX4; ENDOV; INO80E; BOD1L1; TOPBP1; RAD54L; UPF1; HDAC10; MCRS1; DDX11; OTUB1; ALKBH3; PNKP; MMS19; NABP2; HINFP; PAGR1; WRAP53; DMAP1; SIRT7; UBQLN4; TDP1; UVRAG; PARP2; CEP164; POLH; FAN1; SUPT16H; PARP3; DDB2; RFC2; INO80; NSMCE4A; DOT1L; TRRAP; LIG1; RMI2; ATRIP; SMARCB1; TIMELESS; RAD9A; RFC4;	GO:0006281~DNA repair	79	228	34.6491228070175	0	0	0	0	0	0	0
down	SUPT5H; TAF4; DVL2; ZBTB7B; FOXN1; HSF2BP; NCOR1; TAF5L; NFIC; PARP1; THRA; IRF1; TAL1; ATF4; POLR2E; ERCC3; NFKB1; TAF1; USF1; POLR2A; ARRB2; GTF2F1; RBMX; TAF6; CDK9; POLR2H; POLR2J; GTF2I; IRF9; MLLT1; KMT2A; CEBPZ; SSRP1; NFATC3; RUNX3; VEZF1; TRIM29; TFDP1; NFE2L1; IRF3; NFATC4; NFIX; TAF5; TAF1C; ZFHX3; SNAPC4; TAF3; PMF1; NFRKB; SUPT6H; NCAPG2; NELFB; RTF1; RREB1; IWS1; MNT; NELFA; ZNF768; SCAF1; ASH1L; PHRF1; GTF2IRD1; MBD1; NOCT; TCFL5; YBX2; KLF13; SUPT16H; ETV7; TAF6L; RPAP1;	GO:0006366~transcription by RNA polymerase II	71	266	26.6917293233083	0	0	0	0	0	0	0
down	PRPF3; KHDRBS3; SCAF4; PRKACA; SON; U2AF2; PTBP1; ADAR; HSF1; RNASEL; KHDRBS1; SF3B2; RRP1B; NONO; SF3B4; SF3A2; SF3A1; PAN2; USP39; RPUSD3; PRPF8; ALKBH5; SUPT6H; TSEN54; METTL3; SUGP2; CCAR2; CLASRP; RBM15B; CELF1; KHSRP; IWS1; TSEN34; NSRP1; SCAF1; PRKRIP1; RBM28; CDK12; PHRF1; ACIN1; AKAP8L; TTF2; THRAP3; RBM38;	GO:0006397~mRNA processing	44	152	28.9473684210526	0	0	0	0	0	0	0
down	WDR91; PPP1R11; RNF40; FBXO21; UBE4B; ARIH2; USP17L7; TAF1; CBL; USP6; BAG6; UBE2L3; OS9; KEAP1; CUL7; DDB1; WDR81; DCST1; UBR4; RNF213; USP30; USP43; SYVN1; CUL9; FBXL14; CDC26; NPLOC4; TRPC4AP; PSMF1; USP7; SPSB1; RNF126; KCTD10; USP42; USP40; DTL; BFAR; USP36; USP35; ANAPC5; ANAPC2; USP21; ZNRF3; CBLC; USP18; USP22; BTRC; USP20; FBXO7; NUB1; RNF167; UBE2D4; RNF144A; UBE3B; UBL7; UBE3C; CUL1; UBE2O; UBA1; SPOP; RNF166; PSMD3; HUWE1; UBQLN4;	GO:0006511~ubiquitin-dependent protein catabolic process	64	291	21.9931271477663	0	0	0	0	0	0	0
down	AP4M1; TOM1L1; AP1G2; AP2A2; HERC2; AP2A1; CD74; SCG5; EIF2D; BCAP31; SEC13; RHOB; AP2B1; COG7; AP1B1; CTTN; WLS; TGFBRAP1; SNX33; ACD; AP2M1; VPS39; SNX27; AP1M1; ASPSCR1; SIL1; VPS16; VPS11; VIPAS39; SNX15; GGA3; VPS18; COPZ2; HDAC6; GGA2; GGA1; COPG1; RABGAP1; SEC31B; TBC1D22A; EVI5L; TBC1D10C; STX1B; RAB1B; RAB34; TBC1D2B; TBC1D8; STX16-NPEPL1; STX2; RAB19; RAB44; TBC1D13; USP6; RAB36; ARFRP1; TBC1D17; STX4; TBC1D1; TBC1D10B; ARF3; RAB4B; RAB15; RAB3D; RAB32; RAB11B; RAB8A; SGSM2; RAB33A; TBC1D16; TSNARE1; TBC1D9B; ARFIP2;	GO:0006886~intracellular protein transport	72	317	22.7129337539432	0	0	0	0	0	0	0
down	PIK3CD; IKBKB; RPS6KA4; ATRN; APOL3; C5; CSF1R; CSF1; BMP2; CYBA; FOLR2; HK1; NFKB1; TNFRSF1B; ITGAL; PTGS1; F2R; CD40; AXL; AKT1; NDST1; F2RL1; HDAC4; TIRAP; LYZ; RELA; FUT7; HYAL1; NFATC3; TCIRG1; NFE2L1; NFATC4; AGER; THEMIS2; DAB2IP; NFRKB; SCUBE1; SCYL3; ABCF1; IL17RE; NFKBID; SCYL1; GBP5; P2RX7; SIGLEC1; NLRP1; IL1RL2; NLRC4; PLA2G4C; NOD1; LAT; CCL11; CXCL1; CCL17; C3AR1; TNFRSF4; CXCL9; PTGIR; TLR4; CMKLR1; CCL22; LTB4R2; CIITA; TAC4; CX3CL1; CXCL11; GGT5; CXCL10;	GO:0006954~inflammatory response	68	381	17.8477690288714	0	0	0	0	0	0	0
down	APBB1; MEN1; CHD2; OGG1; PHF1; SUV39H1; BRD4; POLQ; UBR5; HERC2; CHEK2; ABL1; TP53; PARP1; BCL3; TAF1; UBA1; CBL; RPA1; AKT1; MCM7; GNL1; BRCA1; CDKN1A; RAD52; CBX5; BTG2; RAD51; TP53BP1; NFATC2; IRF3; NCOA6; PSME4; DDB1; MICA; CTC1; FBXO31; INTS3; RFWD3; BRAT1; APTX; SLFN11; METTL3; CCAR2; C17orf53; BOD1L1; SETD7; TOPBP1; ZDHHC16; DDX11; OTUB1; HMCES; ZNF385A; MMS19; RAD9A; NABP2; MACROD1; WDR76; SIRT7; UBQLN4; ZBTB40; AATF; DTL; ZBTB4; ASH2L; BAZ1B; MCM8; TAOK2; TIMELESS; SAMHD1; MORC2; ZBTB47; FANCG; ZNF652; HIC1; ZBTB42; ZBTB3;	GO:0006974~cellular response to DNA damage stimulus	77	245	31.4285714285714	0	0	0	0	0	0	0
down	SUV39H1; EPB41L2; RAB11FIP3; STK10; PAK4; SRC; TRIM21; CSNK2A2; TAF1; RBL1; MKI67; RASSF2; HCFC1; RAE1; RBBP4; SMARCB1; CHAF1A; CHAF1B; MAPK7; CAMK1; E2F2; NEDD9; RPS6KA1; TERF2; USP39; DAB2IP; STEAP3; PMF1; STOX1; MICAL3; NCAPG2; CCAR2; SPC24; DBF4B; CDC26; PARD3B; SENP5; MARK4; HMCN1; CDCA3; SPAG8; CABLES2; RBM38; RASSF4; BRD7; KMT5A; BABAM1; HMG20B; KLHL42; APEX2; ANAPC5; ANAPC2; CASP8AP2; USP22; RABGAP1;	GO:0007049~cell cycle	55	248	22.1774193548387	0	0	0	0	0	0	0
down	WIPF3; AXIN1; DIAPH2; ARIH2; CLPTM1; FGF1; ERG; BMP1; ZNF3; ZNF7; GPX4; PLXNA3; HUNK; PRDM15; DCAF7; FGD1; ZNF45; NOTCH2; TLE1; C19orf57; NFATC3; ZMYM3; HIC1; HLX; PSME4; DGKD; TSNAXIP1; ODF2; ZMYM4; DIEXF; TSSK4; ZSCAN2; LDB1; GGN; ERC1; PHC2; LTBP4; MINK1; ZFP41; KDM1B; VANGL1; SPATA20; CCHCR1; CACTIN; TWIST2; EDARADD; CCL17; RREB1; USP7; DDX11; CCDC120; MNT; APOL2; EBF4; LSM14B; TSSK6; CADM1; NELFA; PLEKHB1; GTF2IRD1; PLXNA1; ANGPTL2; TCFL5; SUFU; CEP131; RBM19; TLL2; RARG; FGFR2; ROR1; CSF1R; ERBB2; CDH5; IGF1R; DDR1; FLT4; FGFR3; PDGFRB; CDH6; NR1I3; ZNF296; CDH13; THRA; EGFR; ERBB3; LDB2; BCL11B; TIE1; EPHB6; MST1R; AXL; FGFR4; CDH1; TEK; CDH24; EPHB3; KDR; NR1H2;	GO:0007275~multicellular organism development	98	513	19.1033138401559	0	0	0	0	0	0	0
down	MEN1; KCNK3; PHGDH; CTNS; TULP3; MBD3; GAS8; COL4A1; APOD; ATXN1L; PTPRG; ARRB2; MTOR; CASP2; BAG6; SLC6A11; NES; PPT1; HAP1; RELN; FPGS; ADCY1; BPTF; ABR; SHROOM2; NCOA6; GRIN2C; MED1; DPYSL2; C2CD3; SPATA5; CDK5RAP3; CIC; CDK5RAP2; CDK5RAP1; PYGO2; SMG9; ZNF335; ARNT2; ROBO2; CHD8; PCDH18; SPHK2; STK36; IFT172; SLC23A1; PHF8; ADGRG1; KLHL17; GRHL2; ZFHX3; NNAT; THRA;	GO:0007420~brain development	53	217	24.4239631336406	0	0	0	0	0	0	0
down	MEN1; DLL1; SLC9A3R1; IFIT3; HGS; SMAD6; ALDH1A2; GDF11; GAS8; HRAS; LMNA; TFF1; TP53; APP; TFAP2A; CSF1R; CXCL1; GLI3; IRF1; BMP2; BMP4; SKI; RARG; EIF2AK2; IGFBP6; F2R; DNAJB2; PML; CDH5; NF2; ACVRL1; NUP62; CDKN1A; COL18A1; CDKN2C; CTCF; TSC2; SMARCA2; CDKN2D; CDH13; HDAC4; RIPPLY3; BTG2; HSF1; TNFRSF9; DPT; DDR1; RBBP4; TMEM115; PTPRJ; ZBTB17; CTBP1; FZD5; PKD2; MXD4; GPNMB; CDK10; DHCR24; PTPN14; TBRG1; DAB2IP; TNS2; ZBTB49; PODN; CHERP; SIRT2; ING5; TSC1; DLC1; TSPAN32; MNT; CDC6; EIF2AK1; LZTS2; FUZ; FOXP3; BCL11B; RNF41; BRD7; DLL4; SH3BP4; SIRPG; PIM2; ADAMTS1; FBXO2; ATF5; KLF13; ADGRG1; CLMN; NUPR1;	GO:0008285~negative regulation of cell population proliferation	90	396	22.7272727272727	0	0	0	0	0	0	0
down	PRPF4; PRPF3; DHX16; PRPF6; SON; PTBP1; FUS; SNRPD3; SF3B2; THOC5; DDX39B; DHX8; RRP1B; NONO; SF3B3; SF3B4; SNRNP35; USP39; PRPF8; SUPT6H; THOC6; SUGP2; CCAR2; CLASRP; RBM15B; RP9; KHSRP; PPP1R9B; IWS1; USB1; DDX23; NSRP1; RBM38; SCAF1; PRKRIP1; RBM28; CDK12; ACIN1; AKAP8L; TTF2; THRAP3; RNPS1; SCNM1; SART3;	GO:0008380~RNA splicing	44	156	28.2051282051282	0	0	0	0	0	0	0
down	NRP1; FOXN1; HRAS; BMP2; ITGAX; FGFR2; STX2; COL18A1; DGCR2; FGD1; FLI1; RELA; NOTCH2; TLE1; TLE2; EP300; CUL1; E2F4; NEK8; LFNG; SMARCC1; ETV7; LAMC2; ASXL2; LAMC1; LAMB3; ASXL1; ATRN; THRA; AGRN; EGFLAM; LAMB2; LAMA2; MEGF8; LAMC3;	GO:0009887~animal organ morphogenesis	35	111	31.5315315315315	0	0	0	0	0	0	0
down	SH3PXD2B; TLR4; PIK3CD; CLDN5; HGS; ZBTB7B; TYROBP; ALDH1A2; UBR5; LMNA; AMH; CD74; TP53; APP; TFAP2A; CD3E; CSF1; BMP2; BMP4; CD36; BMP7; ATF4; ITGAX; ERBB3; FGFR4; ITGA3; MSN; DNMT1; CD34; AKT1; ARRB2; CDH5; BRCA1; CASR; MTOR; PPM1F; CTCF; GSK3A; GSK3B; HCFC1; MYOM1; DGKQ; WNT3; WNT3A; E2F1; CAV1; TLE1; ROCK1; PKP1; LRRC32; GAS6; TERF2; MED1; STOX1; TTC21B; IQGAP3; LILRB1; EDA; DTNBP1; P2RX7; SMO; HINFP; WNT10A; MOV10; DLL4; DROSHA; DNMT3B; AGO1; TNRC6B; LAMP3; HEY1; ROBO1; PIAS3;	GO:0010628~positive regulation of gene expression	73	374	19.5187165775401	0	0	0	0	0	0	0
down	NBAS; COPE; SCAMP2; AP5Z1; AKAP8; EXOC3; PRAF2; DNAJC13; TRIM3; APBA3; CD3G; KDELR1; GDI1; ARRB2; NASP; PPT1; CORO7; VAMP2; TAP1; GOLGA2; TMEM115; SELENBP1; COG2; MVP; ACAP1; RABEP1; STXBP2; DGKD; DUOXA1; MIA3; VPS53; SNX30; DENND4C; RHBDF2; DNAJC14; RINL; SNX20; ATG4D; SNX32; ERC1; SLC15A3; VPS52; FAM160A2; ARFGAP2; ARFGAP1; ATG16L2; EHBP1; BICD2; DENND1A; COG1; CHMP7; GBF1; VPS33A; RHBDF1; SLC7A6OS; HOOK2; ANKRD27; GORASP1; SEC22C; FUZ; LMAN2L; RBSN; PTPN23; RABEP2; MVB12B; COG4; AP5S1; BET1L; AGAP1; EXOC7; EXOC6B; ATG4B; SNX10; SCAMP4;	GO:0015031~protein transport	74	310	23.8709677419355	0	0	0	0	0	0	0
down	PODXL; PLXNB1; PAK4; PDGFRB; PTPRF; LAMC1; LCP1; JUP; PLCG1; SLC9A1; EFNA1; FGFR4; GSK3A; EPHB3; EMP2; ADAMTS12; PTK7; NFATC2; DGKZ; SHROOM2; TNFAIP1; SCRIB; DOCK1; MAPRE1; BRAT1; SYDE1; SKAP1; FMNL3; SCYL3; KCTD13; MYO18A; ELMO3; RHBDF1; PPP1R9B; PEAK1; ARHGAP35; LIMD1; TAOK2; CDC42BPB; ADGRG1; LAMB3; TSPAN11; GPC4; NEDD9; KDR; FMNL2; AXL; FMNL1; NDE1; GPC1; LAMB2; PIK3C2B; RHOJ; EFS; SDC3; RHOB; PIK3CD; ITGB7; LAMC3; CLEC14A; APC2; ITGB5;	GO:0016477~cell migration	62	225	27.5555555555556	0	0	0	0	0	0	0
down	SLC9A3R1; TYROBP; NPHP4; FLNB; ABL1; CXCL1; TNXB; NF2; ADD1; ARFIP2; RAC3; FGD1; ARHGEF5; ABR; ROCK1; INF2; FGD3; KLHL17; FGD5; FGD6; FGD2; SSH1; ARHGEF17; DLC1; CYTH2; INPP5K; RHOJ; TAOK2; NISCH; WASF2; SHROOM2; PDLIM4; SSH3; LIMK2; MICALL1; TESK1; IQSEC2; IQSEC1; MICAL3; AMOTL1; LIMK1; RAC2; EHBP1;	GO:0030036~actin cytoskeleton organization	43	157	27.3885350318471	0	0	0	0	0	0	0
down	WIPF3; DLL1; APAF1; SUV39H1; TNFSF12; SOX15; CLPTM1; TFF1; FGF1; MGP; BMP1; ZNF3; ARNT; AKT1; STX2; BAG6; HSD17B7; RHOB; FOXK1; GNA12; AAMP; HLX; TSNAXIP1; MEIG1; NXN; ALKBH5; ILDR2; ARHGAP22; BMP8A; HUWE1; ZSCAN2; GGN; GPSM1; ZFP41; SPATA5; SPATA20; CCHCR1; TWIST2; EDARADD; EDA; DAZAP1; NOTCH4; SPAG8; BCL7B; SPATA25; CADM1; RBM38; UNC45A; VIPAS39; USP42; SPAG4; PRMT7; ASF1B; TCFL5; CEP131; TLL2; NHSL2; LCK; THRA; SOX12; KIAA1522; FLI1; NR1I3; NR1H2; HEYL; CAV1; TNK2; ETS2; PRRC2A; NR2C2; ZFPM1; SPI1; RBL1; PRRC2B; SOX18; EGFR; HEY1; ERG; SRC; RXRB; ETV7; TNK1; HES2; BHLHE40; RARG; DLX3;	GO:0030154~cell differentiation	86	572	15.034965034965	0	0	0	0	0	0	0
down	DCDC2B; SOCS7; SOCS3; CIT; UNC13B; PLXNB1; EFS; LAT; TYROBP; SMPD2; DEPDC5; RPS6KA4; ERBB2; CXCL1; SRC; PRKCSH; HCLS1; S100A1; JAK1; TYK2; AKT1; GUCY1A2; GSK3B; JAK3; RAC3; ARHGEF5; MAP4K2; MAP3K12; ARHGEF7; TNS2; CDC42BPG; DNMBP; MARK2; PREX1; ASB13; INPP5D; DVL3; SIPA1; ASB2; MAP3K3; GNB1L; PRKD2; SIK2; ARHGEF4; CISH; ASB6; GMIP; SIRPG; PLA2G4C; NOD1; GRIP1; ASB1; CDC42BPB; NLRC3; CAMKK1; MAST3; DGKD; PKN3; STK32B; STK32C; RPS6KA1; MARK4; MAST2; AKT2; MAPK7; NLRC5; SH2B1; MAPKAPK3; TSSK6; MAPKAPK5; DGKQ; HUNK; TSSK4; DGKZ; MAPK12;	GO:0035556~intracellular signal transduction	75	371	20.2156334231806	0	0	0	0	0	0	0
down	APBB1; WNT10B; APAF1; UNC13B; ARHGEF9; TRIO; ALDH1A2; PLEKHG5; ABL1; LTA; TP53; PDGFRB; IGF2R; CDK4; BMP2; BMP4; SRC; RARG; SMPD1; BMP7; ATF4; ERCC3; SLC9A1; ITGA6; AKT1; CASP2; HTT; RASSF2; RHOB; FGD1; E2F1; NOTCH2; ARHGEF5; AKAP13; ABR; EIF2B5; RIPK1; ARHGEF7; SCRIB; RRP1B; PTPA; RNPS1; PLEKHN1; ANO6; FGD3; PIP5KL1; DAB2IP; FGD2; ARHGEF19; CCAR2; FLCN; LILRB1; PREX1; CTNNBL1; ING5; NCSTN; NSMAF; INPP5D; ARHGEF1; APH1A; BMF; ARHGEF17; SUDS3; CALHM2; NLRC4; ARHGEF4; SPHK2; MTCH1; ARHGEF12; IP6K2; ZNF346; FAF1; MAP3K10; BBC3; TNFRSF10B; MAP3K11;	GO:0043065~positive regulation of apoptotic process	76	332	22.8915662650602	0	0	0	0	0	0	0
down	HAX1; EEF2K; SOCS3; IFIT3; IKBKB; HDAC3; OGG1; SMAD6; NUPR1; TIAF1; EGFR; PROC; CD74; TP53; TFAP2A; CSF1R; IGF1R; ANXA5; PDGFRB; GLI3; ARAF; BMP4; SRC; UNG; IL2RB; SON; EIF2AK2; SLC9A1; NFKB1; BCL3; FLNA; CBL; RPL10; SHC1; CCND2; AKT1; AKT2; GRK5; FLT4; KDR; NUP62; CDKN1A; CASP2; BAG6; GSK3B; PPT1; STAT5B; ARHGDIA; ADAR; SOX10; CX3CL1; TEK; RELA; NOTCH2; BNIP1; RIPK1; FHL2; GAS6; BECN1; DHCR24; RPS6KA1; MED1; DDB1; BCL2A1; WDR73; THOC6; ERC1; RHBDD1; SH3RF2; TWIST2; MYO18A; SIN3A; PHB2; SMO; CARD14; BCL11B; ARNT2; HYPK; AATF; BFAR; PIM2; ATF5; UBE2O; AXL;	GO:0043066~negative regulation of apoptotic process	84	489	17.1779141104294	0	0	0	0	0	0	0
down	MAN2B1; PDXK; APAF1; AGPAT2; PSMD3; TYROBP; DNAJC13; STK10; NFASC; TMEM63A; AP2A2; RAB3D; CYB5R3; HLA-B; GPI; CXCL1; ALOX5; HLA-C; PYGB; LAMP1; IGF2R; IMPDH2; CYBA; EEF2; JUP; ARSA; GNS; DSP; PECAM1; CD36; GM2A; CD53; NFKB1; TNFRSF1B; ITGAL; ITGAX; PTPRB; CTSS; CFP; GALNS; ACTR1B; HK3; ACLY; RAB4B; LYZ; VAMP2; CKAP4; DSC1; BST2; PTPRJ; PSMD2; KCNAB2; ROCK1; TCIRG1; PKP1; COTL1; DYNC1H1; FGL2; MVP; STXBP2; C3AR1; ANO6; UBR4; HGSNAT; LAIR1; RAB44; HUWE1; TMEM179B; HRNR; TBC1D10C; SLC44A2; STK11IP; GHDC; PLEKHO2; NCSTN; PTPRN2; ATP6V0A1; CPNE1; ARHGAP9; AP1M1; DSN1; CTSZ; BIN2; DPP7; PADI2;	GO:0043312~neutrophil degranulation	85	483	17.5983436853002	0	0	0	0	0	0	0
down	AGRN; DVL2; NRP1; RGS12; RGS16; SGSM2; PLXNB1; ARHGAP6; SRGAP3; SIPA1L3; SRGAP2; DEPDC5; ARHGEF15; HRAS; ERBB2; ITGA6; F2R; CD40; GDI1; ARHGAP25; RGS3; TSC2; GSK3B; CCL11; ARHGDIA; F2RL1; WNT4; ARHGAP4; ARHGAP1; ARHGEF5; NPRL3; MYO9B; RAPGEF1; ARHGEF7; DOCK1; ACAP1; RABEP1; RALBP1; EZH2; ARHGAP31; ARHGAP11B; AGAP7P; DAB2IP; IQSEC1; LLGL2; RINL; ARHGAP22; ARHGAP30; RASAL3; RASGRP3; ARHGEF19; ARHGAP18; ARFGAP2; ARFGAP1; PREX1; DENND1A; NPRL2; SMAP2; ARAP3; STARD8; RGP1; ARHGEF1; DVL3; EVI5L; ELMOD3; SIPA1; ANKRD27; AGAP3; ARAP1; ACAP3; SYNGAP1; ALS2; DLC1; PKP4; ARHGAP9; TBCD; RABEP2; RANBP3; ADAP2; RIC8A; ARHGAP35; RIC8B; ARHGEF12; GMIP; ARHGAP23; ASAP1; AGAP1; GIT1; CX3CL1; CCL17; FLCN; CCL22;	GO:0043547~positive regulation of GTPase activity	92	322	28.5714285714286	0	0	0	0	0	0	0
down	MEN1; SOCS3; PSMD3; TGOLN2; ICMT; FBXO21; PROC; APP; SERPIND1; P4HB; MELTF; CSF1; LAMC1; BMP4; PRKCSH; PSMB9; PSMB10; CCNF; PSMD4; LAMB2; RAB8A; DCAF7; WDR5; CKAP4; MFGE8; PSMD2; CUL1; KEAP1; GAS6; MBTPS1; PSME4; CUL7; LRRC41; RAB11B; DDB1; RBBP7; TMEM132A; MIA3; DCAF8; FBXO31; CUL9; FAM20C; FBXL14; WDTC1; SUMF2; PCSK9; RHBDD1; ASB13; DDB2; PSMF1; SPSB1; FBXO17; KCTD7; ASB2; RAB1B; FN3K; VIPAS39; COPS7B; FN3KRP; TULP4; CISH; ASB6; DCAF16; FBXL12; DTL; KLHL42; COPS7A; FBXO2; FBXW2; BTRC; FBXO7; ASB1; NUB1;	GO:0043687~post-translational protein modification	73	344	21.2209302325581	0	0	0	0	0	0	0
down	E2F8; HAX1; TLR4; APBB1; MEN1; SUPT5H; AGRN; MEIS1; DLL1; KMT2D; IKBKB; ZNF609; KDM6B; FOXN1; SOX12; HDAC3; TET3; SOX15; KDM1A; KPNA6; BRD4; TBL1X; LRP5; LRP6; RPS6KA4; MTA2; PRPF6; CAMTA2; KAT7; ABL1; EGFR; HRAS; CXCL10; CD3D; TP53; APP; FGF1; TFAP2A; PFKM; NFIC; PARP1; GLI3; MYBL2; IRF1; ERG; BMP2; BMP4; SKI; RARG; IRF2; HCLS1; ETS2; TCF4; TCF3; TAL1; ENG; SPI1; BMP7; ATF4; NCL; ERCC3; TFEB; SLC9A1; NFKB1; BCL3; TAF1; FGFR2; USF1; ITGA6; CD40; ARNT; RXRB; RBL1; AKT1; CIITA; GTF2F1; SOX18; ZNF76; ACVR1B; SREBF1; ACVRL1; RBMX; BRCA1; PBX2; STAT1; STAT6; WAS; RFX2; RFX5; NR2C2; FLT3LG; GSK3A; CDK9; SMARCA2; STAT5B; NR1H2; F2RL1; MLLT6; CDH13; HDAC4; WNT3A; PRDM15; CD81; CX3CL1; HSF1; E2F1; FOXK2; FLI1; KMT2A; CEBPZ; RELA; ACVR1; RNASEL; FOXM1; EP300; TEF; SREBF2; SMARCB1; BPTF; TP53BP1; FOXF1; FOXF2; NFATC3; ZBTB17; MAPK7; GPS2; FZD5; RIPK1; PKD2; SNW1; CAMK1; VEZF1; TFDP1; TFDP2; E2F2; NFE2L1; IRF3; RRP1B; NCOA6; NFIX; NR1I3; PPP2R5B; RPS6KA1; SAFB; TCEA2; MED1; ZFHX3; E2F4; GLYR1; CDON; DAB2IP; GRHL2; MAMSTR; ZBTB49; CREB3L2; ASXL2; MAVS; AKNA; LDB1; BCL9L; NLRC5; SKAP1; CARM1; ARID3B; SIRT2; ASXL1; PELP1; NFATC2IP; ZMIZ2; FLCN; LILRB1; GABPB2; DOT1L; RTF1; MAML1; TFAP2C; RREB1; CREBBP; KAT2A; DDX17; SMARCC1; KAT5; MED12; RGMA; CDK5RAP3; MAML3; TOX2; RBM14; SIN3A; SMO; ATF6B; PAGR1; HELZ2; GLIS2; PRKD2; FOXP3; BCL11B; BRD8; IRF2BPL; MLXIP; ARNT2; CHD8; HEYL; RPRD1B; PRDM10; ASH1L; SIRT7; AATF; FOXJ2; ZFAT; ASH2L; AGO1; INO80; AKAP8L; TFR2; PLAGL2; ATF5; THRAP3; KLF13; HEY1; FHOD1; GMEB1; FOXO6; ZNF821; MGA; SOX13; TBX2; KDM1B; STAT5A; NPAS1; RAI1; STAT2; SOX10; TAF4; EBF4; NFATC4; DLX3; PPRC1; CTCF; MCRS1; PTOV1; THRA; CRTC2; GFI1; TEAD4; KAT8; BCL9; SPAG8; NFATC2; TEAD2; JUP; ZNF740; IKZF4; LDB2; DPF2; TCF20; KAT6A;	GO:0045944~positive regulation of transcription by RNA polymerase II	257	1138	22.5834797891037	0	0	0	0	0	0	0
down	SIPA1L1; ARHGAP6; SRGAP3; ARHGEF9; SIPA1L3; SRGAP2; TRIO; PLEKHG5; RHOBTB1; A2M; RAC2; GDI1; INPP5B; ARHGAP25; TSC2; ARHGDIA; RAC3; RHOB; ARHGAP4; FGD1; ARHGAP1; ARHGEF5; AKAP13; ABR; MYO9B; ARHGEF7; RALBP1; ARHGAP31; RALGAPA2; ARHGAP11B; FGD3; SYDE1; ARHGAP22; ARHGAP30; FGD2; ARHGEF19; RHOT2; ARHGAP18; PREX1; ARAP3; STARD8; ARHGEF1; SIPA1; ARAP1; ARHGEF17; DLC1; ARHGAP9; RHOJ; ARHGEF4; ARHGAP35; ARHGEF12; GMIP; ARHGAP23;	GO:0051056~regulation of small GTPase mediated signal transduction	53	141	37.5886524822695	0	0	0	0	0	0	0
down	SAC3D1; EPB41L2; BUB1; RAB11FIP3; CHEK2; CDK4; TPR; RCC1; LIG1; MAP4; CCND2; CDC25B; CDC25C; CCNF; NCAPD3; KNTC1; RAE1; NSUN2; CKAP5; DCTN1; DYNC1H1; BECN1; NEDD9; SMC1A; NUMA1; NCAPD2; MAPRE1; USP39; E4F1; PMF1; LLGL2; PSRC1; STOX1; MICAL3; CNTRL; NCAPG2; KIF18B; SIRT2; SPC24; CDC26; PARD3B; STAG1; CENPT; CDCA5; SENP5; BOD1; MARK4; SPAG5; HMCN1; CDCA3; KIF2C; CDC6; CABLES2; KATNB1; KIFC1; CDT1; DSN1; REEP4; CENPJ; NEK6; KMT5A; BABAM1; NDE1; KLHL42; ANAPC5; ANAPC2; INO80; TPX2; VPS4A; TIMELESS; CEP164; AURKC; TACC3; MAU2;	GO:0051301~cell division	74	347	21.3256484149856	0	0	0	0	0	0	0
down	RRP8; TP53; PRKACA; BRCA1; ZBTB17; PKD2; PPP2R5B; DAB2IP; RNF112;	GO:0071158~positive regulation of cell cycle arrest	9	25	36	0.00010940844687468	0.00192922599066885	0.689820257544866	0.731176650463496	0.395511535451973	0.689820257544866	0.0181050388243489
down	KCNN4; GNB3; ADD1; CLCN6; E2F4; SLC12A7; SLC12A9; SLC12A4;	GO:0006884~cell volume homeostasis	8	19	42.1052631578947	0.0001106966623019	0.00192996965588287	0.697831759151185	0.739785794163606	0.397602015010438	0.69749966916428	0.018112017834396
down	IGF2R; M6PR; LRP1; VPS53; HGSNAT; VPS52; PCSK9; ALS2;	GO:0007041~lysosomal transport	8	19	42.1052631578947	0.0001106966623019	0.00192996965588287	0.697831759151185	0.739785794163606	0.397602015010438	0.69749966916428	0.018112017834396
down	MYO1G; SMAD6; SORBS3; VWF; ITGA6; PRKX; GAS6; FAT2;	GO:0031589~cell-substrate adhesion	8	19	42.1052631578947	0.0001106966623019	0.00192996965588287	0.697831759151185	0.739785794163606	0.397602015010438	0.69749966916428	0.018112017834396
down	TOM1L1; RNF126; PTPN23; MVB12B; HDAC6; VPS4A; RNF115; VPS37C;	GO:0043162~ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway	8	19	42.1052631578947	0.0001106966623019	0.00192996965588287	0.697831759151185	0.739785794163606	0.397602015010438	0.69749966916428	0.018112017834396
down	SLC24A1; ATP2A2; ATP2B4; NCS1; CACNB1; PKD2; GAS6; ANO6; CACHD1; TRPM4; PKD1L1; TRPC4AP; ATP2A3; ORAI1; ORAI2; P2RX4; P2RX7; STIM2; CACNG4; TRPV2;	GO:0070588~calcium ion transmembrane transport	20	115	17.3913043478261	0.00011948657053717	0.00203946187999399	0.751928988390443	0.798528750899941	0.409029583963771	0.751928988390443	0.0191395599565135
down	TULP3; GLI3; MTHFD1; NDST1; MTHFD1L; MED12;	GO:0048702~embryonic neurocranium morphogenesis	6	9	66.6666666666667	0.00012624102422653	0.00209867851966653	0.793298596239556	0.843668764905944	0.41735282609293	0.793046114191103	0.0196952851880335
down	TLR4; CD74; CD36; HLA-G; LILRB1; GPRC5B;	GO:0060907~positive regulation of macrophage cytokine production	6	9	66.6666666666667	0.00012624102422653	0.00209867851966653	0.793298596239556	0.843668764905944	0.41735282609293	0.793046114191103	0.0196952851880335
down	ABCB1; CD34; NES; WNT3; WNT7B; ZNRF3;	GO:0072089~stem cell proliferation	6	9	66.6666666666667	0.00012624102422653	0.00209867851966653	0.793298596239556	0.843668764905944	0.41735282609293	0.793046114191103	0.0196952851880335
down	DLL1; IDO1; JAK3; AGER; PDCD1LG2; FOXP3; CD274;	GO:0032693~negative regulation of interleukin-10 production	7	14	50	0.0001308156423887	0.00216396271802898	0.821653049843451	0.87424093808371	0.42296057329532	0.821522234201062	0.0203079521081795
down	ADAR; TTLL12; DCST1; METTL3; NLRC5; CACTIN; SAMHD1;	GO:0060339~negative regulation of type I interferon-mediated signaling pathway	7	14	50	0.0001308156423887	0.00216396271802898	0.821653049843451	0.87424093808371	0.42296057329532	0.821522234201062	0.0203079521081795
down	EFNA1; NF2; PRDM15; CAV1; DAG1; LEMD2; P2RX7; ASH1L;	GO:0043409~negative regulation of MAPK cascade	8	20	40	0.00014704270278342	0.00239679605536989	0.922545917263232	0.982686382701654	0.442899689867465	0.922545917263232	0.0224930028137727
down	STAT1; IL12RB1; MAVS; APOBEC3F; LILRB1; ZDHHC1; TRIM44; SIN3A; EIF2AK4;	GO:0002230~positive regulation of defense response to virus by host	9	27	33.3333333333333	0.00017658431938616	0.00278986526349346	1	1	0.474658650510008	0.998790808935051	0.026181805114879
down	ATRN; APP; GHR; CDK4; STAT5A; STAT5B; GPAT4; FTO; AFG3L2;	GO:0040014~regulation of multicellular organism growth	9	27	33.3333333333333	0.00017658431938616	0.00278986526349346	1	1	0.474658650510008	0.998790808935051	0.026181805114879
down	SUPT5H; POLR2E; POLR2A; GTF2F1; CDK9; POLR2H; POLR2J; NELFB; NELFA;	GO:0050434~positive regulation of viral transcription	9	27	33.3333333333333	0.00017658431938616	0.00278986526349346	1	1	0.474658650510008	0.998790808935051	0.026181805114879
down	AP2A2; AP2A1; CD4; LCK; AP2B1; AP1B1; PACS1; AP2M1; AP1M1;	GO:0050690~regulation of defense response to virus by virus	9	27	33.3333333333333	0.00017658431938616	0.00278986526349346	1	1	0.474658650510008	0.998790808935051	0.026181805114879
down	SMAD6; BMP4; NOTCH2; ROBO2; HEYL; HEY1; ROBO1;	GO:0003184~pulmonary valve morphogenesis	7	15	46.6666666666667	0.00018218052196661	0.00287149157618602	1	1	0.479648850181879	0.998790808935051	0.0269478364494843
down	AGPAT2; CD74; AXL; GAS6; TRIM44; AGPAT1;	GO:0001961~positive regulation of cytokine-mediated signaling pathway	6	10	60	0.00019197396684733	0.00296690531480809	1	1	0.486891711283591	0.998790808935051	0.0278432574372193
down	HTATSF1; TSFM; TCEA2; LDB1; CCAR2; SETD5;	GO:0032784~regulation of DNA-templated transcription, elongation	6	10	60	0.00019197396684733	0.00296690531480809	1	1	0.486891711283591	0.998790808935051	0.0278432574372193
down	KAT7; HCFC1; WDR5; KMT2A; MCRS1; KAT8; JADE2; KANSL3;	GO:0043984~histone H4-K16 acetylation	8	21	38.0952380952381	0.00019267348595342	0.00296690531480809	1	1	0.487450276921857	0.998790808935051	0.0278432574372193
down	SH3PXD2B; HGS; CPE; RAB32; AGER; HPS6; TM9SF1; TM9SF4;	GO:0072657~protein localization to membrane	8	21	38.0952380952381	0.00019267348595342	0.00296690531480809	1	1	0.487450276921857	0.998790808935051	0.0278432574372193
down	FANCG; OGG1; LRP5; CCL11; BACE1; SMC1A; PNKP; MECP2; POLH;	GO:0009314~response to radiation	9	28	32.1428571428571	0.0002212861663865	0.0033686912299795	1	1	0.508702335351531	0.998790808935051	0.0316138626584007
down	TFEB; HPS6; PLEKHM2; FLCN; BORCS5; VPS33A; KXD1; RAB34; HDAC6;	GO:0032418~lysosome localization	9	28	32.1428571428571	0.0002212861663865	0.0033686912299795	1	1	0.508702335351531	0.998790808935051	0.0316138626584007
down	CSF1; F2R; ADD1; FLT3LG; RAC3; GIGYF2; ILDR2; P2RX7; SMO;	GO:0048873~homeostasis of number of cells within a tissue	9	28	32.1428571428571	0.0002212861663865	0.0033686912299795	1	1	0.508702335351531	0.998790808935051	0.0316138626584007
down	POLQ; TYMS; LIG1; POLD1; POLG; POLD3; POLM; SMPD3; POLL;	GO:0071897~DNA biosynthetic process	9	28	32.1428571428571	0.0002212861663865	0.0033686912299795	1	1	0.508702335351531	0.998790808935051	0.0316138626584007
down	RAB11FIP3; AP1G2; TSC2; VAMP2; RAB32; RABEP1; ZFYVE27; ARAP3; VPS33A; CPNE1; KXD1; VPS4A; MAPK8IP3; MYO5A; TVP23A; VPS39; ARF3; AP2B1; GDI1; TGFBRAP1; SYT11; AP1B1;	GO:0016192~vesicle-mediated transport	22	141	15.6028368794326	0.00022483512381543	0.00340719531169742	1	1	0.51127786201484	0.998790808935051	0.0319752085545118
down	LDB2; EMP2; LDB1; NLRC5; SLAMF8;	GO:0043549~regulation of kinase activity	5	6	83.3333333333333	0.00023444999224298	0.0035288948156753	1	1	0.517900032864743	0.998790808935051	0.0331173112708761
down	TP53; TSC2; CLEC16A; USP30; RNF41;	GO:1901525~negative regulation of mitophagy	5	6	83.3333333333333	0.00023444999224298	0.0035288948156753	1	1	0.517900032864743	0.998790808935051	0.0331173112708761
down	TLR4; C5; CD74; FGF1; GHR; BMP2; SHC1; MAP2K2; CD81; SHC2; TAB1; MAP3K11; MAPKAPK3; IQGAP3; MAPKAPK5; MADD; P2RX7; TAOK2; NOD1; MAP2K7;	GO:0000187~activation of MAPK activity	20	122	16.3934426229508	0.00023981097381198	0.00360147581569771	1	1	0.521010907237352	0.998790808935051	0.0337984558488942
down	BRCA1; CTCF; GSK3A; MECP2; KCNQ1; KDM1B; PRMT7;	GO:0006349~regulation of gene expression by genetic imprinting	7	16	43.75	0.00024868124978638	0.00364270836167431	1	1	0.526134789453029	0.998790808935051	0.0341854073254676
down	TARBP2; DGCR8; DDX17; KHSRP; XPO5; DROSHA; AGO1;	GO:0010586~miRNA metabolic process	7	16	43.75	0.00024868124978638	0.00364270836167431	1	1	0.526134789453029	0.998790808935051	0.0341854073254676
down	MECP2; EZH2; CARM1; EHMT2; NSD1; EHMT1; PRMT7;	GO:0016571~histone methylation	7	16	43.75	0.00024868124978638	0.00364270836167431	1	1	0.526134789453029	0.998790808935051	0.0341854073254676
down	KAT7; HCFC1; WDR5; MCRS1; KAT8; JADE2; KANSL3;	GO:0043981~histone H4-K5 acetylation	7	16	43.75	0.00024868124978638	0.00364270836167431	1	1	0.526134789453029	0.998790808935051	0.0341854073254676
down	KAT7; HCFC1; WDR5; MCRS1; KAT8; JADE2; KANSL3;	GO:0043982~histone H4-K8 acetylation	7	16	43.75	0.00024868124978638	0.00364270836167431	1	1	0.526134789453029	0.998790808935051	0.0341854073254676
down	DNMT1; BRCA1; WDR5; KMT2A; SNW1; RTF1; DNMT3B;	GO:0051571~positive regulation of histone H3-K4 methylation	7	16	43.75	0.00024868124978638	0.00364270836167431	1	1	0.526134789453029	0.998790808935051	0.0341854073254676
down	CBL; AKT1; NUP62; HAP1; SHKBP1; CNOT9; ARAP1; DOK1;	GO:0045742~positive regulation of epidermal growth factor receptor signaling pathway	8	22	36.3636363636364	0.00024930978963499	0.00364270836167431	1	1	0.526508649262902	0.998790808935051	0.0341854073254676
down	PFKFB1; HK1; KHK; HK3; GALK2; PFKFB4; TKFC; GNPTG;	GO:0046835~carbohydrate phosphorylation	8	22	36.3636363636364	0.00024930978963499	0.00364270836167431	1	1	0.526508649262902	0.998790808935051	0.0341854073254676
down	RPA1; POLD1; RFC4; RFC2; RFC1; RFC5; NPLOC4; POLH;	GO:0070987~error-free translesion synthesis	8	22	36.3636363636364	0.00024930978963499	0.00364270836167431	1	1	0.526508649262902	0.998790808935051	0.0341854073254676
down	KDM1A; FLNA; NES; WNT3A; CDON; DLL4; CTSZ; ADGRG1;	GO:2000179~positive regulation of neural precursor cell proliferation	8	22	36.3636363636364	0.00024930978963499	0.00364270836167431	1	1	0.526508649262902	0.998790808935051	0.0341854073254676
down	HLA-B; HLA-A; HLA-F; IL12RB1; P2RX7; FCGRT; HLA-C; HLA-G; MICA;	GO:0001916~positive regulation of T cell mediated cytotoxicity	9	29	31.0344827586207	0.00027498868768394	0.00394366823989652	1	1	0.541285579108003	0.998790808935051	0.0370097992350414
down	NUPR1; CHEK2; TP53; BCL3; PML; CDKN1A; BAG6; EP300; SNW1;	GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	9	29	31.0344827586207	0.00027498868768394	0.00394366823989652	1	1	0.541285579108003	0.998790808935051	0.0370097992350414
down	KAT7; EGFR; HRAS; TNFAIP1; CTC1; KCTD13; CDT1; BRPF3; FAF1;	GO:0045740~positive regulation of DNA replication	9	29	31.0344827586207	0.00027498868768394	0.00394366823989652	1	1	0.541285579108003	0.998790808935051	0.0370097992350414
down	SRC; EPHB3; WNT4; FUT7; MINK1; CELSR2;	GO:0022407~regulation of cell-cell adhesion	6	11	54.5454545454545	0.00028199896971448	0.00399279473432601	1	1	0.545376722961567	0.998790808935051	0.0374708323608918
down	ZBTB7B; AKAP8; TP53; SREBF1; CTBP1; AKAP8L;	GO:0031065~positive regulation of histone deacetylation	6	11	54.5454545454545	0.00028199896971448	0.00399279473432601	1	1	0.545376722961567	0.998790808935051	0.0374708323608918
down	IL2RB; JAK1; SHC1; STAT5A; STAT5B; JAK3;	GO:0038110~interleukin-2-mediated signaling pathway	6	11	54.5454545454545	0.00028199896971448	0.00399279473432601	1	1	0.545376722961567	0.998790808935051	0.0374708323608918
down	AKT1; MTOR; TSC2; E2F1; TFDP1; BMF;	GO:0043276~anoikis	6	11	54.5454545454545	0.00028199896971448	0.00399279473432601	1	1	0.545376722961567	0.998790808935051	0.0374708323608918
down	PARP1; FUS; WAS; MMS19; WRAP53; TIMELESS;	GO:1905168~positive regulation of double-strand break repair via homologous recombination	6	11	54.5454545454545	0.00028199896971448	0.00399279473432601	1	1	0.545376722961567	0.998790808935051	0.0374708323608918
down	PLA2G6; SMPD2; NSMAF; SPHK2; SIRT3; SMPD3;	GO:2000304~positive regulation of ceramide biosynthetic process	6	11	54.5454545454545	0.00028199896971448	0.00399279473432601	1	1	0.545376722961567	0.998790808935051	0.0374708323608918
down	RBMX; BACE1; DAG1; SPPL3; SPPL2B; NCSTN; APH1A; P2RX7;	GO:0006509~membrane protein ectodomain proteolysis	8	23	34.7826086956522	0.00031886818654369	0.00443957518889902	1	1	0.566354173715103	0.998790808935051	0.0416636939100979
down	SNRNP70; RBMX; SNW1; PRPF19; THRAP3; NCL; SF3B4; DAZAP1;	GO:0048026~positive regulation of mRNA splicing, via spliceosome	8	23	34.7826086956522	0.00031886818654369	0.00443957518889902	1	1	0.566354173715103	0.998790808935051	0.0416636939100979
down	B3GAT3; OAZ2; PCNT; TPR; VAMP2; PRR5L; CEP131; ICE1;	GO:0090316~positive regulation of intracellular protein transport	8	23	34.7826086956522	0.00031886818654369	0.00443957518889902	1	1	0.566354173715103	0.998790808935051	0.0416636939100979
up	PI3; WFDC12; SERPINB7; SERPINB2;	GO:0010951~negative regulation of endopeptidase activity	4	148	2.7027027027027	0.00032536272796179	0.00845943092700674	0.0816660447184112	0.0845943092700674	0.0816660447184112	0.0816660447184112	0.0519393759199928
down	MEPCE; METTL3; FTSJ3; TRMT2A; RBM15B; NSUN2; NSUN4;	GO:0001510~RNA methylation	7	17	41.1764705882353	0.00033339664098874	0.00458454681425474	1	1	0.573108825859658	0.998790808935051	0.0430241964734002
down	CYTH3; IQSEC2; IQSEC1; GBF1; CYTH2; CYTH4; ARFGAP1;	GO:0032012~regulation of ARF protein signal transduction	7	17	41.1764705882353	0.00033339664098874	0.00458454681425474	1	1	0.573108825859658	0.998790808935051	0.0430241964734002
down	TAL1; KDR; FLT3LG; KMT2A; MED1; ZFPM1; CCDC134;	GO:0035162~embryonic hemopoiesis	7	17	41.1764705882353	0.00033339664098874	0.00458454681425474	1	1	0.573108825859658	0.998790808935051	0.0430241964734002
down	TRIM28; SETDB1; APOBEC3F; MPHOSPH8; INPP5K; MORC2; APOBEC3C;	GO:0045869~negative regulation of single stranded viral RNA replication via double stranded DNA intermediate	7	17	41.1764705882353	0.00033339664098874	0.00458454681425474	1	1	0.573108825859658	0.998790808935051	0.0430241964734002
down	GSK3B; TRIM29; FLCN; SIN3A; LZTS2; TMEM98; MAGED1;	GO:1900181~negative regulation of protein localization to nucleus	7	17	41.1764705882353	0.00033339664098874	0.00458454681425474	1	1	0.573108825859658	0.998790808935051	0.0430241964734002
down	AXIN1; APP; CALM3; BMP7; GSK3A; STOX1; RPTOR; CEMIP; TNKS1BP1;	GO:0010800~positive regulation of peptidyl-threonine phosphorylation	9	30	30	0.00033903912207311	0.00464302961642341	1	1	0.575688429280149	0.998790808935051	0.043573034924127
down	UBA7; IRF3; PCBP2; MAVS; NLRC5; NPLOC4; OTUD5; GPATCH3; RNF216;	GO:0032480~negative regulation of type I interferon production	9	30	30	0.00033903912207311	0.00464302961642341	1	1	0.575688429280149	0.998790808935051	0.043573034924127
down	TP53; RBBP4; CHAF1A; CHAF1B; CDAN1;	GO:0031497~chromatin assembly	5	7	71.4285714285714	0.00038251726091909	0.00516436940347936	1	1	0.594814340729186	0.998790808935051	0.0484656069353787
down	MTOR; LARP1; RPTOR; CARD11; NPRL3;	GO:0038202~TORC1 signaling	5	7	71.4285714285714	0.00038251726091909	0.00516436940347936	1	1	0.594814340729186	0.998790808935051	0.0484656069353787
down	SREBF1; ACLY; GPAT4; ACSS2; PRPF19; DOLPP1;	GO:0008610~lipid biosynthetic process	6	12	50	0.00040208242414996	0.00533808181311569	1	1	0.601973629418117	0.998790808935051	0.0500958306292066
down	TULP3; ALDH1A2; RARG; NES; PPP1R13L; IFT140;	GO:0031076~embryonic camera-type eye development	6	12	50	0.00040208242414996	0.00533808181311569	1	1	0.601973629418117	0.998790808935051	0.0500958306292066
down	LAMC1; ITGA6; LAMB3; LAMC2; COL17A1; DST;	GO:0031581~hemidesmosome assembly	6	12	50	0.00040208242414996	0.00533808181311569	1	1	0.601973629418117	0.998790808935051	0.0500958306292066
down	ERBB2; UBTF; ATF4; TAF1; DHX33; PHF8;	GO:0045943~positive regulation of transcription by RNA polymerase I	6	12	50	0.00040208242414996	0.00533808181311569	1	1	0.601973629418117	0.998790808935051	0.0500958306292066
down	NRP1; SEMA3F; PLXNB1; PLXNA1; PLXNA3; PLXND1;	GO:1902287~semaphorin-plexin signaling pathway involved in axon guidance	6	12	50	0.00040208242414996	0.00533808181311569	1	1	0.601973629418117	0.998790808935051	0.0500958306292066
down	HAX1; HCLS1; ARHGAP18; PREX1; GBA2; COTL1; FCHSD1; CTTN;	GO:0030833~regulation of actin filament polymerization	8	24	33.3333333333333	0.00040346633178367	0.00533808181311569	1	1	0.602497070485346	0.998790808935051	0.0500958306292066
down	CCDC88B; HRAS; BCL3; CD40; BATF2; TSPAN32; GBP2; GBP4;	GO:0042832~defense response to protozoan	8	24	33.3333333333333	0.00040346633178367	0.00533808181311569	1	1	0.602497070485346	0.998790808935051	0.0500958306292066
down	TLR4; SMAD6; LTA; THBD; CNP; IDO1; ATP2A2; PLCG2; FGFR2; F2R; CD6; PTGIR; TIRAP; ABR; IL10RA; MAPKAPK3; OTUD5; P2RX7; IL12RB2; NOCT; GGT5;	GO:0032496~response to lipopolysaccharide	21	138	15.2173913043478	0.00041488143083823	0.0054157431437623	1	1	0.606683285644591	0.998790808935051	0.0508246521427608
down	ABL1; EGFR; IGF1R; KDR; DDR1; SRC; LCK; TNK1; TNK2;	GO:0038083~peptidyl-tyrosine autophosphorylation	9	31	29.0322580645161	0.00041491253772352	0.0054157431437623	1	1	0.606683285644591	0.998790808935051	0.0508246521427608
down	NRP1; TNFSF12; ABL1; PECAM1; STAT1; PXN; PRKX; CDH13; PLXND1;	GO:0043542~endothelial cell migration	9	31	29.0322580645161	0.00041491253772352	0.0054157431437623	1	1	0.606683285644591	0.998790808935051	0.0508246521427608
down	ABL1; APP; TAL1; CDC25B; STAT5B; HSF1; EIF4EBP1; USP22; CDC25C;	GO:0045931~positive regulation of mitotic cell cycle	9	31	29.0322580645161	0.00041491253772352	0.0054157431437623	1	1	0.606683285644591	0.998790808935051	0.0508246521427608
down	BMP2; ENG; ACVRL1; ACVR1; TBX2; HEYL; HEY1;	GO:0003203~endocardial cushion morphogenesis	7	18	38.8888888888889	0.00043975157586806	0.00566254293164985	1	1	0.615366461547632	0.998790808935051	0.0531407725781878
down	TAF4; TCF4; TAF1; TAF6; NCOA6; TAF5; BRF1;	GO:0006352~DNA-templated transcription, initiation	7	18	38.8888888888889	0.00043975157586806	0.00566254293164985	1	1	0.615366461547632	0.998790808935051	0.0531407725781878
down	BRD4; GTF2F1; SUPT6H; RTF1; CDK9; SUPT16H; CDK12;	GO:0032968~positive regulation of transcription elongation from RNA polymerase II promoter	7	18	38.8888888888889	0.00043975157586806	0.00566254293164985	1	1	0.615366461547632	0.998790808935051	0.0531407725781878
down	ATF4; FLNA; ARNT; SOX18; SREBF1; MED1; SUPT6H;	GO:0042789~mRNA transcription by RNA polymerase II	7	18	38.8888888888889	0.00043975157586806	0.00566254293164985	1	1	0.615366461547632	0.998790808935051	0.0531407725781878
down	ARHGAP6; APOD; SRC; ACVRL1; MMP14; LRP1; DLC1;	GO:0051895~negative regulation of focal adhesion assembly	7	18	38.8888888888889	0.00043975157586806	0.00566254293164985	1	1	0.615366461547632	0.998790808935051	0.0531407725781878
down	LRP6; DAG1; NFE2L1; AACS; GRAMD1A; SMO; OSBPL7;	GO:0071397~cellular response to cholesterol	7	18	38.8888888888889	0.00043975157586806	0.00566254293164985	1	1	0.615366461547632	0.998790808935051	0.0531407725781878
down	FKBP9; GNAO1; PRKCSH; GNB3; GNAZ; CSNK2A2; GNG2; GNB1; PPIL2; MOGS; PDIA5; GANAB; FUT10; LTBP4; DNAJC7; TBCD; ALG12; LMAN2L; SIL1; TRAP1; QSOX2; P4HB;	GO:0006457~protein folding	22	150	14.6666666666667	0.00048053972210782	0.00608228591448212	1	1	0.627528291417012	0.998790808935051	0.0570798979254426
down	WNT10B; TPP1; APOD; G6PD; PC; CD36; SREBF1; PLTP; LRP1; SREBF2; STARD3; BTN2A1; PTPRN2; CPNE1; APOL2; RUBCNL; GDPD2; PLAGL2; NR1H2; NR1I3;	GO:0006629~lipid metabolic process	20	130	15.3846153846154	0.00049688791509217	0.00627731935077689	1	1	0.632353440150614	0.998790808935051	0.0589102111978336
down	MYO18A; CDC42BPB; EPB41L5; EPB41L2; CIT; ROCK1; EPB41L1; FRMD3; CDC42BPG;	GO:0031032~actomyosin structure organization	9	32	28.125	0.00050421509050113	0.00631358197647423	1	1	0.6345004839045	0.998790808935051	0.0592505218972015
down	RAB11FIP3; TULP3; ARL3; CSNK1D; TTC21B; DZIP1L; IFT140; IFT122; SNX10;	GO:0061512~protein localization to cilium	9	32	28.125	0.00050421509050113	0.00631358197647423	1	1	0.6345004839045	0.998790808935051	0.0592505218972015
down	EGFR; CCND2; AKT1; HYAL1; TFDP1; MEPCE; RPTOR; ADAMTS1; CDC45;	GO:1900087~positive regulation of G1/S transition of mitotic cell cycle	9	32	28.125	0.00050421509050113	0.00631358197647423	1	1	0.6345004839045	0.998790808935051	0.0592505218972015
down	PRPF4; PRPF3; PRPF6; SF3B3; SF3B4; PRPF8; KHSRP; DDX23;	GO:0000375~RNA splicing, via transesterification reactions	8	25	32	0.00050542665829922	0.00631358197647423	1	1	0.634815882823825	0.998790808935051	0.0592505218972015
down	AGRN; SDC3; GPC4; GNS; GPC1; SGSH; NAGLU; HGSNAT;	GO:0006027~glycosaminoglycan catabolic process	8	25	32	0.00050542665829922	0.00631358197647423	1	1	0.634815882823825	0.998790808935051	0.0592505218972015
down	PARP1; ZC3HAV1; SIRT2; PARP16; SIRT3; PARP2; PARP3; PARP6;	GO:0006471~protein ADP-ribosylation	8	25	32	0.00050542665829922	0.00631358197647423	1	1	0.634815882823825	0.998790808935051	0.0592505218972015
down	NBAS; EXOSC10; DHX34; UPF1; AGO1; THRAP3;	GO:0000956~nuclear-transcribed mRNA catabolic process	6	13	46.1538461538462	0.00055863645721632	0.00683766931057999	1	1	0.650710028189927	0.998790808935051	0.0641688785735205
down	SLC9A3R1; SYNE2; FHOD1; DYNC1H1; SYNE3; CLMN;	GO:0007097~nuclear migration	6	13	46.1538461538462	0.00055863645721632	0.00683766931057999	1	1	0.650710028189927	0.998790808935051	0.0641688785735205
down	ATXN7L3; KAT2A; USP36; USP21; USP22; TRRAP;	GO:0016578~histone deubiquitination	6	13	46.1538461538462	0.00055863645721632	0.00683766931057999	1	1	0.650710028189927	0.998790808935051	0.0641688785735205
down	WNT10B; ARAF; RAD23A; GNA12; FOXF2; UBQLN4;	GO:0032434~regulation of proteasomal ubiquitin-dependent protein catabolic process	6	13	46.1538461538462	0.00055863645721632	0.00683766931057999	1	1	0.650710028189927	0.998790808935051	0.0641688785735205
down	CDK11B; SUPT6H; IWS1; SAFB; SLTM; SAFB2;	GO:0050684~regulation of mRNA processing	6	13	46.1538461538462	0.00055863645721632	0.00683766931057999	1	1	0.650710028189927	0.998790808935051	0.0641688785735205
down	MICALL1; SNX33; EHD2; BIN2; PACSIN3; BIN3;	GO:0097320~plasma membrane tubulation	6	13	46.1538461538462	0.00055863645721632	0.00683766931057999	1	1	0.650710028189927	0.998790808935051	0.0641688785735205
down	LPXN; PXN; PTPN14; TCERG1L; SND1; SGF29;	GO:1903506~regulation of nucleic acid-templated transcription	6	13	46.1538461538462	0.00055863645721632	0.00683766931057999	1	1	0.650710028189927	0.998790808935051	0.0641688785735205
down	MYH3; MYO9B; MYO5A; WASF2; WAS; WIPF2; WIPF3;	GO:0030048~actin filament-based movement	7	19	36.8421052631579	0.000571516623598	0.00691928549910405	1	1	0.654422506580637	0.998790808935051	0.064934814896725
down	LCAT; CETP; CD36; CAV1; STARD3; LDLRAP1; OSBPL5;	GO:0030301~cholesterol transport	7	19	36.8421052631579	0.000571516623598	0.00691928549910405	1	1	0.654422506580637	0.998790808935051	0.064934814896725
down	NFKB1; RELA; MBTPS1; SPPL2B; RHBDD1; NCSTN; APH1A;	GO:0031293~membrane protein intracellular domain proteolysis	7	19	36.8421052631579	0.000571516623598	0.00691928549910405	1	1	0.654422506580637	0.998790808935051	0.064934814896725
down	SLC9A3R1; RAC2; SMG8; TSC1; CAMKK2; FAF1; ANKRD54;	GO:0045859~regulation of protein kinase activity	7	19	36.8421052631579	0.000571516623598	0.00691928549910405	1	1	0.654422506580637	0.998790808935051	0.064934814896725
down	MTHFD1; FOLR2; SHMT2; SLC19A1; MTHFR; FPGS; MTHFD1L;	GO:0046655~folic acid metabolic process	7	19	36.8421052631579	0.000571516623598	0.00691928549910405	1	1	0.654422506580637	0.998790808935051	0.064934814896725
down	TLR4; KPNA6; CD6; IL17RC; IL17RA; GBP5; GPSM3;	GO:1900017~positive regulation of cytokine production involved in inflammatory response	7	19	36.8421052631579	0.000571516623598	0.00691928549910405	1	1	0.654422506580637	0.998790808935051	0.064934814896725
down	SLC9A3R1; HGS; APOD; PTGIR; PTPRJ;	GO:0010642~negative regulation of platelet-derived growth factor receptor signaling pathway	5	8	62.5	0.00059163824105956	0.00707319922182663	1	1	0.660420613515872	0.998790808935051	0.0663792355809633
down	DNMT1; KCNQ1; SCMH1; KMT2B; SRCAP;	GO:0016458~gene silencing	5	8	62.5	0.00059163824105956	0.00707319922182663	1	1	0.660420613515872	0.998790808935051	0.0663792355809633
down	TGFBRAP1; VPS39; VPS11; ANKFY1; VPS4A;	GO:0034058~endosomal vesicle fusion	5	8	62.5	0.00059163824105956	0.00707319922182663	1	1	0.660420613515872	0.998790808935051	0.0663792355809633
down	HDAC4; SIRT2; HDAC10; SIRT3; HDAC6;	GO:0034983~peptidyl-lysine deacetylation	5	8	62.5	0.00059163824105956	0.00707319922182663	1	1	0.660420613515872	0.998790808935051	0.0663792355809633
down	TPR; IFI27; PTPN14; SIRT7; XPO5;	GO:0046825~regulation of protein export from nucleus	5	8	62.5	0.00059163824105956	0.00707319922182663	1	1	0.660420613515872	0.998790808935051	0.0663792355809633
down	ATF4; CBL; CACNB3; AQP3; TSC1;	GO:0090650~cellular response to oxygen-glucose deprivation	5	8	62.5	0.00059163824105956	0.00707319922182663	1	1	0.660420613515872	0.998790808935051	0.0663792355809633
down	DVL2; DLG4; DVL3; FZD4; GRIP1;	GO:0150012~positive regulation of neuron projection arborization	5	8	62.5	0.00059163824105956	0.00707319922182663	1	1	0.660420613515872	0.998790808935051	0.0663792355809633
down	NUDT2; FPGS; SLC29A2; DPYSL2; DDX12P; SLC23A2; SLC23A1; POLR3H; OAS3;	GO:0006139~nucleobase-containing compound metabolic process	9	33	27.2727272727273	0.00060868653436874	0.00725107327840694	1	1	0.665488109475909	0.998790808935051	0.0680485147197513
down	EFNA3; ROCK1; CDK5RAP3; CDK5RAP2; CDK5RAP1; BCL11B; S1PR5; ZFHX3;	GO:0045664~regulation of neuron differentiation	8	26	30.7692307692308	0.00062727841567	0.00744600648654113	1	1	0.668536883605356	0.998790808935051	0.0698778873896689
down	MFN2; NUP62; TNK1; RAPGEF1; DAB2IP; RASAL3; SYNGAP1; MAPKAP1;	GO:0046580~negative regulation of Ras protein signal transduction	8	26	30.7692307692308	0.00062727841567	0.00744600648654113	1	1	0.668536883605356	0.998790808935051	0.0698778873896689
down	CSF1R; CSF1; MST1R; DOK1;	GO:0038145~macrophage colony-stimulating factor signaling pathway	4	4	100	0.00067668711594559	0.00794780315617648	1	1	0.676245637506169	0.998790808935051	0.0745870548120542
down	POLA1; MCM3; MCM4; MCM2;	GO:1902975~mitotic DNA replication initiation	4	4	100	0.00067668711594559	0.00794780315617648	1	1	0.676245637506169	0.998790808935051	0.0745870548120542
down	BMP4; ENG; CDH5; ACVRL1; NOTCH2; NUMA1; NEO1; UBE2O; RNF165;	GO:0030513~positive regulation of BMP signaling pathway	9	34	26.4705882352941	0.00073020194467576	0.00845824961192384	1	1	0.684674030637392	0.998790808935051	0.0793773971274474
down	FOXP2; HS6ST1; ATXN1L; BMP4; FGFR2; FLT4; FOXF1; CIC; SMPD3;	GO:0048286~lung alveolus development	9	34	26.4705882352941	0.00073020194467576	0.00845824961192384	1	1	0.684674030637392	0.998790808935051	0.0793773971274474
down	APAF1; TNFRSF10B; TP53; ATF4; PML; BAG6; DAB2IP; ATP2A3; BBC3;	GO:0070059~intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress	9	34	26.4705882352941	0.00073020194467576	0.00845824961192384	1	1	0.684674030637392	0.998790808935051	0.0793773971274474
down	EGFR; TFEB; ARNT; HSF1; BPTF; PKD2; MED1;	GO:0001892~embryonic placenta development	7	20	35	0.0007328036099512	0.00845824961192384	1	1	0.685115928933869	0.998790808935051	0.0793773971274474
down	F2RL1; GPS2; GAS6; PELI3; PIAS4; TRAIP; CARD8;	GO:0010804~negative regulation of tumor necrosis factor-mediated signaling pathway	7	20	35	0.0007328036099512	0.00845824961192384	1	1	0.685115928933869	0.998790808935051	0.0793773971274474
down	RPS6KA4; RELN; ADCY1; CRTC2; TSSK4; PRKD2; LPAR5;	GO:0032793~positive regulation of CREB transcription factor activity	7	20	35	0.0007328036099512	0.00845824961192384	1	1	0.685115928933869	0.998790808935051	0.0793773971274474
down	SIPA1L1; EFNA1; GSK3B; EPHB3; MARK2; ARHGAP35; UST;	GO:0050770~regulation of axonogenesis	7	20	35	0.0007328036099512	0.00845824961192384	1	1	0.685115928933869	0.998790808935051	0.0793773971274474
down	KMT2D; SETD1A; TET3; KMT2A; RTF1; ZNF335; KMT2B;	GO:0080182~histone H3-K4 trimethylation	7	20	35	0.0007328036099512	0.00845824961192384	1	1	0.685115928933869	0.998790808935051	0.0793773971274474
down	CHEK2; TP53; BRCA1; CDKN1A; FOXM1; KAT5;	GO:0006978~DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator	6	14	42.8571428571429	0.00075868774036136	0.00863766638643099	1	1	0.68909340535597	0.998790808935051	0.0810611540765569
down	SLC9A3R1; TSC2; DAB2IP; NLRC3; BTN2A2; INPP5E;	GO:0014067~negative regulation of phosphatidylinositol 3-kinase signaling	6	14	42.8571428571429	0.00075868774036136	0.00863766638643099	1	1	0.68909340535597	0.998790808935051	0.0810611540765569
down	CTCF; HDAC4; MTA1; TFAP2C; ZNF335; HDAC6;	GO:0040029~regulation of gene expression, epigenetic	6	14	42.8571428571429	0.00075868774036136	0.00863766638643099	1	1	0.68909340535597	0.998790808935051	0.0810611540765569
down	GHR; PTPN1; STAT5A; STAT5B; JAK3; STAT6;	GO:0060397~growth hormone receptor signaling pathway via JAK-STAT	6	14	42.8571428571429	0.00075868774036136	0.00863766638643099	1	1	0.68909340535597	0.998790808935051	0.0810611540765569
down	DLL1; NOTCH2; PKD1L1; SMO; EPB41L5; IFT172;	GO:0070986~left/right axis specification	6	14	42.8571428571429	0.00075868774036136	0.00863766638643099	1	1	0.68909340535597	0.998790808935051	0.0810611540765569
down	PIK3CD; CD4; NFATC2IP; KAT2A; FOXP3; NFATC2; NFATC4; NFATC3;	GO:0001816~cytokine production	8	27	29.6296296296296	0.00077175801176832	0.00874179456380963	1	1	0.691187097275047	0.998790808935051	0.082038356697332
down	NRP1; AKT1; FLT4; KDR; RELA; DAB2IP; PRKD2; DLL4;	GO:0035924~cellular response to vascular endothelial growth factor stimulus	8	27	29.6296296296296	0.00077175801176832	0.00874179456380963	1	1	0.691187097275047	0.998790808935051	0.082038356697332
down	SKI; CD34; MMP14; DST; ENPP2; CTTN; IGSF8; PLD2;	GO:0048870~cell motility	8	27	29.6296296296296	0.00077175801176832	0.00874179456380963	1	1	0.691187097275047	0.998790808935051	0.082038356697332
down	NUPR1; LRP6; CDK4; TRIM21; FGFR2; FLT3LG; HCFC1; RAD23A; C6orf89;	GO:0045787~positive regulation of cell cycle	9	35	25.7142857142857	0.00087077262203949	0.00969309993297407	1	1	0.706719021073546	0.998790808935051	0.090965989191316
down	HLA-B; HLA-A; HLA-C; HLA-G; HLA-F;	GO:0002480~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent	5	9	55.5555555555556	0.00087604853501666	0.00969309993297407	1	1	0.707558615228113	0.998790808935051	0.090965989191316
down	ENG; GRHL2; HEYL; DLL4; HEY1;	GO:0003208~cardiac ventricle morphogenesis	5	9	55.5555555555556	0.00087604853501666	0.00969309993297407	1	1	0.707558615228113	0.998790808935051	0.090965989191316
down	VWF; GPI; FLI1; ZNF385A; HPS4;	GO:0007599~hemostasis	5	9	55.5555555555556	0.00087604853501666	0.00969309993297407	1	1	0.707558615228113	0.998790808935051	0.090965989191316
down	JAK1; STAT1; STAT5A; STAT5B; JAK3;	GO:0038113~interleukin-9-mediated signaling pathway	5	9	55.5555555555556	0.00087604853501666	0.00969309993297407	1	1	0.707558615228113	0.998790808935051	0.090965989191316
down	TLR4; IL18BP; HRAS; HLA-DRB1; BCL3;	GO:0042088~T-helper 1 type immune response	5	9	55.5555555555556	0.00087604853501666	0.00969309993297407	1	1	0.707558615228113	0.998790808935051	0.090965989191316
down	TLR4; CD36; F2RL1; GBP5; NLRC4;	GO:0050702~interleukin-1 beta secretion	5	9	55.5555555555556	0.00087604853501666	0.00969309993297407	1	1	0.707558615228113	0.998790808935051	0.090965989191316
down	GP1BA; PLEK; F2R; DGKQ; F2RL1;	GO:0070493~thrombin-activated receptor signaling pathway	5	9	55.5555555555556	0.00087604853501666	0.00969309993297407	1	1	0.707558615228113	0.998790808935051	0.090965989191316
down	FOXN3; MMP14; FREM1; TIFAB; MEGF8;	GO:0097094~craniofacial suture morphogenesis	5	9	55.5555555555556	0.00087604853501666	0.00969309993297407	1	1	0.707558615228113	0.998790808935051	0.090965989191316
down	TLR4; CD36; ATAT1; GBP5; DHX33;	GO:1900227~positive regulation of NLRP3 inflammasome complex assembly	5	9	55.5555555555556	0.00087604853501666	0.00969309993297407	1	1	0.707558615228113	0.998790808935051	0.090965989191316
down	NRP1; AKT1; KDR; MIA3; CLEC14A; MMRN2; ROBO1;	GO:0002042~cell migration involved in sprouting angiogenesis	7	21	33.3333333333333	0.00092805724575884	0.0100685171646207	1	1	0.715606432368235	0.998790808935051	0.0944891345289623
down	CSNK1D; COG7; ARFRP1; PACS1; BICD2; GBF1; GBP5;	GO:0034067~protein localization to Golgi apparatus	7	21	33.3333333333333	0.00092805724575884	0.0100685171646207	1	1	0.715606432368235	0.998790808935051	0.0944891345289623
down	ARID1A; KDM6B; BMP2; BMP4; SLC9A1; AKAP13; TSC1;	GO:0055007~cardiac muscle cell differentiation	7	21	33.3333333333333	0.00092805724575884	0.0100685171646207	1	1	0.715606432368235	0.998790808935051	0.0944891345289623
down	SMAD6; BMP4; EFNA1; ROCK1; ROBO2; HEYL; DLL4; ROBO1;	GO:0003180~aortic valve morphogenesis	8	28	28.5714285714286	0.00094180763818485	0.0101681751954594	1	1	0.717767789199184	0.998790808935051	0.0954243865555372
down	FOXN1; TNFSF14; STAT5B; JAK3; TCIRG1; P2RX7; FOXP3; RIPK3;	GO:0043029~T cell homeostasis	8	28	28.5714285714286	0.00094180763818485	0.0101681751954594	1	1	0.717767789199184	0.998790808935051	0.0954243865555372
down	NUPR1; LTA; TP53; SKI; EMD; DAB2IP; NLRC3; DACH1;	GO:0048147~negative regulation of fibroblast proliferation	8	28	28.5714285714286	0.00094180763818485	0.0101681751954594	1	1	0.717767789199184	0.998790808935051	0.0954243865555372
down	RAD51; MCM7; MCM2; RPA1; MCM4; MCM6;	GO:0006268~DNA unwinding involved in DNA replication	6	15	40	0.00100983657955833	0.0106953056437216	1	1	0.727965809540014	0.998790808935051	0.10037130167976
down	NUPR1; NAA10; EP300; ING5; CREBBP; KAT6A;	GO:0006473~protein acetylation	6	15	40	0.00100983657955833	0.0106953056437216	1	1	0.727965809540014	0.998790808935051	0.10037130167976
down	ADCY6; ARRB2; GSK3A; GSK3B; NCSTN; GNAO1;	GO:0007212~dopamine receptor signaling pathway	6	15	40	0.00100983657955833	0.0106953056437216	1	1	0.727965809540014	0.998790808935051	0.10037130167976
down	TLR4; DLL1; LAMB2; ROR1; EIF2B5; LAMC3;	GO:0014002~astrocyte development	6	15	40	0.00100983657955833	0.0106953056437216	1	1	0.727965809540014	0.998790808935051	0.10037130167976
down	KDM1A; PHF2; KDM4A; PHF8; HR; KDM3B;	GO:0033169~histone H3-K9 demethylation	6	15	40	0.00100983657955833	0.0106953056437216	1	1	0.727965809540014	0.998790808935051	0.10037130167976
down	PPP1R11; LRRC32; BTN2A2; SYT11; FOXP3; TNFRSF4;	GO:0050710~negative regulation of cytokine secretion	6	15	40	0.00100983657955833	0.0106953056437216	1	1	0.727965809540014	0.998790808935051	0.10037130167976
down	KCNN4; LCK; CD81; RELA; CARD11; PRKD2;	GO:0050862~positive regulation of T cell receptor signaling pathway	6	15	40	0.00100983657955833	0.0106953056437216	1	1	0.727965809540014	0.998790808935051	0.10037130167976
down	SLC9A1; WAS; ROCK1; ALMS1; TSC1; FHOD1;	GO:0051492~regulation of stress fiber assembly	6	15	40	0.00100983657955833	0.0106953056437216	1	1	0.727965809540014	0.998790808935051	0.10037130167976
down	ROCK1; GIGYF2; METTL3; METTL16; MEX3D; FTO;	GO:0061157~mRNA destabilization	6	15	40	0.00100983657955833	0.0106953056437216	1	1	0.727965809540014	0.998790808935051	0.10037130167976
down	ATP2B4; MTOR; GSK3B; MAPK7; FHL2; TBC1D10C;	GO:0070885~negative regulation of calcineurin-NFAT signaling cascade	6	15	40	0.00100983657955833	0.0106953056437216	1	1	0.727965809540014	0.998790808935051	0.10037130167976
down	PDGFRB; SRC; FGFR4; ARRB2; DDX39B; PRKD2;	GO:2000573~positive regulation of DNA biosynthetic process	6	15	40	0.00100983657955833	0.0106953056437216	1	1	0.727965809540014	0.998790808935051	0.10037130167976
down	ARHGAP1; TCIRG1; ATP6AP1; RAB11B; STEAP3; ATP6V0E2; ATP6V0A1; ATP6V1E2; TFR2;	GO:0033572~transferrin transport	9	36	25	0.00103254615262038	0.0108858670404464	1	1	0.730328417021739	0.998790808935051	0.102159646592596
down	GDI1; LIMK1; ZFYVE27; ADNP; ANAPC2; MACF1; TRPV2; HCLS1; CTTN;	GO:0045773~positive regulation of axon extension	9	36	25	0.00103254615262038	0.0108858670404464	1	1	0.730328417021739	0.998790808935051	0.102159646592596
down	MAP2K7; IKBKB; PSMD3; LAT; GRAP2; PLCG2; PLCG1; NFKB1; PSMB9; SHC1; PSMB10; PSMD4; GRB2; RELA; NFATC3; PSMD2; NFATC2; CUL1; PSME4; TAB1; PSMF1; CARD11; BTRC;	GO:0038095~Fc-epsilon receptor signaling pathway	23	171	13.4502923976608	0.00104994238061362	0.0109980641530421	1	1	0.732216654813522	0.998790808935051	0.103212573045666
down	TLR4; HLA-DRB1; AXL; GAS6; LILRB1; PDCD1LG2; FOXP3; CD274;	GO:0032689~negative regulation of interferon-gamma production	8	29	27.5862068965517	0.00114057218203845	0.0118360930008741	1	1	0.7420229726272	0.998790808935051	0.11107714925359
down	TP53; GLI3; ZFP36L2; STAT5B; FZD5; NCAPH2; BCL11B; RIPK3;	GO:0033077~T cell differentiation in thymus	8	29	27.5862068965517	0.00114057218203845	0.0118360930008741	1	1	0.7420229726272	0.998790808935051	0.11107714925359
down	CXCL11; ABL1; CXCL10; PLCG1; F2R; CX3CL1; CXCL9; CEMIP;	GO:0051281~positive regulation of release of sequestered calcium ion into cytosol	8	29	27.5862068965517	0.00114057218203845	0.0118360930008741	1	1	0.7420229726272	0.998790808935051	0.11107714925359
down	APP; ROBO3; ROBO2; ROBO1;	GO:0016199~axon midline choice point recognition	4	5	80	0.00116155158162345	0.0118835539265063	1	1	0.744332552089126	0.998790808935051	0.111522551661274
down	PHGDH; GHR; STAT5A; STAT5B;	GO:0019530~taurine metabolic process	4	5	80	0.00116155158162345	0.0118835539265063	1	1	0.744332552089126	0.998790808935051	0.111522551661274
down	ACACB; ACLY; ACACA; AGPAT1;	GO:0031325~positive regulation of cellular metabolic process	4	5	80	0.00116155158162345	0.0118835539265063	1	1	0.744332552089126	0.998790808935051	0.111522551661274
down	DYNC1H1; NUMA1; SPAG5; CAPN10;	GO:0032388~positive regulation of intracellular transport	4	5	80	0.00116155158162345	0.0118835539265063	1	1	0.744332552089126	0.998790808935051	0.111522551661274
down	ADAR; TCIRG1; UBAP2L; NLE1;	GO:0061484~hematopoietic stem cell homeostasis	4	5	80	0.00116155158162345	0.0118835539265063	1	1	0.744332552089126	0.998790808935051	0.111522551661274
down	CDK4; ADAM15; MAP4K1; SPHK2;	GO:1904628~cellular response to phorbol 13-acetate 12-myristate	4	5	80	0.00116155158162345	0.0118835539265063	1	1	0.744332552089126	0.998790808935051	0.111522551661274
down	SLC9A3R1; RARG; MSN; MTOR; IQGAP3; RPTOR; WDTC1;	GO:0008361~regulation of cell size	7	22	31.8181818181818	0.00116204298751721	0.0118835539265063	1	1	0.744332552089126	0.998790808935051	0.111522551661274
down	ITGA3; TNFAIP1; FLCN; KCTD13; DLC1; ARHGAP35; KCTD10;	GO:0035024~negative regulation of Rho protein signal transduction	7	22	31.8181818181818	0.00116204298751721	0.0118835539265063	1	1	0.744332552089126	0.998790808935051	0.111522551661274
down	TP53; TFAP2A; G6PD; BRCA1; SIRT2; SIRT3; AATF;	GO:2000378~negative regulation of reactive oxygen species metabolic process	7	22	31.8181818181818	0.00116204298751721	0.0118835539265063	1	1	0.744332552089126	0.998790808935051	0.111522551661274
down	ANO9; CLIC1; CLCN6; ANO6; SLC26A6; TTYH3; SLC26A1; CLIC5; CLCN2;	GO:0006821~chloride transport	9	37	24.3243243243243	0.00121780560860762	0.0123853543063045	1	1	0.750245801509129	0.998790808935051	0.116231753902101
down	TRAV19; TRAV17; TRGV4; PIK3CD; BTN3A1; LAT; LILRB5; CD4; HLA-B; CD3D; HLA-DOA; CD3E; CD7; CD3G; HLA-C; TFEB; CTSS; HLA-DMA; CD6; CD86; JAK3; TAP1; HLA-DRB5; LAIR1; SKAP1; LILRB1; TRPM4; TSC1; ORAI1; OTUB1; SIGLEC10; TNFRSF13C; PDCD1LG2; PRKD2; CD244; CD274; EIF2AK4; LAMP3;	GO:0002250~adaptive immune response	38	347	10.9510086455331	0.00125000083632543	0.0123853543063045	1	1	0.753719605890579	0.998790808935051	0.116231753902101
down	CDC45; CDC6; CDT1; RAD9A; TIMELESS;	GO:0000076~DNA replication checkpoint	5	10	50	0.00125095229040184	0.0123853543063045	1	1	0.753719605890579	0.998790808935051	0.116231753902101
down	"NASP; RBBP4; CHAF1A; CHAF1B; ASF1B;"	GO:0006335~DNA replication-dependent nucleosome assembly	5	10	50	0.00125095229040184	0.0123853543063045	1	1	0.753719605890579	0.998790808935051	0.116231753902101
down	ACOT7; COASY; PPCDC; DCAKD; PANK4;	GO:0015937~coenzyme A biosynthetic process	5	10	50	0.00125095229040184	0.0123853543063045	1	1	0.753719605890579	0.998790808935051	0.116231753902101
down	AP2A2; AP2A1; AP2B1; PCSK9; AP2M1;	GO:0032802~low-density lipoprotein particle receptor catabolic process	5	10	50	0.00125095229040184	0.0123853543063045	1	1	0.753719605890579	0.998790808935051	0.116231753902101
down	CDH13; RHBDF1; MVB12B; WDR54; RHBDF2;	GO:0042058~regulation of epidermal growth factor receptor signaling pathway	5	10	50	0.00125095229040184	0.0123853543063045	1	1	0.753719605890579	0.998790808935051	0.116231753902101
down	TAL1; STAT5B; LDB1; NCAPG2; KLF13;	GO:0045647~negative regulation of erythrocyte differentiation	5	10	50	0.00125095229040184	0.0123853543063045	1	1	0.753719605890579	0.998790808935051	0.116231753902101
down	MTOR; RPTOR; BRF1; CHD8; ICE1;	GO:0045945~positive regulation of transcription by RNA polymerase III	5	10	50	0.00125095229040184	0.0123853543063045	1	1	0.753719605890579	0.998790808935051	0.116231753902101
down	HLA-G; HLA-F; ARRB2; MICA; LILRB1;	GO:0045953~negative regulation of natural killer cell mediated cytotoxicity	5	10	50	0.00125095229040184	0.0123853543063045	1	1	0.753719605890579	0.998790808935051	0.116231753902101
down	CD4; HLA-DRB1; CD74; P4HB; TRIM21;	GO:0046598~positive regulation of viral entry into host cell	5	10	50	0.00125095229040184	0.0123853543063045	1	1	0.753719605890579	0.998790808935051	0.116231753902101
down	EHMT2; SETD5; EHMT1; ASH1L; SETDB1;	GO:0051567~histone H3-K9 methylation	5	10	50	0.00125095229040184	0.0123853543063045	1	1	0.753719605890579	0.998790808935051	0.116231753902101
down	CD81; SZT2; GGA3; SH3BP4; KPTN;	GO:0061462~protein localization to lysosome	5	10	50	0.00125095229040184	0.0123853543063045	1	1	0.753719605890579	0.998790808935051	0.116231753902101
down	KDM4A; KDM8; KDM2B; PHF8; KDM2A;	GO:0070544~histone H3-K36 demethylation	5	10	50	0.00125095229040184	0.0123853543063045	1	1	0.753719605890579	0.998790808935051	0.116231753902101
down	MEN1; ENG; ROCK1; RUNX3; ZFHX3;	GO:0071559~response to transforming growth factor beta	5	10	50	0.00125095229040184	0.0123853543063045	1	1	0.753719605890579	0.998790808935051	0.116231753902101
down	EIF3D; PTBP1; EIF2D; EIF3B; PCBP2;	GO:0075522~IRES-dependent viral translational initiation	5	10	50	0.00125095229040184	0.0123853543063045	1	1	0.753719605890579	0.998790808935051	0.116231753902101
down	TLR4; CD36; AKT1; MIA3; SMPD3;	GO:0140052~cellular response to oxidised low-density lipoprotein particle stimulus	5	10	50	0.00125095229040184	0.0123853543063045	1	1	0.753719605890579	0.998790808935051	0.116231753902101
down	PIP4K2A; PIP4K2B; LRSAM1; KIAA1324; PIP4K2C;	GO:2000786~positive regulation of autophagosome assembly	5	10	50	0.00125095229040184	0.0123853543063045	1	1	0.753719605890579	0.998790808935051	0.116231753902101
down	SUPT5H; KAT7; THOC5; DDX39B; SCAF8; SUPT16H;	GO:0032786~positive regulation of DNA-templated transcription, elongation	6	16	37.5	0.00132020760114637	0.0128802151802353	1	1	0.759969353866454	0.998790808935051	0.120875831567706
down	PLCD4; PLCB3; PLCG2; PLCG1; PLCD1; PLCB2;	GO:0032959~inositol trisphosphate biosynthetic process	6	16	37.5	0.00132020760114637	0.0128802151802353	1	1	0.759969353866454	0.998790808935051	0.120875831567706
down	CD4; CXCL10; BMP7; STC1; CDKN2D; AQP3;	GO:0033280~response to vitamin D	6	16	37.5	0.00132020760114637	0.0128802151802353	1	1	0.759969353866454	0.998790808935051	0.120875831567706
down	BMP4; BMP7; CDKN1A; CDKN2C; CDKN2D; PRKRIP1;	GO:0042326~negative regulation of phosphorylation	6	16	37.5	0.00132020760114637	0.0128802151802353	1	1	0.759969353866454	0.998790808935051	0.120875831567706
down	CEP152; PKD2; CEP192; NDE1; CKAP5; SAC3D1;	GO:0051298~centrosome duplication	6	16	37.5	0.00132020760114637	0.0128802151802353	1	1	0.759969353866454	0.998790808935051	0.120875831567706
down	SOCS3; IL6R; SPI1; CBL; JAK1; STAT1;	GO:0070102~interleukin-6-mediated signaling pathway	6	16	37.5	0.00132020760114637	0.0128802151802353	1	1	0.759969353866454	0.998790808935051	0.120875831567706
down	ADCY6; AKAP8; AKT1; GNG2; GNB1; ACACA;	GO:0071380~cellular response to prostaglandin E stimulus	6	16	37.5	0.00132020760114637	0.0128802151802353	1	1	0.759969353866454	0.998790808935051	0.120875831567706
down	ANO9; KCNK3; ATP2A2; ATP2B4; GJC1; SCNN1D; CLCN2; CLCN6; CLCN7; ATP1B3; TCIRG1; ATP6AP1; ANO6; ATP13A5; TMC8; ATP6V0E2; ATP6V0A1; ATP2A3; ATP6V1E2; SFXN2; P2RX4; TSC22D3; TTYH3; FXYD6; ATP13A1; ANO2;	GO:0034220~ion transmembrane transport	26	208	12.5	0.0013504664234717	0.0131562202741419	1	1	0.762719242975839	0.998790808935051	0.123466032490286
down	SH3PXD2B; LRP5; CDK4; AMER1; AACS; ZNF516; FTO; DYRK1B;	GO:0060612~adipose tissue development	8	30	26.6666666666667	0.00137139444729983	0.0133212632141058	1	1	0.764536477387286	0.998790808935051	0.125014896568514
down	KDM1A; CHEK2; HRAS; TP53; CYBA; CDKN1A; HSF1; RAD51;	GO:0071480~cellular response to gamma radiation	8	30	26.6666666666667	0.00137139444729983	0.0133212632141058	1	1	0.764536477387286	0.998790808935051	0.125014896568514
down	AGRN; HS6ST1; SDC3; GPC4; B3GAT3; PDGFRB; GPC1; NDST1; XYLT2;	GO:0006024~glycosaminoglycan biosynthetic process	9	38	23.6842105263158	0.00142896788358959	0.0137803641645444	1	1	0.769754594015765	0.998790808935051	0.129323381200273
down	SNAP47; DYSF; STX4; TSNARE1; STX16-NPEPL1; STX2; STX1B; VAMP2; SYT11;	GO:0006906~vesicle fusion	9	38	23.6842105263158	0.00142896788358959	0.0137803641645444	1	1	0.769754594015765	0.998790808935051	0.129323381200273
down	JUP; DSP; GJA5; KCNQ1; KCNJ2; CAV1; SCN4B; TRPM4; SCN3B;	GO:0086091~regulation of heart rate by cardiac conduction	9	38	23.6842105263158	0.00142896788358959	0.0137803641645444	1	1	0.769754594015765	0.998790808935051	0.129323381200273
down	PMPCB; PMPCA; SLC8B1; PHB2; PARL; SPG7; AFG3L2;	GO:0006851~mitochondrial calcium ion transmembrane transport	7	23	30.4347826086957	0.00143983135204051	0.0137856632173162	1	1	0.770619148623551	0.998790808935051	0.129373110758464
down	RFC1; WRAP53; TNKS1BP1; SMG6; RPA1; SMG5; TELO2;	GO:0007004~telomere maintenance via telomerase	7	23	30.4347826086957	0.00143983135204051	0.0137856632173162	1	1	0.770619148623551	0.998790808935051	0.129373110758464
down	RCC1; CDC25C; MKI67; NFE2L1; CUL7; CUL9; PKMYT1;	GO:0007088~regulation of mitotic nuclear division	7	23	30.4347826086957	0.00143983135204051	0.0137856632173162	1	1	0.770619148623551	0.998790808935051	0.129373110758464
down	SRC; PRKACA; HDAC4; CAMK1; CDON; LDLRAP1; PRMT7;	GO:0043393~regulation of protein binding	7	23	30.4347826086957	0.00143983135204051	0.0137856632173162	1	1	0.770619148623551	0.998790808935051	0.129373110758464
down	APAF1; CASP2; NFATC4; DAB2IP; TRAF7; MAGED1; ING5;	GO:2001235~positive regulation of apoptotic signaling pathway	7	23	30.4347826086957	0.00143983135204051	0.0137856632173162	1	1	0.770619148623551	0.998790808935051	0.129373110758464
down	SMC1A; SPAG5; KIFC1; INCENP; INO80; KIF18B; TUBG2; DSN1;	GO:0000070~mitotic sister chromatid segregation	8	31	25.8064516129032	0.00163780872479335	0.0155696667251693	1	1	0.788443970919805	0.998790808935051	0.146115292819392
down	SOCS3; GHR; STAT1; PKD2; STAT5B; STAT5A; STAT2; STAT6;	GO:0007259~receptor signaling pathway via JAK-STAT	8	31	25.8064516129032	0.00163780872479335	0.0155696667251693	1	1	0.788443970919805	0.998790808935051	0.146115292819392
down	HRAS; ERBB2; AKT2; CACNB3; PDZK1; CEMIP; MIEF1; TCAF1;	GO:0090314~positive regulation of protein targeting to membrane	8	31	25.8064516129032	0.00163780872479335	0.0155696667251693	1	1	0.788443970919805	0.998790808935051	0.146115292819392
down	AKAP8; NCAPD3; NCAPD2; NCAPH2; CDCA5; AKAP8L;	GO:0007076~mitotic chromosome condensation	6	17	35.2941176470588	0.00169839337219657	0.0160124501956787	1	1	0.793896557164064	0.998790808935051	0.150270644221005
down	CRTAM; HLA-A; EMP2; MICA; CADM1;	GO:0001913~T cell mediated cytotoxicity	5	11	45.4545454545455	0.00173230607384045	0.0160124501956787	1	1	0.796860793966607	0.998790808935051	0.150270644221005
down	LRPAP1; DLG4; ANKRD13D; ANKRD13B; WDR54;	GO:0002091~negative regulation of receptor internalization	5	11	45.4545454545455	0.00173230607384045	0.0160124501956787	1	1	0.796860793966607	0.998790808935051	0.150270644221005
down	BMP4; NDST1; TAB1; CRELD1; PLXND1;	GO:0003279~cardiac septum development	5	11	45.4545454545455	0.00173230607384045	0.0160124501956787	1	1	0.796860793966607	0.998790808935051	0.150270644221005
down	EXOSC10; METTL3; RBM15B; UPF1; BRCA1;	GO:0009048~dosage compensation by inactivation of X chromosome	5	11	45.4545454545455	0.00173230607384045	0.0160124501956787	1	1	0.796860793966607	0.998790808935051	0.150270644221005
down	HLA-B; HLA-DRB1; HLA-A; NLRC4; NOD1;	GO:0016045~detection of bacterium	5	11	45.4545454545455	0.00173230607384045	0.0160124501956787	1	1	0.796860793966607	0.998790808935051	0.150270644221005
down	PEX14; PEX5; PEX26; LONP2; PEX16;	GO:0016558~protein import into peroxisome matrix	5	11	45.4545454545455	0.00173230607384045	0.0160124501956787	1	1	0.796860793966607	0.998790808935051	0.150270644221005
down	GLI3; RELN; DAB2IP; MBOAT7; ADGRG1;	GO:0021819~layer formation in cerebral cortex	5	11	45.4545454545455	0.00173230607384045	0.0160124501956787	1	1	0.796860793966607	0.998790808935051	0.150270644221005
down	MEN1; TTLL12; SETD7; EHMT2; SUV39H1;	GO:0034968~histone lysine methylation	5	11	45.4545454545455	0.00173230607384045	0.0160124501956787	1	1	0.796860793966607	0.998790808935051	0.150270644221005
down	TYMS; MTHFD1; SHMT2; MTHFR; MTHFD1L;	GO:0035999~tetrahydrofolate interconversion	5	11	45.4545454545455	0.00173230607384045	0.0160124501956787	1	1	0.796860793966607	0.998790808935051	0.150270644221005
down	CD74; CD3D; ITPKB; CD3E; CD3G;	GO:0045059~positive thymic T cell selection	5	11	45.4545454545455	0.00173230607384045	0.0160124501956787	1	1	0.796860793966607	0.998790808935051	0.150270644221005
down	CD4; HLA-DRB1; CD74; CSF1; ACIN1;	GO:0045657~positive regulation of monocyte differentiation	5	11	45.4545454545455	0.00173230607384045	0.0160124501956787	1	1	0.796860793966607	0.998790808935051	0.150270644221005
down	PTPRS; RTN4RL1; RGMA; KREMEN1; INPP5F;	GO:0048681~negative regulation of axon regeneration	5	11	45.4545454545455	0.00173230607384045	0.0160124501956787	1	1	0.796860793966607	0.998790808935051	0.150270644221005
down	APP; PPT1; SYNGAP1; MX1; DNM1;	GO:0050803~regulation of synapse structure or activity	5	11	45.4545454545455	0.00173230607384045	0.0160124501956787	1	1	0.796860793966607	0.998790808935051	0.150270644221005
down	GPI; G6PD; HK1; HK3; NFE2L1;	GO:0051156~glucose 6-phosphate metabolic process	5	11	45.4545454545455	0.00173230607384045	0.0160124501956787	1	1	0.796860793966607	0.998790808935051	0.150270644221005
down	ARRB2; EP300; TRIM68; HDAC6; SAFB2;	GO:0060765~regulation of androgen receptor signaling pathway	5	11	45.4545454545455	0.00173230607384045	0.0160124501956787	1	1	0.796860793966607	0.998790808935051	0.150270644221005
down	XPC; DDB1; DDB2; INO80; ERCC1;	GO:0070914~UV-damage excision repair	5	11	45.4545454545455	0.00173230607384045	0.0160124501956787	1	1	0.796860793966607	0.998790808935051	0.150270644221005
down	DNMT1; TRIM28; SETDB1; MPHOSPH8; MORC2;	GO:0090309~positive regulation of DNA methylation-dependent heterochromatin assembly	5	11	45.4545454545455	0.00173230607384045	0.0160124501956787	1	1	0.796860793966607	0.998790808935051	0.150270644221005
down	EGFR; TP53; BMP4; MAP2K2; RIPK1;	GO:1903800~positive regulation of production of miRNAs involved in gene silencing by miRNA	5	11	45.4545454545455	0.00173230607384045	0.0160124501956787	1	1	0.796860793966607	0.998790808935051	0.150270644221005
down	CYBA; NFKB1; HSF1; RELA; CDC6;	GO:1904385~cellular response to angiotensin	5	11	45.4545454545455	0.00173230607384045	0.0160124501956787	1	1	0.796860793966607	0.998790808935051	0.150270644221005
down	TOM1L1; CALM3; SRC; RASSF2; GPNMB; TNKS1BP1; TAOK2;	GO:0031954~positive regulation of protein autophosphorylation	7	24	29.1666666666667	0.00176677894197719	0.0162189336115845	1	1	0.80020533463676	0.998790808935051	0.15220841111801
down	AP2A2; AP2A1; CD36; AP2B1; LDLRAP1; PCSK9; AP2M1;	GO:0034383~low-density lipoprotein particle clearance	7	24	29.1666666666667	0.00176677894197719	0.0162189336115845	1	1	0.80020533463676	0.998790808935051	0.15220841111801
down	GRB2; LBH; SYNGAP1; RNF41; WDR54; PRDM11; ROR1;	GO:0043408~regulation of MAPK cascade	7	24	29.1666666666667	0.00176677894197719	0.0162189336115845	1	1	0.80020533463676	0.998790808935051	0.15220841111801
down	FUS; MTOR; E2F1; ELAVL1; LARP1; NOCT; THRAP3;	GO:0048255~mRNA stabilization	7	24	29.1666666666667	0.00176677894197719	0.0162189336115845	1	1	0.80020533463676	0.998790808935051	0.15220841111801
down	DLL1; AP2A2; AP2A1; AP2B1; GPR107; AP2M1; INPP5F;	GO:0072583~clathrin-dependent endocytosis	7	24	29.1666666666667	0.00176677894197719	0.0162189336115845	1	1	0.80020533463676	0.998790808935051	0.15220841111801
down	CD34; GJA4; KDR; GJA5;	GO:0003158~endothelium development	4	6	66.6666666666667	0.00184633461060346	0.0166294531033193	1	1	0.807057972236412	0.998790808935051	0.156060977573137
down	POLD1; POLG; POLE; POLL;	GO:0006287~base-excision repair, gap-filling	4	6	66.6666666666667	0.00184633461060346	0.0166294531033193	1	1	0.807057972236412	0.998790808935051	0.156060977573137
down	MTA2; CHD3; HIRIP3; BAZ1B;	GO:0006333~chromatin assembly or disassembly	4	6	66.6666666666667	0.00184633461060346	0.0166294531033193	1	1	0.807057972236412	0.998790808935051	0.156060977573137
down	CD4; ERBB2; JAK3; GAS6;	GO:0007167~enzyme linked receptor protein signaling pathway	4	6	66.6666666666667	0.00184633461060346	0.0166294531033193	1	1	0.807057972236412	0.998790808935051	0.156060977573137
down	KAT7; BAG6; EP300; KAT2A;	GO:0018393~internal peptidyl-lysine acetylation	4	6	66.6666666666667	0.00184633461060346	0.0166294531033193	1	1	0.807057972236412	0.998790808935051	0.156060977573137
down	PLCG2; STIM1; STIM2; TMEM110-MUSTN1;	GO:0032237~activation of store-operated calcium channel activity	4	6	66.6666666666667	0.00184633461060346	0.0166294531033193	1	1	0.807057972236412	0.998790808935051	0.156060977573137
down	KMT2D; SETD1A; KMT2A; KMT2B;	GO:0044648~histone H3-K4 dimethylation	4	6	66.6666666666667	0.00184633461060346	0.0166294531033193	1	1	0.807057972236412	0.998790808935051	0.156060977573137
down	BTN3A1; CRTAM; ABL1; CADM1;	GO:0050798~activated T cell proliferation	4	6	66.6666666666667	0.00184633461060346	0.0166294531033193	1	1	0.807057972236412	0.998790808935051	0.156060977573137
down	KDM1A; DNMT1; BRCA1; DNMT3B;	GO:0051573~negative regulation of histone H3-K9 methylation	4	6	66.6666666666667	0.00184633461060346	0.0166294531033193	1	1	0.807057972236412	0.998790808935051	0.156060977573137
down	NRP1; ARHGEF15; RHOJ; FZD4;	GO:0061299~retina vasculature morphogenesis in camera-type eye	4	6	66.6666666666667	0.00184633461060346	0.0166294531033193	1	1	0.807057972236412	0.998790808935051	0.156060977573137
down	FGF1; TEK; LRRK1; PRKD2;	GO:1902533~positive regulation of intracellular signal transduction	4	6	66.6666666666667	0.00184633461060346	0.0166294531033193	1	1	0.807057972236412	0.998790808935051	0.156060977573137
down	CLDN5; PROC; CDH5; ADD1;	GO:1903142~positive regulation of establishment of endothelial barrier	4	6	66.6666666666667	0.00184633461060346	0.0166294531033193	1	1	0.807057972236412	0.998790808935051	0.156060977573137
down	HLA-G; ZBTB46; LILRB1; TMEM176A;	GO:2001199~negative regulation of dendritic cell differentiation	4	6	66.6666666666667	0.00184633461060346	0.0166294531033193	1	1	0.807057972236412	0.998790808935051	0.156060977573137
down	CPSF4; SNRPD3; CPSF7; ZNF473; SYMPK; WDR33; TTF2; MED18; SCAF8;	GO:0006369~termination of RNA polymerase II transcription	9	40	22.5	0.00193932151745224	0.0172951125319377	1	1	0.815575117579304	0.998790808935051	0.162307933532274
down	CIT; APAF1; TP53; APP; ERBB3; ATN1; NCSTN; PIGT; NLRP1;	GO:0051402~neuron apoptotic process	9	40	22.5	0.00193932151745224	0.0172951125319377	1	1	0.815575117579304	0.998790808935051	0.162307933532274
down	E2F8; NRP1; ENG; FLT4; CDH13; TEK; RNF213; KDR;	GO:0002040~sprouting angiogenesis	8	32	25	0.00194353277143278	0.0172951125319377	1	1	0.816055773122078	0.998790808935051	0.162307933532274
down	HDAC3; SEC13; RELN; GAS6; WDR59; RPTOR; FLCN; WDR24;	GO:0032008~positive regulation of TOR signaling	8	32	25	0.00194353277143278	0.0172951125319377	1	1	0.816055773122078	0.998790808935051	0.162307933532274
down	VAMP2; ARFRP1; RAB34; GGA3; GGA2; GGA1; MACF1; C16orf70;	GO:0043001~Golgi to plasma membrane protein transport	8	32	25	0.00194353277143278	0.0172951125319377	1	1	0.816055773122078	0.998790808935051	0.162307933532274
down	ERBB2; EFNA1; EMP2; MAPK7; ENPP2; GPNMB; PLXND1; VASH1;	GO:0045765~regulation of angiogenesis	8	32	25	0.00194353277143278	0.0172951125319377	1	1	0.816055773122078	0.998790808935051	0.162307933532274
down	POLR1A; POLR2E; POLR2H; EP300; TAF1C; KAT2A; SPHK2; BAZ1B;	GO:0045815~positive regulation of gene expression, epigenetic	8	32	25	0.00194353277143278	0.0172951125319377	1	1	0.816055773122078	0.998790808935051	0.162307933532274
down	POLR3D; SNAPC4; GTF3C2; BRF1; GTF3C4; POLR3H; GTF3C5;	GO:0006383~transcription by RNA polymerase III	7	25	28	0.00214850647283538	0.0187628691326195	1	1	0.827450326111448	0.998790808935051	0.176082260836886
down	NRP1; PLXNA3; WNT3; WNT3A; SEMA6B; SEMA3F; SEMA4C;	GO:0048843~negative regulation of axon extension involved in axon guidance	7	25	28	0.00214850647283538	0.0187628691326195	1	1	0.827450326111448	0.998790808935051	0.176082260836886
down	APAF1; HRAS; TP53; CDKN1A; PPM1F; MSH6; CUL1;	GO:0097193~intrinsic apoptotic signaling pathway	7	25	28	0.00214850647283538	0.0187628691326195	1	1	0.827450326111448	0.998790808935051	0.176082260836886
down	PML; PRKX; TIRAP; NCOA6; KAT6A; KAT8;	GO:0030099~myeloid cell differentiation	6	18	33.3333333333333	0.00215339228261546	0.0187628691326195	1	1	0.827777650477987	0.998790808935051	0.176082260836886
down	ARID1A; CARM1; DDX54; DDX17; PADI2; SAFB;	GO:0030520~intracellular estrogen receptor signaling pathway	6	18	33.3333333333333	0.00215339228261546	0.0187628691326195	1	1	0.827777650477987	0.998790808935051	0.176082260836886
down	ADCY6; ADCY3; PRKACA; PRKAR1B; ADCY7; ADCY1;	GO:0034199~activation of protein kinase A activity	6	18	33.3333333333333	0.00215339228261546	0.0187628691326195	1	1	0.827777650477987	0.998790808935051	0.176082260836886
down	RPS6KA4; BRCA1; GLYR1; KAT2A; FOXP3; BRD7;	GO:0035066~positive regulation of histone acetylation	6	18	33.3333333333333	0.00215339228261546	0.0187628691326195	1	1	0.827777650477987	0.998790808935051	0.176082260836886
down	ALDH1A2; BMP7; GJC1; NPRL3; TBX2; TAZ;	GO:0048738~cardiac muscle tissue development	6	18	33.3333333333333	0.00215339228261546	0.0187628691326195	1	1	0.827777650477987	0.998790808935051	0.176082260836886
down	PECAM1; MSN; SOX18; F2RL1; RAPGEF1; ROBO4;	GO:0061028~establishment of endothelial barrier	6	18	33.3333333333333	0.00215339228261546	0.0187628691326195	1	1	0.827777650477987	0.998790808935051	0.176082260836886
down	TAF1; P2RY2; TRPM4; SSH1; P2RX4; P2RX7;	GO:0071318~cellular response to ATP	6	18	33.3333333333333	0.00215339228261546	0.0187628691326195	1	1	0.827777650477987	0.998790808935051	0.176082260836886
down	AKT1; CASP2; CASP7; BNIP1; MADD; BBC3;	GO:0097194~execution phase of apoptosis	6	18	33.3333333333333	0.00215339228261546	0.0187628691326195	1	1	0.827777650477987	0.998790808935051	0.176082260836886
down	PLD2; AGPAT2; DGKQ; DGKZ; SLC27A1; GPAT4; AGPAT1; PLA2G2F; AGPAT3;	GO:0006654~phosphatidic acid biosynthetic process	9	41	21.9512195121951	0.00224398870095588	0.0195013998549911	1	1	0.832519808054631	0.998790808935051	0.183013085668287
down	SLC3A2; SLC7A1; SLC6A6; SLC1A4; SLC43A2; SLC25A29; SFXN2; SLC7A7; SLC25A45;	GO:0006865~amino acid transport	9	41	21.9512195121951	0.00224398870095588	0.0195013998549911	1	1	0.832519808054631	0.998790808935051	0.183013085668287
down	CHEK2; E2F1; ATRIP; RAD9A; HINFP; EIF2AK4; TP53BP1; DOT1L;	GO:0000077~DNA damage checkpoint	8	33	24.2424242424242	0.00229245826979063	0.0196668788408354	1	1	0.834761960209872	0.998790808935051	0.184566041868243
down	SMAD6; GJA5; AP2B1; NPRL3; PTK7; LUZP1; DCTN5; SUFU;	GO:0003281~ventricular septum development	8	33	24.2424242424242	0.00229245826979063	0.0196668788408354	1	1	0.834761960209872	0.998790808935051	0.184566041868243
down	SUPT5H; POLR2E; ERCC3; POLR2A; GTF2F1; POLR2H; POLR2J; CMTR1;	GO:0006370~7-methylguanosine mRNA capping	8	33	24.2424242424242	0.00229245826979063	0.0196668788408354	1	1	0.834761960209872	0.998790808935051	0.184566041868243
down	CTNS; MTOR; MECP2; RELN; ADCY1; NFATC4; KAT2A; EIF2AK4;	GO:0007616~long-term memory	8	33	24.2424242424242	0.00229245826979063	0.0196668788408354	1	1	0.834761960209872	0.998790808935051	0.184566041868243
down	EPM2A; SUPT5H; KDR; TSC2; LARP1; GPSM1; TSC1; PIM2;	GO:0016239~positive regulation of macroautophagy	8	33	24.2424242424242	0.00229245826979063	0.0196668788408354	1	1	0.834761960209872	0.998790808935051	0.184566041868243
down	ARFIP2; CDH13; ARHGEF7; NUP85; PARVB; ARHGEF4; SH2B1; WASF2;	GO:0030032~lamellipodium assembly	8	33	24.2424242424242	0.00229245826979063	0.0196668788408354	1	1	0.834761960209872	0.998790808935051	0.184566041868243
down	PDGFRB; F2R; F2RL1; AKAP13; GPR55; ADGRG1; ROBO1; GPR35;	GO:0035025~positive regulation of Rho protein signal transduction	8	33	24.2424242424242	0.00229245826979063	0.0196668788408354	1	1	0.834761960209872	0.998790808935051	0.184566041868243
down	DLL1; WNT3; CX3CL1; DLL4; HEYL; HEY1; BHLHE40; HES2;	GO:0050767~regulation of neurogenesis	8	33	24.2424242424242	0.00229245826979063	0.0196668788408354	1	1	0.834761960209872	0.998790808935051	0.184566041868243
down	BMP2; BMP4; BMP7; ACVRL1; ADAMTS12; ACVR1; HEYL; TMEM100;	GO:0071773~cellular response to BMP stimulus	8	33	24.2424242424242	0.00229245826979063	0.0196668788408354	1	1	0.834761960209872	0.998790808935051	0.184566041868243
down	MAP4K2; TAB1; DAB2IP; TRAF7; MAP4K1;	GO:0000185~activation of MAPKKK activity	5	12	41.6666666666667	0.00233660070051656	0.0198418074733826	1	1	0.837034128505765	0.998790808935051	0.186207679343104
down	FARP2; APP; CX3CL1; SCARF1; ANKS1A;	GO:0016322~neuron remodeling	5	12	41.6666666666667	0.00233660070051656	0.0198418074733826	1	1	0.837034128505765	0.998790808935051	0.186207679343104
down	TERF2; SMG6; UPF1; SMG5; YLPM1;	GO:0032204~regulation of telomere maintenance	5	12	41.6666666666667	0.00233660070051656	0.0198418074733826	1	1	0.837034128505765	0.998790808935051	0.186207679343104
down	ARNT; HDAC4; PIAS4; RASD2; PIAS3;	GO:0033235~positive regulation of protein sumoylation	5	12	41.6666666666667	0.00233660070051656	0.0198418074733826	1	1	0.837034128505765	0.998790808935051	0.186207679343104
down	SCD; PPT1; ACLY; ACACA; PPT2;	GO:0046949~fatty-acyl-CoA biosynthetic process	5	12	41.6666666666667	0.00233660070051656	0.0198418074733826	1	1	0.837034128505765	0.998790808935051	0.186207679343104
down	PRR5L; ZC3HAV1; UPF1; KHSRP; MOV10;	GO:0061014~positive regulation of mRNA catabolic process	5	12	41.6666666666667	0.00233660070051656	0.0198418074733826	1	1	0.837034128505765	0.998790808935051	0.186207679343104
down	SRC; LCP1; MSN; ARHGEF5; ASAP1;	GO:0071803~positive regulation of podosome assembly	5	12	41.6666666666667	0.00233660070051656	0.0198418074733826	1	1	0.837034128505765	0.998790808935051	0.186207679343104
down	FOXM1; NUDT16; DDX11; WRAP53; TIMELESS;	GO:2000781~positive regulation of double-strand break repair	5	12	41.6666666666667	0.00233660070051656	0.0198418074733826	1	1	0.837034128505765	0.998790808935051	0.186207679343104
down	CCL22; CXCL11; NRP1; GRAP2; LTA; CXCL10; AMH; BMP2; EFNA1; FGFR2; FGFR3; GJA4; PTGIR; EFNA3; GRB2; CX3CL1; TEK; LTB; CXCL9; GPNMB; CCL17; TFAP2C; TSPAN32; PKP4; ASH1L; SIRPG; ADGRG1;	GO:0007267~cell-cell signaling	27	230	11.7391304347826	0.00248728808969256	0.0210145970966061	1	1	0.844851750220467	0.998790808935051	0.197213855791044
down	HCLS1; LONP1; MMP14; FHL2; NCOA6; DHCR24; RBM14; MMS19; PIAS3;	GO:0009725~response to hormone	9	42	21.4285714285714	0.00258550106341704	0.0217522760203002	1	1	0.84986615809048	0.998790808935051	0.204136686821719
down	BGN; CHST15; CHST3; CHSY1; XYLT2; CHST12; CHPF2;	GO:0030206~chondroitin sulfate biosynthetic process	7	26	26.9230769230769	0.0025908741152415	0.0217522760203002	1	1	0.84986615809048	0.998790808935051	0.204136686821719
down	TLR4; IDO1; CD36; HLA-G; CD40; TIRAP; AGER;	GO:0032735~positive regulation of interleukin-12 production	7	26	26.9230769230769	0.0025908741152415	0.0217522760203002	1	1	0.84986615809048	0.998790808935051	0.204136686821719
down	NVL; CEBPZ; ZNF658; MTG2; DDX31; DROSHA; AATF;	GO:0042254~ribosome biogenesis	7	26	26.9230769230769	0.0025908741152415	0.0217522760203002	1	1	0.84986615809048	0.998790808935051	0.204136686821719
down	TP53; NMT1; E2F1; TFDP1; TFDP2; PPP1R13B; BBC3;	GO:1900740~positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway	7	26	26.9230769230769	0.0025908741152415	0.0217522760203002	1	1	0.84986615809048	0.998790808935051	0.204136686821719
down	PRODH; BMP4; CD36; LRP1; SLFN11; KATNB1; SAP30BP; FAF1;	GO:0010942~positive regulation of cell death	8	34	23.5294117647059	0.00268863985463075	0.0223142801102586	1	1	0.854987473772578	0.998790808935051	0.209410877568346
down	ARID1A; SMARCB1; SMARCC2; SMARCC1; SMARCD1; SUPT16H;	GO:0006337~nucleosome disassembly	6	19	31.5789473684211	0.00269454197949703	0.0223142801102586	1	1	0.85529373814454	0.998790808935051	0.209410877568346
down	SCAMP2; ARL3; VAMP2; STX4; GBF1; MYO5A;	GO:0006892~post-Golgi vesicle-mediated transport	6	19	31.5789473684211	0.00269454197949703	0.0223142801102586	1	1	0.85529373814454	0.998790808935051	0.209410877568346
down	RARG; TNFRSF1B; AKT1; MTOR; SIRT2; LGI4;	GO:0031641~regulation of myelination	6	19	31.5789473684211	0.00269454197949703	0.0223142801102586	1	1	0.85529373814454	0.998790808935051	0.209410877568346
down	AKT1; MTOR; EIF4EBP1; LARP1; RPTOR; FLCN;	GO:0031929~TOR signaling	6	19	31.5789473684211	0.00269454197949703	0.0223142801102586	1	1	0.85529373814454	0.998790808935051	0.209410877568346
down	APOL3; APOM; LRP1; PCSK9; APOL2; APOL6;	GO:0042157~lipoprotein metabolic process	6	19	31.5789473684211	0.00269454197949703	0.0223142801102586	1	1	0.85529373814454	0.998790808935051	0.209410877568346
down	CSNK1D; C2CD3; CEP192; SPAG5; CEP131; SNX10;	GO:0071539~protein localization to centrosome	6	19	31.5789473684211	0.00269454197949703	0.0223142801102586	1	1	0.85529373814454	0.998790808935051	0.209410877568346
down	TNFSF14; CD53; FLT3LG; CXCL9; NFATC2; EHD2;	GO:1901741~positive regulation of myoblast fusion	6	19	31.5789473684211	0.00269454197949703	0.0223142801102586	1	1	0.85529373814454	0.998790808935051	0.209410877568346
down	HAX1; NRP1; ABL1; HRAS; HCLS1; TEK;	GO:2000251~positive regulation of actin cytoskeleton reorganization	6	19	31.5789473684211	0.00269454197949703	0.0223142801102586	1	1	0.85529373814454	0.998790808935051	0.209410877568346
down	BRF1; GTF3C4; GTF3C5; POLR3H;	GO:0006384~transcription initiation from RNA polymerase III promoter	4	7	57.1428571428571	0.00276741153536109	0.0224449166150706	1	1	0.858986769887617	0.998790808935051	0.21063685057666
down	SMPD2; SMPD1; SMPD4; SMPD3;	GO:0006685~sphingomyelin catabolic process	4	7	57.1428571428571	0.00276741153536109	0.0224449166150706	1	1	0.858986769887617	0.998790808935051	0.21063685057666
down	NCAPD2; INCENP; NCAPD3; NCAPH2;	GO:0010032~meiotic chromosome condensation	4	7	57.1428571428571	0.00276741153536109	0.0224449166150706	1	1	0.858986769887617	0.998790808935051	0.21063685057666
down	DNMT1; CTCF; ZNF445; USP7;	GO:0010216~maintenance of DNA methylation	4	7	57.1428571428571	0.00276741153536109	0.0224449166150706	1	1	0.858986769887617	0.998790808935051	0.21063685057666
down	GPR37; CLN6; FZD4; MYO5A;	GO:0031987~locomotion involved in locomotory behavior	4	7	57.1428571428571	0.00276741153536109	0.0224449166150706	1	1	0.858986769887617	0.998790808935051	0.21063685057666
down	PLA2G6; TAZ; PGS1; SLC27A1;	GO:0032049~cardiolipin biosynthetic process	4	7	57.1428571428571	0.00276741153536109	0.0224449166150706	1	1	0.858986769887617	0.998790808935051	0.21063685057666
down	BMP2; BMP4; APCDD1; WNT10A;	GO:0042487~regulation of odontogenesis of dentin-containing tooth	4	7	57.1428571428571	0.00276741153536109	0.0224449166150706	1	1	0.858986769887617	0.998790808935051	0.21063685057666
down	BRCA1; KAT2A; RBM14; CDK5RAP2;	GO:0046600~negative regulation of centriole replication	4	7	57.1428571428571	0.00276741153536109	0.0224449166150706	1	1	0.858986769887617	0.998790808935051	0.21063685057666
down	NSUN2; NOM1; TRPC4AP; MYO5A;	GO:0048820~hair follicle maturation	4	7	57.1428571428571	0.00276741153536109	0.0224449166150706	1	1	0.858986769887617	0.998790808935051	0.21063685057666
down	OGG1; TYMS; EEF2; MTHFR;	GO:0051593~response to folic acid	4	7	57.1428571428571	0.00276741153536109	0.0224449166150706	1	1	0.858986769887617	0.998790808935051	0.21063685057666
down	MTOR; PABPC1L; CLMN; SYNE3;	GO:0051647~nucleus localization	4	7	57.1428571428571	0.00276741153536109	0.0224449166150706	1	1	0.858986769887617	0.998790808935051	0.21063685057666
down	WAS; BIN3; WIPF2; WIPF3;	GO:0051666~actin cortical patch localization	4	7	57.1428571428571	0.00276741153536109	0.0224449166150706	1	1	0.858986769887617	0.998790808935051	0.21063685057666
down	ACVRL1; RHOB; CCM2; PRKD2;	GO:0061154~endothelial tube morphogenesis	4	7	57.1428571428571	0.00276741153536109	0.0224449166150706	1	1	0.858986769887617	0.998790808935051	0.21063685057666
down	SEC16A; MIA3; GBF1; BCAP31;	GO:0070973~protein localization to endoplasmic reticulum exit site	4	7	57.1428571428571	0.00276741153536109	0.0224449166150706	1	1	0.858986769887617	0.998790808935051	0.21063685057666
down	NUP62; GSK3B; MARK4; CEP250;	GO:1904781~positive regulation of protein localization to centrosome	4	7	57.1428571428571	0.00276741153536109	0.0224449166150706	1	1	0.858986769887617	0.998790808935051	0.21063685057666
down	SRC; ENPP2; ARHGEF7; RREB1;	GO:2000394~positive regulation of lamellipodium morphogenesis	4	7	57.1428571428571	0.00276741153536109	0.0224449166150706	1	1	0.858986769887617	0.998790808935051	0.21063685057666
down	SEC16A; CNP; CALM3; G6PD; S100A1; SIRT2; MAPKAP1; SUDS3; PADI2;	GO:0021762~substantia nigra development	9	43	20.9302325581395	0.00296688971717274	0.0239754824424007	1	1	0.869298687131612	0.998790808935051	0.225000618150322
down	CLIC1; FIBP; PLEK; FLNA; MPL; WNT3A; TSPAN32; TLN1; GP1BA;	GO:0070527~platelet aggregation	9	43	20.9302325581395	0.00296688971717274	0.0239754824424007	1	1	0.869298687131612	0.998790808935051	0.225000618150322
up	GAS2; SKIL; CDKN2A;	GO:0007050~cell cycle arrest	3	131	2.29007633587786	0.00299505965976898	0.0648929592949947	0.745769855282477	0.778715511539936	0.350421980192971	0.745769855282477	0.398431033537161
down	ZBTB7B; STX2; NF2; ZBTB17; EPB41L5;	GO:0007398~ectoderm development	5	13	38.4615384615385	0.00308064619143456	0.0242304044466778	1	1	0.874903518367414	0.998790808935051	0.227392962441214
down	APP; FBLN1; MAPK12; CAV1; PSME4;	GO:0010952~positive regulation of peptidase activity	5	13	38.4615384615385	0.00308064619143456	0.0242304044466778	1	1	0.874903518367414	0.998790808935051	0.227392962441214
down	AGPAT2; CDS2; GPAT4; AGPAT1; AGPAT3;	GO:0016024~CDP-diacylglycerol biosynthetic process	5	13	38.4615384615385	0.00308064619143456	0.0242304044466778	1	1	0.874903518367414	0.998790808935051	0.227392962441214
down	INTS3; INTS1; INTS4; TUT1; INTS9;	GO:0016180~snRNA processing	5	13	38.4615384615385	0.00308064619143456	0.0242304044466778	1	1	0.874903518367414	0.998790808935051	0.227392962441214
down	HGS; EPN2; PTPN1; DAB2IP; MMRN2;	GO:0030948~negative regulation of vascular endothelial growth factor receptor signaling pathway	5	13	38.4615384615385	0.00308064619143456	0.0242304044466778	1	1	0.874903518367414	0.998790808935051	0.227392962441214
down	STX1B; PRRT2; STX4; STX2; SNAP47;	GO:0031629~synaptic vesicle fusion to presynaptic active zone membrane	5	13	38.4615384615385	0.00308064619143456	0.0242304044466778	1	1	0.874903518367414	0.998790808935051	0.227392962441214
down	POLA1; TRIM21; IRF3; RNF26; ZBP1;	GO:0032479~regulation of type I interferon production	5	13	38.4615384615385	0.00308064619143456	0.0242304044466778	1	1	0.874903518367414	0.998790808935051	0.227392962441214
down	TLR4; STAT1; IRF3; MAVS; SETD2;	GO:0032727~positive regulation of interferon-alpha production	5	13	38.4615384615385	0.00308064619143456	0.0242304044466778	1	1	0.874903518367414	0.998790808935051	0.227392962441214
down	TNXB; TNS2; P2RX7; VIPAS39; SMPD3;	GO:0032963~collagen metabolic process	5	13	38.4615384615385	0.00308064619143456	0.0242304044466778	1	1	0.874903518367414	0.998790808935051	0.227392962441214
down	DYNC1H1; PATL1; LIMD1; NOCT; EDC3;	GO:0033962~cytoplasmic mRNA processing body assembly	5	13	38.4615384615385	0.00308064619143456	0.0242304044466778	1	1	0.874903518367414	0.998790808935051	0.227392962441214
down	KDM1A; HMBOX1; DDX11; PYGO2; CDT1;	GO:0035563~positive regulation of chromatin binding	5	13	38.4615384615385	0.00308064619143456	0.0242304044466778	1	1	0.874903518367414	0.998790808935051	0.227392962441214
down	CRTAM; ABL1; HLA-DOA; METTL3; CARD11;	GO:0045580~regulation of T cell differentiation	5	13	38.4615384615385	0.00308064619143456	0.0242304044466778	1	1	0.874903518367414	0.998790808935051	0.227392962441214
down	SOCS3; HGS; BCL3; NF2; CAV1;	GO:0046426~negative regulation of receptor signaling pathway via JAK-STAT	5	13	38.4615384615385	0.00308064619143456	0.0242304044466778	1	1	0.874903518367414	0.998790808935051	0.227392962441214
down	WNT4; ACVR1; FOXF1; NFATC4; TMEM204;	GO:0051145~smooth muscle cell differentiation	5	13	38.4615384615385	0.00308064619143456	0.0242304044466778	1	1	0.874903518367414	0.998790808935051	0.227392962441214
down	EDNRA; MMP14; LIMK2; IL11RA; MKS1;	GO:0060322~head development	5	13	38.4615384615385	0.00308064619143456	0.0242304044466778	1	1	0.874903518367414	0.998790808935051	0.227392962441214
down	AKT1; AKT2; LBH; SMO; ZNF703;	GO:0060644~mammary gland epithelial cell differentiation	5	13	38.4615384615385	0.00308064619143456	0.0242304044466778	1	1	0.874903518367414	0.998790808935051	0.227392962441214
down	EZH2; CARM1; LEMD2; CHMP7; MCM8;	GO:0071168~protein localization to chromatin	5	13	38.4615384615385	0.00308064619143456	0.0242304044466778	1	1	0.874903518367414	0.998790808935051	0.227392962441214
down	PRKACA; SLC9A1; ATP2B4; KCNQ1; SIRT2;	GO:0071872~cellular response to epinephrine stimulus	5	13	38.4615384615385	0.00308064619143456	0.0242304044466778	1	1	0.874903518367414	0.998790808935051	0.227392962441214
down	MEN1; CXCL10; TP53; PARP1; CBL; PML; POLG;	GO:0010332~response to gamma radiation	7	27	25.9259259259259	0.003099954481806	0.0242304044466778	1	1	0.875987450497988	0.998790808935051	0.227392962441214
down	CD36; SREBF1; RARG; THRA; SREBF2; NR1H2; NR1I3;	GO:0033993~response to lipid	7	27	25.9259259259259	0.003099954481806	0.0242304044466778	1	1	0.875987450497988	0.998790808935051	0.227392962441214
down	MEN1; HDAC3; NCOR1; AKT1; F2RL1; GPS2; SH3RF2;	GO:0046329~negative regulation of JNK cascade	7	27	25.9259259259259	0.003099954481806	0.0242304044466778	1	1	0.875987450497988	0.998790808935051	0.227392962441214
down	ARHGAP6; SRC; ARHGEF7; CTTN; DLC1; PEAK1; TAOK2;	GO:0048041~focal adhesion assembly	7	27	25.9259259259259	0.003099954481806	0.0242304044466778	1	1	0.875987450497988	0.998790808935051	0.227392962441214
down	MAP2K7; IKBKB; NFKB1; CUL1; CCM2; TAOK2; BTRC;	GO:0051403~stress-activated MAPK cascade	7	27	25.9259259259259	0.003099954481806	0.0242304044466778	1	1	0.875987450497988	0.998790808935051	0.227392962441214
down	GPI; PFKM; HK1; HK3; FOXK1; FOXK2; ADPGK;	GO:0061621~canonical glycolysis	7	27	25.9259259259259	0.003099954481806	0.0242304044466778	1	1	0.875987450497988	0.998790808935051	0.227392962441214
down	KAT7; PARP1; SRC; AKT1; CDK5RAP3; GLIS2; GTSE1;	GO:1900182~positive regulation of protein localization to nucleus	7	27	25.9259259259259	0.003099954481806	0.0242304044466778	1	1	0.875987450497988	0.998790808935051	0.227392962441214
down	TP53; PDGFRB; CDKN1A; GRB2; RIPK1; RNF41; RIPK3;	GO:2000379~positive regulation of reactive oxygen species metabolic process	7	27	25.9259259259259	0.003099954481806	0.0242304044466778	1	1	0.875987450497988	0.998790808935051	0.227392962441214
down	NUP62; EMP2; RIPK1; MAP3K11; ALS2; PRKD2; NDOR1; FAF1;	GO:0008219~cell death	8	35	22.8571428571429	0.00313628280546041	0.0244286456746992	1	1	0.878055530796817	0.998790808935051	0.229253379596733
down	DYSF; EGFR; FLNA; RELA; GRIN2C; SF3B3; SIRT2; AZIN2;	GO:0042177~negative regulation of protein catabolic process	8	35	22.8571428571429	0.00313628280546041	0.0244286456746992	1	1	0.878055530796817	0.998790808935051	0.229253379596733
down	SMAD6; TP53; BMP2; SPI1; RELA; APLN; SREBF1; SREBF2;	GO:1902895~positive regulation of pri-miRNA transcription by RNA polymerase II	8	35	22.8571428571429	0.00313628280546041	0.0244286456746992	1	1	0.878055530796817	0.998790808935051	0.229253379596733
down	LAMC1; BMP4; BPTF; MED12; KIF16B; EPB41L5;	GO:0007492~endoderm development	6	20	30	0.00333144958624243	0.0258283962701371	1	1	0.887529096609406	0.998790808935051	0.242389496877645
down	SRC; EXOSC10; TERF2; CTC1; ACD; NAT10;	GO:0032211~negative regulation of telomere maintenance via telomerase	6	20	30	0.00333144958624243	0.0258283962701371	1	1	0.887529096609406	0.998790808935051	0.242389496877645
down	PLXNA3; DDR1; CPNE1; PAK6; EIF2AK4; PLXNA1;	GO:1990138~neuron projection extension	6	20	30	0.00333144958624243	0.0258283962701371	1	1	0.887529096609406	0.998790808935051	0.242389496877645
down	EGFR; BMP4; EIF2AK2; F2R; RAPGEF1; MAP3K14; MAP3K3; TAOK2; MAP3K6;	GO:0000186~activation of MAPKK activity	9	44	20.4545454545455	0.00339129192611209	0.0260805568955203	1	1	0.889983784195523	0.998790808935051	0.244755926696969
down	RAD51D; PARP1; RPA1; POLD1; POLD3; TERF2; CTC1; ACD; PARP3;	GO:0000723~telomere maintenance	9	44	20.4545454545455	0.00339129192611209	0.0260805568955203	1	1	0.889983784195523	0.998790808935051	0.244755926696969
down	ITPKB; PML; CDH5; STAT2; RAD51; FLCN; PPP1R9B; SMPD3; CCDC88C;	GO:0001932~regulation of protein phosphorylation	9	44	20.4545454545455	0.00339129192611209	0.0260805568955203	1	1	0.889983784195523	0.998790808935051	0.244755926696969
down	THBD; PFKFB1; SREBF1; STAT1; DGKQ; TEK; RELA; CARM1; DUOX1;	GO:0051591~response to cAMP	9	44	20.4545454545455	0.00339129192611209	0.0260805568955203	1	1	0.889983784195523	0.998790808935051	0.244755926696969
down	ARIH2; RNF126; UBE2O; BFAR; PRPF19; UBE2D4; RNF115; PELI3; TRAF1;	GO:0070534~protein K63-linked ubiquitination	9	44	20.4545454545455	0.00339129192611209	0.0260805568955203	1	1	0.889983784195523	0.998790808935051	0.244755926696969
down	SPN; STAT6; MTOR;	GO:0002296~T-helper 1 cell lineage commitment	3	3	100	0.00350042001712825	0.0264032810095577	1	1	0.893985829442786	0.998790808935051	0.247784567531408
down	CDS2; PGS1; SLC27A1;	GO:0006655~phosphatidylglycerol biosynthetic process	3	3	100	0.00350042001712825	0.0264032810095577	1	1	0.893985829442786	0.998790808935051	0.247784567531408
down	PARP1; PARP2; PARP3;	GO:0030592~DNA ADP-ribosylation	3	3	100	0.00350042001712825	0.0264032810095577	1	1	0.893985829442786	0.998790808935051	0.247784567531408
down	CD320; TNFSF13B; TNFRSF13C;	GO:0031296~B cell costimulation	3	3	100	0.00350042001712825	0.0264032810095577	1	1	0.893985829442786	0.998790808935051	0.247784567531408
down	MCM3AP; SETD2; SUPT6H;	GO:0034728~nucleosome organization	3	3	100	0.00350042001712825	0.0264032810095577	1	1	0.893985829442786	0.998790808935051	0.247784567531408
down	SLC9A3R1; ANO6; P2RX7;	GO:0034767~positive regulation of ion transmembrane transport	3	3	100	0.00350042001712825	0.0264032810095577	1	1	0.893985829442786	0.998790808935051	0.247784567531408
down	ALKBH5; ALKBH3; FTO;	GO:0035553~oxidative single-stranded RNA demethylation	3	3	100	0.00350042001712825	0.0264032810095577	1	1	0.893985829442786	0.998790808935051	0.247784567531408
down	UCK2; UCK1; UCKL1;	GO:0044211~CTP salvage	3	3	100	0.00350042001712825	0.0264032810095577	1	1	0.893985829442786	0.998790808935051	0.247784567531408
down	STK10; RAC2; JAM2;	GO:0071593~lymphocyte aggregation	3	3	100	0.00350042001712825	0.0264032810095577	1	1	0.893985829442786	0.998790808935051	0.247784567531408
down	BMP4; NOTCH2; NOTCH3;	GO:0072104~glomerular capillary formation	3	3	100	0.00350042001712825	0.0264032810095577	1	1	0.893985829442786	0.998790808935051	0.247784567531408
down	FLNA; SIRT2; HDAC6;	GO:0090042~tubulin deacetylation	3	3	100	0.00350042001712825	0.0264032810095577	1	1	0.893985829442786	0.998790808935051	0.247784567531408
down	WNT3A; MED12; LRP6;	GO:0090245~axis elongation involved in somitogenesis	3	3	100	0.00350042001712825	0.0264032810095577	1	1	0.893985829442786	0.998790808935051	0.247784567531408
down	SLC9A3R1; SLC6A6; SLC39A14;	GO:0098739~import across plasma membrane	3	3	100	0.00350042001712825	0.0264032810095577	1	1	0.893985829442786	0.998790808935051	0.247784567531408
down	ADCY6; RANGAP1; CDC6;	GO:1904117~cellular response to vasopressin	3	3	100	0.00350042001712825	0.0264032810095577	1	1	0.893985829442786	0.998790808935051	0.247784567531408
down	GSK3A; GSK3B; INPP5K;	GO:2000466~negative regulation of glycogen (starch) synthase activity	3	3	100	0.00350042001712825	0.0264032810095577	1	1	0.893985829442786	0.998790808935051	0.247784567531408
down	HRAS; NFKB1; RELA;	GO:2000630~positive regulation of miRNA metabolic process	3	3	100	0.00350042001712825	0.0264032810095577	1	1	0.893985829442786	0.998790808935051	0.247784567531408
down	UBE4B; TRIM21; CBL; CUL1; HUWE1; RNF126; UBE2O; DTL;	GO:0006513~protein monoubiquitination	8	36	22.2222222222222	0.00363972951282254	0.0273306880159473	1	1	0.899013189667168	0.998790808935051	0.256487923145457
down	TFAP2A; LTBP4; TCFL5; RUNX3; PTBP1; BCL6B; APC2; PLEKHB1;	GO:0045595~regulation of cell differentiation	8	36	22.2222222222222	0.00363972951282254	0.0273306880159473	1	1	0.899013189667168	0.998790808935051	0.256487923145457
down	TLR4; NONO; MAVS; RBM14; SIN3A; NLRC4; ZCCHC3;	GO:0002218~activation of innate immune response	7	28	25	0.00368200359932058	0.027555240822239	1	1	0.900818991863595	0.998790808935051	0.258595264273812
down	ZMYM3; STRIP1; ZMYM4; BCL9L; FITM2; FMNL2; QRICH1;	GO:0022604~regulation of cell morphogenesis	7	28	25	0.00368200359932058	0.027555240822239	1	1	0.900818991863595	0.998790808935051	0.258595264273812
down	CDK9; RAD51; SETMAR; RFWD3; BOD1L1; DDX11; TONSL;	GO:0031297~replication fork processing	7	28	25	0.00368200359932058	0.027555240822239	1	1	0.900818991863595	0.998790808935051	0.258595264273812
down	MECP2; VAMP2; RELN; STX4; MPP2; NFATC4; SNAP47; GRIN2C; SLC24A1;	GO:0060291~long-term synaptic potentiation	9	45	20	0.00386194377883498	0.0285487717835361	1	1	0.907556788026219	0.998790808935051	0.267919167597984
down	EXOSC7; ERI3; EXOSC10; EXOSC2;	GO:0000467~exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)	4	8	50	0.00395985867257576	0.0285487717835361	1	1	0.910767494692424	0.998790808935051	0.267919167597984
down	STIM1; ORAI1; STIM2; ORAI2;	GO:0002115~store-operated calcium entry	4	8	50	0.00395985867257576	0.0285487717835361	1	1	0.910767494692424	0.998790808935051	0.267919167597984
down	CD48; IRF1; ADCY7; RIPK3;	GO:0002819~regulation of adaptive immune response	4	8	50	0.00395985867257576	0.0285487717835361	1	1	0.910767494692424	0.998790808935051	0.267919167597984
down	AKT1; MTOR; PPP1R3F; INPP5K;	GO:0005979~regulation of glycogen biosynthetic process	4	8	50	0.00395985867257576	0.0285487717835361	1	1	0.910767494692424	0.998790808935051	0.267919167597984
down	SLC9A1; GSK3B; DST; CARMIL2;	GO:0030011~maintenance of cell polarity	4	8	50	0.00395985867257576	0.0285487717835361	1	1	0.910767494692424	0.998790808935051	0.267919167597984
down	TP53; FBXO31; RFWD3; GIGYF2;	GO:0031571~mitotic G1 DNA damage checkpoint	4	8	50	0.00395985867257576	0.0285487717835361	1	1	0.910767494692424	0.998790808935051	0.267919167597984
down	AXL; FLT3LG; STAT5B; GAS6;	GO:0032825~positive regulation of natural killer cell differentiation	4	8	50	0.00395985867257576	0.0285487717835361	1	1	0.910767494692424	0.998790808935051	0.267919167597984
down	KDM1A; KDM5A; KDM5C; KDM1B;	GO:0034720~histone H3-K4 demethylation	4	8	50	0.00395985867257576	0.0285487717835361	1	1	0.910767494692424	0.998790808935051	0.267919167597984
down	CTCF; FLCN; PYGO2; SETD5;	GO:0035065~regulation of histone acetylation	4	8	50	0.00395985867257576	0.0285487717835361	1	1	0.910767494692424	0.998790808935051	0.267919167597984
down	CDH1; SRC; CBL; GRB2;	GO:0035635~entry of bacterium into host cell	4	8	50	0.00395985867257576	0.0285487717835361	1	1	0.910767494692424	0.998790808935051	0.267919167597984
down	ENG; ACVRL1; DLL4; HEY1;	GO:0035912~dorsal aorta morphogenesis	4	8	50	0.00395985867257576	0.0285487717835361	1	1	0.910767494692424	0.998790808935051	0.267919167597984
down	LFNG; POFUT1; SLC35C2; POFUT2;	GO:0036066~protein O-linked fucosylation	4	8	50	0.00395985867257576	0.0285487717835361	1	1	0.910767494692424	0.998790808935051	0.267919167597984
down	TLR4; IRF1; RELA; LTB;	GO:0045084~positive regulation of interleukin-12 biosynthetic process	4	8	50	0.00395985867257576	0.0285487717835361	1	1	0.910767494692424	0.998790808935051	0.267919167597984
down	GFI1; PYGO2; KMT2B; ZNF335;	GO:0051569~regulation of histone H3-K4 methylation	4	8	50	0.00395985867257576	0.0285487717835361	1	1	0.910767494692424	0.998790808935051	0.267919167597984
down	MFN2; BRAT1; MARK2; HDAC6;	GO:0051646~mitochondrion localization	4	8	50	0.00395985867257576	0.0285487717835361	1	1	0.910767494692424	0.998790808935051	0.267919167597984
down	CD34; KDR; MCAM; NDNF;	GO:0061042~vascular wound healing	4	8	50	0.00395985867257576	0.0285487717835361	1	1	0.910767494692424	0.998790808935051	0.267919167597984
down	WNT3; WNT4; WNT7B; ORAI1;	GO:0061180~mammary gland epithelium development	4	8	50	0.00395985867257576	0.0285487717835361	1	1	0.910767494692424	0.998790808935051	0.267919167597984
down	KMT2D; SETD1A; KMT2A; KMT2B;	GO:0097692~histone H3-K4 monomethylation	4	8	50	0.00395985867257576	0.0285487717835361	1	1	0.910767494692424	0.998790808935051	0.267919167597984
down	PTPRF; ATP2A2; ADAM15; ATP2A3;	GO:1900121~negative regulation of receptor binding	4	8	50	0.00395985867257576	0.0285487717835361	1	1	0.910767494692424	0.998790808935051	0.267919167597984
down	SETD1A; MKI67; SSRP1; SETD5;	GO:1902275~regulation of chromatin organization	4	8	50	0.00395985867257576	0.0285487717835361	1	1	0.910767494692424	0.998790808935051	0.267919167597984
down	CAMTA2; ATP2A2; HDAC4; EZH2; INPP5F;	GO:0014898~cardiac muscle hypertrophy in response to stress	5	14	35.7142857142857	0.0039813639536519	0.0285487717835361	1	1	0.911732345386284	0.998790808935051	0.267919167597984
down	ABL1; GSK3B; CTTN; DPYSL2; SIN3A;	GO:0030516~regulation of axon extension	5	14	35.7142857142857	0.0039813639536519	0.0285487717835361	1	1	0.911732345386284	0.998790808935051	0.267919167597984
down	CSF1R; PLEK; MTOR; ARFIP2; TCIRG1;	GO:0031529~ruffle organization	5	14	35.7142857142857	0.0039813639536519	0.0285487717835361	1	1	0.911732345386284	0.998790808935051	0.267919167597984
down	CD4; CD3E; CD86; STAT5B; CARD11;	GO:0045086~positive regulation of interleukin-2 biosynthetic process	5	14	35.7142857142857	0.0039813639536519	0.0285487717835361	1	1	0.911732345386284	0.998790808935051	0.267919167597984
down	ALOX5; GNB3; GPS2; ATAT1; HDAC6;	GO:0045598~regulation of fat cell differentiation	5	14	35.7142857142857	0.0039813639536519	0.0285487717835361	1	1	0.911732345386284	0.998790808935051	0.267919167597984
down	TPR; EIF4EBP1; LARP1; EIF2AK4; C8orf88;	GO:0045947~negative regulation of translational initiation	5	14	35.7142857142857	0.0039813639536519	0.0285487717835361	1	1	0.911732345386284	0.998790808935051	0.267919167597984
down	DGKQ; DGKZ; DGKD; PGS1; GPAT4;	GO:0046339~diacylglycerol metabolic process	5	14	35.7142857142857	0.0039813639536519	0.0285487717835361	1	1	0.911732345386284	0.998790808935051	0.267919167597984
down	FOXP2; PDGFRB; BMP4; ENG; SMO;	GO:0048745~smooth muscle tissue development	5	14	35.7142857142857	0.0039813639536519	0.0285487717835361	1	1	0.911732345386284	0.998790808935051	0.267919167597984
down	MT-ATP6; PDGFRB; CDK4; CDKN1A; POLG;	GO:0055093~response to hyperoxia	5	14	35.7142857142857	0.0039813639536519	0.0285487717835361	1	1	0.911732345386284	0.998790808935051	0.267919167597984
down	WNT10B; ARIH2; CD34; SART3; CTC1;	GO:0071425~hematopoietic stem cell proliferation	5	14	35.7142857142857	0.0039813639536519	0.0285487717835361	1	1	0.911732345386284	0.998790808935051	0.267919167597984
down	NSUN2; METTL3; METTL16; CMTR1; PCIF1;	GO:0080009~mRNA methylation	5	14	35.7142857142857	0.0039813639536519	0.0285487717835361	1	1	0.911732345386284	0.998790808935051	0.267919167597984
down	SLC26A5; SLC26A6; SLC26A1; SLC25A10; SLC13A4;	GO:1902358~sulfate transmembrane transport	5	14	35.7142857142857	0.0039813639536519	0.0285487717835361	1	1	0.911732345386284	0.998790808935051	0.267919167597984
down	BMP4; HDAC4; RELA; NFATC3; NFATC4;	GO:1902894~negative regulation of pri-miRNA transcription by RNA polymerase II	5	14	35.7142857142857	0.0039813639536519	0.0285487717835361	1	1	0.911732345386284	0.998790808935051	0.267919167597984
down	MSN; VGLL4; AMER1; VPS11; FAF1;	GO:1903364~positive regulation of cellular protein catabolic process	5	14	35.7142857142857	0.0039813639536519	0.0285487717835361	1	1	0.911732345386284	0.998790808935051	0.267919167597984
down	RPL10; MED12; IFT140; MKS1; RNF112;	GO:1990403~embryonic brain development	5	14	35.7142857142857	0.0039813639536519	0.0285487717835361	1	1	0.911732345386284	0.998790808935051	0.267919167597984
down	CNOT3; TAL1; ELAVL1; KAT2A; SMO;	GO:2000036~regulation of stem cell population maintenance	5	14	35.7142857142857	0.0039813639536519	0.0285487717835361	1	1	0.911732345386284	0.998790808935051	0.267919167597984
down	ERCC1; PARP1; ERCC3; RPA1; DDB1; DDB2;	GO:0006293~nucleotide-excision repair, preincision complex stabilization	6	21	28.5714285714286	0.00407391986508743	0.0289023423125045	1	1	0.915291550569176	0.998790808935051	0.271237290091192
down	FGFR2; C2CD3; TTC21B; CREBBP; IFT140; FUZ;	GO:0008589~regulation of smoothened signaling pathway	6	21	28.5714285714286	0.00407391986508743	0.0289023423125045	1	1	0.915291550569176	0.998790808935051	0.271237290091192
down	ABCD4; TCN2; ABCC1; MMAB; MTR; CD320;	GO:0009235~cobalamin metabolic process	6	21	28.5714285714286	0.00407391986508743	0.0289023423125045	1	1	0.915291550569176	0.998790808935051	0.271237290091192
down	FARP2; CDH13; ALS2; NISCH; WASF2; RAC2;	GO:0016601~Rac protein signal transduction	6	21	28.5714285714286	0.00407391986508743	0.0289023423125045	1	1	0.915291550569176	0.998790808935051	0.271237290091192
down	BCL9; ENG; ITGA3; LTBP4; ZNF703; DKK3;	GO:0017015~regulation of transforming growth factor beta receptor signaling pathway	6	21	28.5714285714286	0.00407391986508743	0.0289023423125045	1	1	0.915291550569176	0.998790808935051	0.271237290091192
down	RPA1; RFC4; RFC2; RFC1; RFC5; POLH;	GO:0042276~error-prone translesion synthesis	6	21	28.5714285714286	0.00407391986508743	0.0289023423125045	1	1	0.915291550569176	0.998790808935051	0.271237290091192
down	TYROBP; CD36; AXL; LRP1; MFGE8; GAS6;	GO:0043277~apoptotic cell clearance	6	21	28.5714285714286	0.00407391986508743	0.0289023423125045	1	1	0.915291550569176	0.998790808935051	0.271237290091192
down	HNRNPL; U2AF2; PTBP1; RBMX; SFSWAP; RNPS1;	GO:0048025~negative regulation of mRNA splicing, via spliceosome	6	21	28.5714285714286	0.00407391986508743	0.0289023423125045	1	1	0.915291550569176	0.998790808935051	0.271237290091192
down	HS6ST1; AKT1; PLCD1; FZD5; VASH1; HEY1;	GO:0060716~labyrinthine layer blood vessel development	6	21	28.5714285714286	0.00407391986508743	0.0289023423125045	1	1	0.915291550569176	0.998790808935051	0.271237290091192
down	WNT10B; BMP2; BMP4; FGFR3; SLC39A14; CREB3L2; SNX19; RUNX3;	GO:0002062~chondrocyte differentiation	8	37	21.6216216216216	0.00420344483404378	0.0297896307803972	1	1	0.920253570696804	0.998790808935051	0.279564148757462
down	IKBKB; TRAF1; RIPK1; SPPL2B; MADD; RNF31; RBCK1;	GO:0010803~regulation of tumor necrosis factor-mediated signaling pathway	7	29	24.1379310344828	0.00434343021064998	0.0306193503141074	1	1	0.925150634868446	0.998790808935051	0.287350745270157
down	TAF1; FGFR2; NDST1; WLS; KDM2B; KAT2A; LRP6;	GO:0030901~midbrain development	7	29	24.1379310344828	0.00434343021064998	0.0306193503141074	1	1	0.925150634868446	0.998790808935051	0.287350745270157
down	F2RL1; DAB2IP; CPNE1; SPHK2; BTRC; CARD8; TRAF1;	GO:0043122~regulation of I-kappaB kinase/NF-kappaB signaling	7	29	24.1379310344828	0.00434343021064998	0.0306193503141074	1	1	0.925150634868446	0.998790808935051	0.287350745270157
down	HRAS; CSF1; ITPKB; SHC1; GRB2; NOTCH2; RAPGEF1;	GO:0046579~positive regulation of Ras protein signal transduction	7	29	24.1379310344828	0.00434343021064998	0.0306193503141074	1	1	0.925150634868446	0.998790808935051	0.287350745270157
down	ABL1; EGFR; ERBB2; ERBB3; ROCK1; ARHGAP18; INPP5F;	GO:2000145~regulation of cell motility	7	29	24.1379310344828	0.00434343021064998	0.0306193503141074	1	1	0.925150634868446	0.998790808935051	0.287350745270157
down	ZBTB7B; MT-CO2; STAT5A; STAT5B; CAV1; DDR1; MED1; GPAT4; APLN;	GO:0007595~lactation	9	46	19.5652173913043	0.00438217218584303	0.0307950123217549	1	1	0.92647263592343	0.998790808935051	0.288999265186333
down	ACACB; MT-ND1; AMH; G6PD; MMP14; BTG2; CD83; LONP2; KAT2A;	GO:0014070~response to organic cyclic compound	9	46	19.5652173913043	0.00438217218584303	0.0307950123217549	1	1	0.92647263592343	0.998790808935051	0.288999265186333
down	WNT10B; TRIO; ZFP36L2; WNT3A; E2F1; GPS2; ZFPM1; SIRT2; ASXL1;	GO:0045599~negative regulation of fat cell differentiation	9	46	19.5652173913043	0.00438217218584303	0.0307950123217549	1	1	0.92647263592343	0.998790808935051	0.288999265186333
up	ANXA9; PDLIM5; CD2AP;	GO:0098609~cell-cell adhesion	3	152	1.97368421052632	0.00450201643570269	0.0710183726361223	1	1	0.436669432547474	0.915809708666219	0.436039963610042
down	TYROBP; ABL1; PARP1; MTOR; GSK3B; SSH1; PPP1R13B; DAXX;	GO:1901216~positive regulation of neuron death	8	38	21.0526315789474	0.00483200046036314	0.0338080259608898	1	1	0.938383515027108	0.998790808935051	0.317275231391784
down	CNOT3; PARN; MLH1; PAN2; CNOT9; TNKS1BP1;	GO:0000289~nuclear-transcribed mRNA poly(A) tail shortening	6	22	27.2727272727273	0.00493188239771269	0.0342261371380207	1	1	0.940761319409077	0.998790808935051	0.321199042874452
down	TNFSF14; MSN; PSMB10; TNFRSF4; NCSTN; P2RX7;	GO:0042098~T cell proliferation	6	22	27.2727272727273	0.00493188239771269	0.0342261371380207	1	1	0.940761319409077	0.998790808935051	0.321199042874452
down	INPP5B; INPP5D; INPP5K; INPP5E; INPP5F; INPP5J;	GO:0046856~phosphatidylinositol dephosphorylation	6	22	27.2727272727273	0.00493188239771269	0.0342261371380207	1	1	0.940761319409077	0.998790808935051	0.321199042874452
down	BMP4; BMP7; CASR; MMP14; MKS1; TIMELESS;	GO:0048754~branching morphogenesis of an epithelial tube	6	22	27.2727272727273	0.00493188239771269	0.0342261371380207	1	1	0.940761319409077	0.998790808935051	0.321199042874452
down	CACNB3; CAV1; P2RX4; P2RX7; SCN3B; CACNG4;	GO:0051899~membrane depolarization	6	22	27.2727272727273	0.00493188239771269	0.0342261371380207	1	1	0.940761319409077	0.998790808935051	0.321199042874452
down	COQ9; PDSS1; COQ7; UBIAD1; FDXR;	GO:0006744~ubiquinone biosynthetic process	5	15	33.3333333333333	0.00505558935804151	0.0346884021353095	1	1	0.943253716773309	0.998790808935051	0.325537220860614
down	HTATSF1; KPNA6; GRK2; CTBP1; GAS6;	GO:0019079~viral genome replication	5	15	33.3333333333333	0.00505558935804151	0.0346884021353095	1	1	0.943253716773309	0.998790808935051	0.325537220860614
down	PODXL; ABL1; CDH1; NF2; EPB41L5;	GO:0022408~negative regulation of cell-cell adhesion	5	15	33.3333333333333	0.00505558935804151	0.0346884021353095	1	1	0.943253716773309	0.998790808935051	0.325537220860614
down	PDGFRB; CALM3; MTOR; PTPA; VRK3;	GO:0032516~positive regulation of phosphoprotein phosphatase activity	5	15	33.3333333333333	0.00505558935804151	0.0346884021353095	1	1	0.943253716773309	0.998790808935051	0.325537220860614
down	SOX18; GJA5; TBX2; MED1; IFT122;	GO:0035050~embryonic heart tube development	5	15	33.3333333333333	0.00505558935804151	0.0346884021353095	1	1	0.943253716773309	0.998790808935051	0.325537220860614
down	DENND3; CHEK2; PPT1; RIPK1; DAB2IP;	GO:0044257~cellular protein catabolic process	5	15	33.3333333333333	0.00505558935804151	0.0346884021353095	1	1	0.943253716773309	0.998790808935051	0.325537220860614
down	TYROBP; CD74; APP; TIRAP; AGER;	GO:0045410~positive regulation of interleukin-6 biosynthetic process	5	15	33.3333333333333	0.00505558935804151	0.0346884021353095	1	1	0.943253716773309	0.998790808935051	0.325537220860614
down	NFATC2; KAT2A; FOXP3; DROSHA; FANCA;	GO:0045589~regulation of regulatory T cell differentiation	5	15	33.3333333333333	0.00505558935804151	0.0346884021353095	1	1	0.943253716773309	0.998790808935051	0.325537220860614
down	LRSAM1; LILRB1; SNX33; SYT11; PACSIN3;	GO:0045806~negative regulation of endocytosis	5	15	33.3333333333333	0.00505558935804151	0.0346884021353095	1	1	0.943253716773309	0.998790808935051	0.325537220860614
down	BMP4; FOXF1; DAG1; ESRP2; CTSZ;	GO:0060441~epithelial tube branching involved in lung morphogenesis	5	15	33.3333333333333	0.00505558935804151	0.0346884021353095	1	1	0.943253716773309	0.998790808935051	0.325537220860614
down	ZNF609; FLNA; DAB2IP; FBXO31; NSMF;	GO:2001224~positive regulation of neuron migration	5	15	33.3333333333333	0.00505558935804151	0.0346884021353095	1	1	0.943253716773309	0.998790808935051	0.325537220860614
down	RBBP4; RBBP7; CENPP; CENPI; CENPT; CENPO; NASP;	GO:0034080~CENP-A containing nucleosome assembly	7	30	23.3333333333333	0.00509076375057183	0.0347868856289075	1	1	0.943895697912582	0.998790808935051	0.326461450310027
down	AGRN; ITGAL; FLNA; ITGB7; SYNGAP1; DLG4; SCRIB;	GO:0043113~receptor clustering	7	30	23.3333333333333	0.00509076375057183	0.0347868856289075	1	1	0.943895697912582	0.998790808935051	0.326461450310027
down	EGFR; F2R; AKT1; GJA5; CASR; CAV1; TRPM4;	GO:0045907~positive regulation of vasoconstriction	7	30	23.3333333333333	0.00509076375057183	0.0347868856289075	1	1	0.943895697912582	0.998790808935051	0.326461450310027
down	PAK4; ABL1; KDR; TEK; MAPK7; GAS6; NDNF;	GO:2000352~negative regulation of endothelial cell apoptotic process	7	30	23.3333333333333	0.00509076375057183	0.0347868856289075	1	1	0.943895697912582	0.998790808935051	0.326461450310027
down	UBTF; SMARCB1; TAF1C; BAZ2A;	GO:0001188~RNA polymerase I preinitiation complex assembly	4	9	44.4444444444444	0.00545684553106196	0.03632280745427	1	1	0.948342354459994	0.998790808935051	0.340875481851097
down	ITPKB; FANCC; NCSTN; FOXP3;	GO:0002262~myeloid cell homeostasis	4	9	44.4444444444444	0.00545684553106196	0.03632280745427	1	1	0.948342354459994	0.998790808935051	0.340875481851097
down	DLL1; BCL3; NOTCH2; LFNG;	GO:0002315~marginal zone B cell differentiation	4	9	44.4444444444444	0.00545684553106196	0.03632280745427	1	1	0.948342354459994	0.998790808935051	0.340875481851097
down	BMP4; ERBB3; FOXF1; CRELD1;	GO:0003197~endocardial cushion development	4	9	44.4444444444444	0.00545684553106196	0.03632280745427	1	1	0.948342354459994	0.998790808935051	0.340875481851097
down	VPS16; VPS11; VPS4A; VPS18;	GO:0007033~vacuole organization	4	9	44.4444444444444	0.00545684553106196	0.03632280745427	1	1	0.948342354459994	0.998790808935051	0.340875481851097
down	MAP3K10; MAP3K12; RIPK1; MAP3K11;	GO:0007256~activation of JNKK activity	4	9	44.4444444444444	0.00545684553106196	0.03632280745427	1	1	0.948342354459994	0.998790808935051	0.340875481851097
down	MTOR; MMP14; MAMSTR; MAML1;	GO:0010831~positive regulation of myotube differentiation	4	9	44.4444444444444	0.00545684553106196	0.03632280745427	1	1	0.948342354459994	0.998790808935051	0.340875481851097
down	NRP1; NRP2; PLXNA3; SEMA3F;	GO:0021612~facial nerve structural organization	4	9	44.4444444444444	0.00545684553106196	0.03632280745427	1	1	0.948342354459994	0.998790808935051	0.340875481851097
down	GP1BA; F2R; F2RL1; CAV1;	GO:0030193~regulation of blood coagulation	4	9	44.4444444444444	0.00545684553106196	0.03632280745427	1	1	0.948342354459994	0.998790808935051	0.340875481851097
down	ERBB2; GSK3B; KLHL42; MACF1;	GO:0032886~regulation of microtubule-based process	4	9	44.4444444444444	0.00545684553106196	0.03632280745427	1	1	0.948342354459994	0.998790808935051	0.340875481851097
down	PDGFRB; AKT1; P2RX4; P2RX7;	GO:0034405~response to fluid shear stress	4	9	44.4444444444444	0.00545684553106196	0.03632280745427	1	1	0.948342354459994	0.998790808935051	0.340875481851097
down	CSF1R; PLEK; PDGFRB; PLCD4;	GO:0046488~phosphatidylinositol metabolic process	4	9	44.4444444444444	0.00545684553106196	0.03632280745427	1	1	0.948342354459994	0.998790808935051	0.340875481851097
down	LRP5; TP53; CTC1; ASXL1;	GO:0048539~bone marrow development	4	9	44.4444444444444	0.00545684553106196	0.03632280745427	1	1	0.948342354459994	0.998790808935051	0.340875481851097
down	LAT; CRTAM; CD4; KAT2A;	GO:0050863~regulation of T cell activation	4	9	44.4444444444444	0.00545684553106196	0.03632280745427	1	1	0.948342354459994	0.998790808935051	0.340875481851097
down	NRP1; USP6; VAMP2; MBTPS1;	GO:0060627~regulation of vesicle-mediated transport	4	9	44.4444444444444	0.00545684553106196	0.03632280745427	1	1	0.948342354459994	0.998790808935051	0.340875481851097
down	SOCS3; FGFR2; GRB2; FZD5;	GO:0060670~branching involved in labyrinthine layer morphogenesis	4	9	44.4444444444444	0.00545684553106196	0.03632280745427	1	1	0.948342354459994	0.998790808935051	0.340875481851097
down	PARP1; ZC3HAV1; PARP2; PARP3;	GO:0070212~protein poly-ADP-ribosylation	4	9	44.4444444444444	0.00545684553106196	0.03632280745427	1	1	0.948342354459994	0.998790808935051	0.340875481851097
down	PODXL; BMP4; NOTCH2; ASXL1;	GO:0072015~glomerular visceral epithelial cell development	4	9	44.4444444444444	0.00545684553106196	0.03632280745427	1	1	0.948342354459994	0.998790808935051	0.340875481851097
down	BTN3A1; F2RL1; TCIRG1; LILRB1;	GO:0072643~interferon-gamma secretion	4	9	44.4444444444444	0.00545684553106196	0.03632280745427	1	1	0.948342354459994	0.998790808935051	0.340875481851097
down	ADGRL1; RELN; DAB2IP; ANAPC2;	GO:0090129~positive regulation of synapse maturation	4	9	44.4444444444444	0.00545684553106196	0.03632280745427	1	1	0.948342354459994	0.998790808935051	0.340875481851097
down	AP4M1; LAMP1; RBSN; ANKFY1;	GO:0090160~Golgi to lysosome transport	4	9	44.4444444444444	0.00545684553106196	0.03632280745427	1	1	0.948342354459994	0.998790808935051	0.340875481851097
down	SYNE3; SYNE2; CLMN; SPAG4;	GO:0090286~cytoskeletal anchoring at nuclear membrane	4	9	44.4444444444444	0.00545684553106196	0.03632280745427	1	1	0.948342354459994	0.998790808935051	0.340875481851097
down	CD4; AKT1; ZFP36L2; PDE1B;	GO:0097011~cellular response to granulocyte macrophage colony-stimulating factor stimulus	4	9	44.4444444444444	0.00545684553106196	0.03632280745427	1	1	0.948342354459994	0.998790808935051	0.340875481851097
down	HRAS; DAG1; IQSEC2; GPC4;	GO:0098696~regulation of neurotransmitter receptor localization to postsynaptic specialization membrane	4	9	44.4444444444444	0.00545684553106196	0.03632280745427	1	1	0.948342354459994	0.998790808935051	0.340875481851097
down	MYH3; SKI; BMP7; GJA5; PBX2; NOTCH2; MEGF8; LRP6;	GO:0030326~embryonic limb morphogenesis	8	39	20.5128205128205	0.00553005842483023	0.036700477113347	1	1	0.948736347959977	0.998790808935051	0.344419765347919
down	RRP8; TP53; ATF4; BECN1; SZT2; ITFG2; TBL2; KPTN;	GO:0042149~cellular response to glucose starvation	8	39	20.5128205128205	0.00553005842483023	0.036700477113347	1	1	0.948736347959977	0.998790808935051	0.344419765347919
down	PLCG1; CD40; AKT1; KDR; STAT5A; AMOTL1; P2RX4; PRKD2;	GO:0043536~positive regulation of blood vessel endothelial cell migration	8	39	20.5128205128205	0.00553005842483023	0.036700477113347	1	1	0.948736347959977	0.998790808935051	0.344419765347919
down	BMP2; BMP4; ENG; BMP7; ACVR1B; ACVRL1; ACVR1; GDF11; BMP8A;	GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation	9	48	18.75	0.00558506806739134	0.0369920811639012	1	1	0.949139951057521	0.998790808935051	0.347156356437899
down	ALDH1A2; TYMS; IL6R; PML; STAT1; MAPKAPK3; CD274; RELA; NFKB1;	GO:0034097~response to cytokine	9	48	18.75	0.00558506806739134	0.0369920811639012	1	1	0.949139951057521	0.998790808935051	0.347156356437899
down	RAD52; RAD51; SWI5;	GO:0000730~DNA recombinase assembly	3	4	75	0.00585961001078272	0.0375325211966518	1	1	0.950633539590471	0.998790808935051	0.352228176858372
down	ITGAL; FGL2; APBB1IP;	GO:0002291~T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell	3	4	75	0.00585961001078272	0.0375325211966518	1	1	0.950633539590471	0.998790808935051	0.352228176858372
down	ROCK1; EPB41L5; CCDC88C;	GO:0003383~apical constriction	3	4	75	0.00585961001078272	0.0375325211966518	1	1	0.950633539590471	0.998790808935051	0.352228176858372
down	SMPD1; SMPD2; SMPD3;	GO:0006684~sphingomyelin metabolic process	3	4	75	0.00585961001078272	0.0375325211966518	1	1	0.950633539590471	0.998790808935051	0.352228176858372
down	EIF2AK2; EIF2AK1; EIF2AK4;	GO:0010998~regulation of translational initiation by eIF2 alpha phosphorylation	3	4	75	0.00585961001078272	0.0375325211966518	1	1	0.950633539590471	0.998790808935051	0.352228176858372
down	ABL1; XRCC1; LRP6;	GO:0021587~cerebellum morphogenesis	3	4	75	0.00585961001078272	0.0375325211966518	1	1	0.950633539590471	0.998790808935051	0.352228176858372
down	LMNA; CKAP5; KIF2C;	GO:0030951~establishment or maintenance of microtubule cytoskeleton polarity	3	4	75	0.00585961001078272	0.0375325211966518	1	1	0.950633539590471	0.998790808935051	0.352228176858372
down	HTT; HAP1; PKD2;	GO:0031587~positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity	3	4	75	0.00585961001078272	0.0375325211966518	1	1	0.950633539590471	0.998790808935051	0.352228176858372
down	DENND4B; DENND1A; MADD;	GO:0032483~regulation of Rab protein signal transduction	3	4	75	0.00585961001078272	0.0375325211966518	1	1	0.950633539590471	0.998790808935051	0.352228176858372
down	M6PR; BLOC1S3; NAGPA;	GO:0033299~secretion of lysosomal enzymes	3	4	75	0.00585961001078272	0.0375325211966518	1	1	0.950633539590471	0.998790808935051	0.352228176858372
down	EGFR; CD40; RELA;	GO:0033590~response to cobalamin	3	4	75	0.00585961001078272	0.0375325211966518	1	1	0.950633539590471	0.998790808935051	0.352228176858372
down	NF2; NEK8; MOB3B;	GO:0035330~regulation of hippo signaling	3	4	75	0.00585961001078272	0.0375325211966518	1	1	0.950633539590471	0.998790808935051	0.352228176858372
down	NRP1; NRP2; SEMA3F;	GO:0036486~ventral trunk neural crest cell migration	3	4	75	0.00585961001078272	0.0375325211966518	1	1	0.950633539590471	0.998790808935051	0.352228176858372
down	ARID1A; INO80; BPTF;	GO:0042766~nucleosome mobilization	3	4	75	0.00585961001078272	0.0375325211966518	1	1	0.950633539590471	0.998790808935051	0.352228176858372
down	IDO1; CD274; RIPK3;	GO:0046006~regulation of activated T cell proliferation	3	4	75	0.00585961001078272	0.0375325211966518	1	1	0.950633539590471	0.998790808935051	0.352228176858372
down	NR1H2; CAV1; PROM2;	GO:0048550~negative regulation of pinocytosis	3	4	75	0.00585961001078272	0.0375325211966518	1	1	0.950633539590471	0.998790808935051	0.352228176858372
down	PROC; ANXA5; PROCR;	GO:0050819~negative regulation of coagulation	3	4	75	0.00585961001078272	0.0375325211966518	1	1	0.950633539590471	0.998790808935051	0.352228176858372
down	BMP2; BMP7; BNC2;	GO:0060485~mesenchyme development	3	4	75	0.00585961001078272	0.0375325211966518	1	1	0.950633539590471	0.998790808935051	0.352228176858372
down	NEURL1B; IL10RA; LRSAM1;	GO:0070086~ubiquitin-dependent endocytosis	3	4	75	0.00585961001078272	0.0375325211966518	1	1	0.950633539590471	0.998790808935051	0.352228176858372
down	JAK3; GIMAP8; CD274;	GO:0070232~regulation of T cell apoptotic process	3	4	75	0.00585961001078272	0.0375325211966518	1	1	0.950633539590471	0.998790808935051	0.352228176858372
down	CCL11; STAT5B; JAK3;	GO:0070670~response to interleukin-4	3	4	75	0.00585961001078272	0.0375325211966518	1	1	0.950633539590471	0.998790808935051	0.352228176858372
down	SH3PXD2B; FARP2; BIN2;	GO:0071800~podosome assembly	3	4	75	0.00585961001078272	0.0375325211966518	1	1	0.950633539590471	0.998790808935051	0.352228176858372
down	DLL1; NOTCH2; HEYL;	GO:0072014~proximal tubule development	3	4	75	0.00585961001078272	0.0375325211966518	1	1	0.950633539590471	0.998790808935051	0.352228176858372
down	NRP1; NRP2; SEMA3F;	GO:0097490~sympathetic neuron projection extension	3	4	75	0.00585961001078272	0.0375325211966518	1	1	0.950633539590471	0.998790808935051	0.352228176858372
down	NRP1; NRP2; SEMA3F;	GO:0097491~sympathetic neuron projection guidance	3	4	75	0.00585961001078272	0.0375325211966518	1	1	0.950633539590471	0.998790808935051	0.352228176858372
down	SETMAR; SETD2; ASH1L;	GO:0097676~histone H3-K36 dimethylation	3	4	75	0.00585961001078272	0.0375325211966518	1	1	0.950633539590471	0.998790808935051	0.352228176858372
down	NUP62; E2F4; RBM14;	GO:0098534~centriole assembly	3	4	75	0.00585961001078272	0.0375325211966518	1	1	0.950633539590471	0.998790808935051	0.352228176858372
down	CXCL10; FGF1; ADAMTS12;	GO:1901509~regulation of endothelial tube morphogenesis	3	4	75	0.00585961001078272	0.0375325211966518	1	1	0.950633539590471	0.998790808935051	0.352228176858372
down	NRP1; NRP2; SEMA3F;	GO:1902285~semaphorin-plexin signaling pathway involved in neuron projection guidance	3	4	75	0.00585961001078272	0.0375325211966518	1	1	0.950633539590471	0.998790808935051	0.352228176858372
down	FBL; CREBBP; SIRT7;	GO:1990258~histone glutamine methylation	3	4	75	0.00585961001078272	0.0375325211966518	1	1	0.950633539590471	0.998790808935051	0.352228176858372
down	CHEK2; THOC5; DDX39B;	GO:2000002~negative regulation of DNA damage checkpoint	3	4	75	0.00585961001078272	0.0375325211966518	1	1	0.950633539590471	0.998790808935051	0.352228176858372
down	TOM1L1; TFDP1; SH2B1;	GO:2000278~regulation of DNA biosynthetic process	3	4	75	0.00585961001078272	0.0375325211966518	1	1	0.950633539590471	0.998790808935051	0.352228176858372
down	NBAS; DHX34; SECISBP2;	GO:2000623~negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay	3	4	75	0.00585961001078272	0.0375325211966518	1	1	0.950633539590471	0.998790808935051	0.352228176858372
down	PARP1; XPC; DDB1; DDB2; COPS7B; COPS7A;	GO:0000715~nucleotide-excision repair, DNA damage recognition	6	23	26.0869565217391	0.00591531876559181	0.0375325211966518	1	1	0.951085057598588	0.998790808935051	0.352228176858372
down	KDM1A; GLI3; SOX10; CX3CL1; SMO; ZNF335;	GO:0002052~positive regulation of neuroblast proliferation	6	23	26.0869565217391	0.00591531876559181	0.0375325211966518	1	1	0.951085057598588	0.998790808935051	0.352228176858372
down	FOXP2; LRP5; FGFR2; STAT1; FOXF1; SMO;	GO:0002053~positive regulation of mesenchymal cell proliferation	6	23	26.0869565217391	0.00591531876559181	0.0375325211966518	1	1	0.951085057598588	0.998790808935051	0.352228176858372
down	ERCC1; PARP1; ERCC3; RPA1; DDB1; DDB2;	GO:0006295~nucleotide-excision repair, DNA incision, 3'-to lesion	6	23	26.0869565217391	0.00591531876559181	0.0375325211966518	1	1	0.951085057598588	0.998790808935051	0.352228176858372
down	SLC37A4; AKT1; AKT2; MFSD12; SLC35B4; RFT1;	GO:0008643~carbohydrate transport	6	23	26.0869565217391	0.00591531876559181	0.0375325211966518	1	1	0.951085057598588	0.998790808935051	0.352228176858372
down	DYSF; CD36; GM2A; STAT5B; CAV1; FITM2;	GO:0019915~lipid storage	6	23	26.0869565217391	0.00591531876559181	0.0375325211966518	1	1	0.951085057598588	0.998790808935051	0.352228176858372
down	ADGRL1; PRKACA; KDR; BCAP31; PTPRJ; TMEM110-MUSTN1;	GO:0035584~calcium-mediated signaling using intracellular calcium source	6	23	26.0869565217391	0.00591531876559181	0.0375325211966518	1	1	0.951085057598588	0.998790808935051	0.352228176858372
down	TYMS; GLI3; SOX10; EIF4H; KDF1; PYGO2;	GO:0048589~developmental growth	6	23	26.0869565217391	0.00591531876559181	0.0375325211966518	1	1	0.951085057598588	0.998790808935051	0.352228176858372
down	HRAS; PML; CDKN1A; TBX2; TERF2; KAT6A;	GO:0090398~cellular senescence	6	23	26.0869565217391	0.00591531876559181	0.0375325211966518	1	1	0.951085057598588	0.998790808935051	0.352228176858372
down	BUB1; HRAS; KNTC1; INTS3; TICRR; PRCC; NABP2;	GO:0007093~mitotic cell cycle checkpoint	7	31	22.5806451612903	0.00593062133527822	0.0375325211966518	1	1	0.951085057598588	0.998790808935051	0.352228176858372
down	KIF3B; KIF4A; HAP1; BLOC1S3; DTNBP1; SPG7; TRAK1;	GO:0008089~anterograde axonal transport	7	31	22.5806451612903	0.00593062133527822	0.0375325211966518	1	1	0.951085057598588	0.998790808935051	0.352228176858372
down	EGFR; SRC; CCND2; AKT1; PKD2; PSRC1; CDC6;	GO:0045737~positive regulation of cyclin-dependent protein serine/threonine kinase activity	7	31	22.5806451612903	0.00593062133527822	0.0375325211966518	1	1	0.951085057598588	0.998790808935051	0.352228176858372
down	APBB1; EGFR; BRCA1; TRIM28; UIMC1; WRAP53; BABAM1;	GO:0045739~positive regulation of DNA repair	7	31	22.5806451612903	0.00593062133527822	0.0375325211966518	1	1	0.951085057598588	0.998790808935051	0.352228176858372
down	NOVA2; RBM28; NCL; SF3B4; DAZAP1; RBM38; RBMX;	GO:0051252~regulation of RNA metabolic process	7	31	22.5806451612903	0.00593062133527822	0.0375325211966518	1	1	0.951085057598588	0.998790808935051	0.352228176858372
down	ICMT; YIF1B; MICALL1; TAOK2; ZDHHC3; VPS37C; ZDHHC1; ZDHHC7; ZDHHC9;	GO:0006612~protein targeting to membrane	9	49	18.3673469387755	0.00627476299755425	0.0392891213936327	1	1	0.953269971795403	0.998790808935051	0.368713189458774
down	DLL1; ABL1; LAMA2; PML; PRKX; PTPRJ; ROCK1; PKP4; FAF1;	GO:0030155~regulation of cell adhesion	9	49	18.3673469387755	0.00627476299755425	0.0392891213936327	1	1	0.953269971795403	0.998790808935051	0.368713189458774
down	ARID1A; FBLN1; STC1; EMP2; DDR1; FUT7; TRIM28; UBE2Q1;	GO:0007566~embryo implantation	8	40	20	0.00630235387803879	0.0392891213936327	1	1	0.953269971795403	0.998790808935051	0.368713189458774
down	ACACB; MBD3; SRC; MTOR; GSS; CHSY1; KAT2A; MBD1;	GO:0031667~response to nutrient levels	8	40	20	0.00630235387803879	0.0392891213936327	1	1	0.953269971795403	0.998790808935051	0.368713189458774
down	SOX18; FLT4; NOTCH4; RIC8A; B9D1;	GO:0001944~vasculature development	5	16	31.25	0.00631988710132503	0.0392891213936327	1	1	0.953529482677016	0.998790808935051	0.368713189458774
down	SIPA1L3; FLNB; RILPL1; GRHL2; BCL11B;	GO:0003382~epithelial cell morphogenesis	5	16	31.25	0.00631988710132503	0.0392891213936327	1	1	0.953529482677016	0.998790808935051	0.368713189458774
down	PYGB; PHKG2; PHKA2; PHKA1; PHKG1;	GO:0005980~glycogen catabolic process	5	16	31.25	0.00631988710132503	0.0392891213936327	1	1	0.953529482677016	0.998790808935051	0.368713189458774
down	AP4M1; AP2A1; CORO7; GBF1; KIF16B;	GO:0006895~Golgi to endosome transport	5	16	31.25	0.00631988710132503	0.0392891213936327	1	1	0.953529482677016	0.998790808935051	0.368713189458774
down	CKAP5; KIF24; KIF18B; KIF2C; KATNB1;	GO:0007019~microtubule depolymerization	5	16	31.25	0.00631988710132503	0.0392891213936327	1	1	0.953529482677016	0.998790808935051	0.368713189458774
down	TMEM129; SYVN1; NPLOC4; AUP1; OS9;	GO:0030970~retrograde protein transport, ER to cytosol	5	16	31.25	0.00631988710132503	0.0392891213936327	1	1	0.953529482677016	0.998790808935051	0.368713189458774
down	NRP1; CASR; RELA; MED1; SIRT2;	GO:0035729~cellular response to hepatocyte growth factor stimulus	5	16	31.25	0.00631988710132503	0.0392891213936327	1	1	0.953529482677016	0.998790808935051	0.368713189458774
down	HGS; PSMD3; CHEK2; PSMD2; FAF1;	GO:0042176~regulation of protein catabolic process	5	16	31.25	0.00631988710132503	0.0392891213936327	1	1	0.953529482677016	0.998790808935051	0.368713189458774
down	LCP1; FLNA; DDR1; CARMIL2; ARHGAP35;	GO:0044319~wound healing, spreading of cells	5	16	31.25	0.00631988710132503	0.0392891213936327	1	1	0.953529482677016	0.998790808935051	0.368713189458774
down	EGFR; IGF1R; F2RL1; RAPGEF1; MAPK8IP3;	GO:0046328~regulation of JNK cascade	5	16	31.25	0.00631988710132503	0.0392891213936327	1	1	0.953529482677016	0.998790808935051	0.368713189458774
down	DYNC1I1; HTT; HAP1; NDE1; TRAK1;	GO:0047496~vesicle transport along microtubule	5	16	31.25	0.00631988710132503	0.0392891213936327	1	1	0.953529482677016	0.998790808935051	0.368713189458774
down	RARG; PML; NR1H2; SNW1; RXRB;	GO:0048384~retinoic acid receptor signaling pathway	5	16	31.25	0.00631988710132503	0.0392891213936327	1	1	0.953529482677016	0.998790808935051	0.368713189458774
down	MEIS1; TAL1; ZFP36L2; ADAR; TEK;	GO:0060216~definitive hemopoiesis	5	16	31.25	0.00631988710132503	0.0392891213936327	1	1	0.953529482677016	0.998790808935051	0.368713189458774
down	SLC9A1; ERBB3; PTBP1; CHERP; SPPL3;	GO:0070886~positive regulation of calcineurin-NFAT signaling cascade	5	16	31.25	0.00631988710132503	0.0392891213936327	1	1	0.953529482677016	0.998790808935051	0.368713189458774
down	SETMAR; KMT5C; PNKP; WRAP53; PARP3;	GO:2001034~positive regulation of double-strand break repair via nonhomologous end joining	5	16	31.25	0.00631988710132503	0.0392891213936327	1	1	0.953529482677016	0.998790808935051	0.368713189458774
down	PRKACA; BMP7; NF2; WNT3; ACVR1; WLS; POFUT2;	GO:0001707~mesoderm formation	7	32	21.875	0.00686967409383676	0.0424307134649825	1	1	0.956639739959644	0.998790808935051	0.398195814458209
down	TFAP2A; BMP4; FGFR2; MMP14; GRHL2; IFT140; SETD2;	GO:0048701~embryonic cranial skeleton morphogenesis	7	32	21.875	0.00686967409383676	0.0424307134649825	1	1	0.956639739959644	0.998790808935051	0.398195814458209
down	LRP4; KREMEN2; KAT2A; KREMEN1; IFT122; IFT172; ZNRF3;	GO:0060173~limb development	7	32	21.875	0.00686967409383676	0.0424307134649825	1	1	0.956639739959644	0.998790808935051	0.398195814458209
down	GSK3B; WNT3A; ROCK1; ATAT1; MARK2; PHLDB1; BICD2;	GO:0070507~regulation of microtubule cytoskeleton organization	7	32	21.875	0.00686967409383676	0.0424307134649825	1	1	0.956639739959644	0.998790808935051	0.398195814458209
down	CALM3; GSK3B; BACE1; NCS1; ADCY1; DTNBP1; VPS18; RIMS3; GIT1;	GO:2000300~regulation of synaptic vesicle exocytosis	9	50	18	0.00702806948846824	0.0433666936405201	1	1	0.957578644829833	0.998790808935051	0.406979625944728
down	CX3CL1; CXCL10; CXCL11; CXCL9; IL16; CXCL1;	GO:0030595~leukocyte chemotaxis	6	24	25	0.00703419061893218	0.0433666936405201	1	1	0.957578644829833	0.998790808935051	0.406979625944728
down	NUP62; BRCA1; GOLGA2; CHD3; CKAP5; CDK5RAP2; UVRAG; KIAA1614;	GO:0007098~centrosome cycle	8	41	19.5121951219512	0.00715367726542726	0.0439816238867069	1	1	0.958561560865813	0.998790808935051	0.41275050817176
down	PFKFB1; CBL; FOXK1; FOXK2; BNIP1; AACS; LRP11; ULK2;	GO:0042594~response to starvation	8	41	19.5121951219512	0.00715367726542726	0.0439816238867069	1	1	0.958561560865813	0.998790808935051	0.41275050817176
down	MYO1G; BTN3A3; GNL1; FOXP3;	GO:0002456~T cell mediated immunity	4	10	40	0.00728916432948068	0.0440846020035469	1	1	0.959242841292868	0.998790808935051	0.413716917919745
down	ADCY6; ADCY3; ADCY7; ADCY1;	GO:0006171~cAMP biosynthetic process	4	10	40	0.00728916432948068	0.0440846020035469	1	1	0.959242841292868	0.998790808935051	0.413716917919745
down	FLNB; JUP; DAG1; TLN1;	GO:0007016~cytoskeletal anchoring at plasma membrane	4	10	40	0.00728916432948068	0.0440846020035469	1	1	0.959242841292868	0.998790808935051	0.413716917919745
down	ALDH1A2; EGFR; FOXF1; SMO;	GO:0007494~midgut development	4	10	40	0.00728916432948068	0.0440846020035469	1	1	0.959242841292868	0.998790808935051	0.413716917919745
down	SLC25A12; SRC; AKT1; AKT2;	GO:0010907~positive regulation of glucose metabolic process	4	10	40	0.00728916432948068	0.0440846020035469	1	1	0.959242841292868	0.998790808935051	0.413716917919745
down	METTL3; DGCR8; SRRT; DROSHA;	GO:0031053~primary miRNA processing	4	10	40	0.00728916432948068	0.0440846020035469	1	1	0.959242841292868	0.998790808935051	0.413716917919745
down	EMP2; ROCK1; ANO6; P2RX7;	GO:0032060~bleb assembly	4	10	40	0.00728916432948068	0.0440846020035469	1	1	0.959242841292868	0.998790808935051	0.413716917919745
down	TLR4; SPN; LILRB1; IL12RB2;	GO:0032609~interferon-gamma production	4	10	40	0.00728916432948068	0.0440846020035469	1	1	0.959242841292868	0.998790808935051	0.413716917919745
down	TICRR; ORC1; CDC6; TOPBP1;	GO:0033314~mitotic DNA replication checkpoint	4	10	40	0.00728916432948068	0.0440846020035469	1	1	0.959242841292868	0.998790808935051	0.413716917919745
down	RAB32; BLOC1S3; ANKRD27; AP1M1;	GO:0035646~endosome to melanosome transport	4	10	40	0.00728916432948068	0.0440846020035469	1	1	0.959242841292868	0.998790808935051	0.413716917919745
down	BACE1; DHCR24; NCSTN; APH1A;	GO:0042987~amyloid precursor protein catabolic process	4	10	40	0.00728916432948068	0.0440846020035469	1	1	0.959242841292868	0.998790808935051	0.413716917919745
down	RARG; CDKN1A; RIPK1; MARK4;	GO:0043068~positive regulation of programmed cell death	4	10	40	0.00728916432948068	0.0440846020035469	1	1	0.959242841292868	0.998790808935051	0.413716917919745
down	AKT1; MTOR; TSC1; AKT1S1;	GO:0045792~negative regulation of cell size	4	10	40	0.00728916432948068	0.0440846020035469	1	1	0.959242841292868	0.998790808935051	0.413716917919745
down	TLR4; CD36; TIRAP; RELA;	GO:0071223~cellular response to lipoteichoic acid	4	10	40	0.00728916432948068	0.0440846020035469	1	1	0.959242841292868	0.998790808935051	0.413716917919745
down	PLA2G6; CD40; FLT4; SPHK2;	GO:0090037~positive regulation of protein kinase C signaling	4	10	40	0.00728916432948068	0.0440846020035469	1	1	0.959242841292868	0.998790808935051	0.413716917919745
down	NCL; MTOR; SMARCB1; DDX11;	GO:1901838~positive regulation of transcription of nucleolar large rRNA by RNA polymerase I	4	10	40	0.00728916432948068	0.0440846020035469	1	1	0.959242841292868	0.998790808935051	0.413716917919745
down	EPN2; ALOX5; E2F2; EPN1;	GO:1903671~negative regulation of sprouting angiogenesis	4	10	40	0.00728916432948068	0.0440846020035469	1	1	0.959242841292868	0.998790808935051	0.413716917919745
down	APP; CD36; RIPK1; RIPK3;	GO:1990000~amyloid fibril formation	4	10	40	0.00728916432948068	0.0440846020035469	1	1	0.959242841292868	0.998790808935051	0.413716917919745
down	KDM1A; SFSWAP; DDX17; SCNM1; ESRP2;	GO:0000380~alternative mRNA splicing, via spliceosome	5	17	29.4117647058824	0.00779038107195729	0.0465680829194012	1	1	0.962198905518731	0.998790808935051	0.437023424580212
down	AP4M1; HGS; NAGPA; VPS4A; M6PR;	GO:0006622~protein targeting to lysosome	5	17	29.4117647058824	0.00779038107195729	0.0465680829194012	1	1	0.962198905518731	0.998790808935051	0.437023424580212
down	CTDNEP1; LEMD2; REEP4; VPS4A; SPAG4;	GO:0006998~nuclear envelope organization	5	17	29.4117647058824	0.00779038107195729	0.0465680829194012	1	1	0.962198905518731	0.998790808935051	0.437023424580212
down	TP53; MSH6; RAD54L; INPP5D; COQ7;	GO:0008340~determination of adult lifespan	5	17	29.4117647058824	0.00779038107195729	0.0465680829194012	1	1	0.962198905518731	0.998790808935051	0.437023424580212
down	CSF1R; BMP4; PDE1B; THOC5; MED1;	GO:0030224~monocyte differentiation	5	17	29.4117647058824	0.00779038107195729	0.0465680829194012	1	1	0.962198905518731	0.998790808935051	0.437023424580212
down	COG7; TCIRG1; CEP250; CNTLN; ARFRP1;	GO:0033365~protein localization to organelle	5	17	29.4117647058824	0.00779038107195729	0.0465680829194012	1	1	0.962198905518731	0.998790808935051	0.437023424580212
down	RASSF2; NOTCH2; LTBP3; LRP5; LRP6;	GO:0046849~bone remodeling	5	17	29.4117647058824	0.00779038107195729	0.0465680829194012	1	1	0.962198905518731	0.998790808935051	0.437023424580212
down	ZFP36L2; PLEKHN1; UPF1; KHSRP; MOV10;	GO:0061158~3'-UTR-mediated mRNA destabilization	5	17	29.4117647058824	0.00779038107195729	0.0465680829194012	1	1	0.962198905518731	0.998790808935051	0.437023424580212
down	CAV1; IRF3; COLEC12; MAVS; ZCCHC3;	GO:0071360~cellular response to exogenous dsRNA	5	17	29.4117647058824	0.00779038107195729	0.0465680829194012	1	1	0.962198905518731	0.998790808935051	0.437023424580212
down	PDGFRB; CASR; STC1; SPHK2; TRPV2;	GO:0090280~positive regulation of calcium ion import	5	17	29.4117647058824	0.00779038107195729	0.0465680829194012	1	1	0.962198905518731	0.998790808935051	0.437023424580212
down	TNFRSF10B; STX4; RIPK1; TMC8; MADD;	GO:1902041~regulation of extrinsic apoptotic signaling pathway via death domain receptors	5	17	29.4117647058824	0.00779038107195729	0.0465680829194012	1	1	0.962198905518731	0.998790808935051	0.437023424580212
down	TYROBP; AKT1; STX4; SNX33; TM9SF4;	GO:2000010~positive regulation of protein localization to cell surface	5	17	29.4117647058824	0.00779038107195729	0.0465680829194012	1	1	0.962198905518731	0.998790808935051	0.437023424580212
down	TLR4; CYBA; CD36; TIRAP; PTPRJ; RIPK1; NFATC4; MAVS; NOD1;	GO:0032760~positive regulation of tumor necrosis factor production	9	51	17.6470588235294	0.00784862848814005	0.0468324858805714	1	1	0.962596837241444	0.998790808935051	0.43950474398002
down	TPR; CAMK1; TESK1; TBC1D1; PLEKHM2; DZIP1L; CELSR2; VPS4A; B9D1;	GO:0032880~regulation of protein localization	9	51	17.6470588235294	0.00784862848814005	0.0468324858805714	1	1	0.962596837241444	0.998790808935051	0.43950474398002
down	PIK3CD; ERBB2; IGF1R; ERBB3; AKT1; SIRT2; PIK3C2B;	GO:0014065~phosphatidylinositol 3-kinase signaling	7	33	21.2121212121212	0.00791461316210196	0.0470581492547397	1	1	0.963001629855927	0.998790808935051	0.441622507357826
down	ABL1; PTPN1; TSC2; CDH13; RAB4B; PACSIN3; ARFGAP1;	GO:0030100~regulation of endocytosis	7	33	21.2121212121212	0.00791461316210196	0.0470581492547397	1	1	0.963001629855927	0.998790808935051	0.441622507357826
down	EXOSC2; EXOSC7; SKIV2L; EDC4; PATL1; EDC3; EXOSC1;	GO:0043928~exonucleolytic catabolism of deadenylated mRNA	7	33	21.2121212121212	0.00791461316210196	0.0470581492547397	1	1	0.963001629855927	0.998790808935051	0.441622507357826
down	PRPF6; DDX39B; SF1; USP39; PRPF19; SF3A2;	GO:0000245~spliceosomal complex assembly	6	25	24	0.00829836942140172	0.0489479283700156	1	1	0.965134996337664	0.998790808935051	0.459357352532523
down	CCDC88B; AGPAT2; EIF2AK2; WNT3A; TMIGD2; AGPAT1;	GO:0001819~positive regulation of cytokine production	6	25	24	0.00829836942140172	0.0489479283700156	1	1	0.965134996337664	0.998790808935051	0.459357352532523
down	PABPC4; EXOSC7; SIDT2; RNASEH2C; SND1; SKIV2L;	GO:0006401~RNA catabolic process	6	25	24	0.00829836942140172	0.0489479283700156	1	1	0.965134996337664	0.998790808935051	0.459357352532523
down	PDGFRB; BMP4; ENG; F2R; ARRB2; WNT4;	GO:0032967~positive regulation of collagen biosynthetic process	6	25	24	0.00829836942140172	0.0489479283700156	1	1	0.965134996337664	0.998790808935051	0.459357352532523
down	PPM1F; RASSF2; CAV1; INPP5K; INPP5F; INPP5J;	GO:0033137~negative regulation of peptidyl-serine phosphorylation	6	25	24	0.00829836942140172	0.0489479283700156	1	1	0.965134996337664	0.998790808935051	0.459357352532523
down	CDK4; IMPDH2; PML; MCM2; KEAP1; ADAMTS13;	GO:0071353~cellular response to interleukin-4	6	25	24	0.00829836942140172	0.0489479283700156	1	1	0.965134996337664	0.998790808935051	0.459357352532523
down	TNFSF12; PML; LTBR; CAV1; RIPK1; RBCK1;	GO:2001238~positive regulation of extrinsic apoptotic signaling pathway	6	25	24	0.00829836942140172	0.0489479283700156	1	1	0.965134996337664	0.998790808935051	0.459357352532523
down	ACACB; OAZ2; APBA3; SCG5; ANXA5; NES; CCAR2; WDTC1; PPP1R12C;	GO:0043086~negative regulation of catalytic activity	9	52	17.3076923076923	0.00874011252037099	0.0513644026784717	1	1	0.967963230759166	0.998790808935051	0.482035028131052
down	NFASC; CNTNAP1; UGT8;	GO:0002175~protein localization to paranode region of axon	3	5	60	0.00896936374768464	0.0513644026784717	1	1	0.968979198463978	0.998790808935051	0.482035028131052
down	DDB2; POLH; MSH6;	GO:0006290~pyrimidine dimer repair	3	5	60	0.00896936374768464	0.0513644026784717	1	1	0.968979198463978	0.998790808935051	0.482035028131052
down	UBTF; TAF1C; MED1;	GO:0006356~regulation of transcription by RNA polymerase I	3	5	60	0.00896936374768464	0.0513644026784717	1	1	0.968979198463978	0.998790808935051	0.482035028131052
down	MTHFD1; MTR; MTHFR;	GO:0009086~methionine biosynthetic process	3	5	60	0.00896936374768464	0.0513644026784717	1	1	0.968979198463978	0.998790808935051	0.482035028131052
down	WNT3A; COPS7B; COPS7A;	GO:0010387~COP9 signalosome assembly	3	5	60	0.00896936374768464	0.0513644026784717	1	1	0.968979198463978	0.998790808935051	0.482035028131052
down	FGFR4; LRP1; DDR1;	GO:0010715~regulation of extracellular matrix disassembly	3	5	60	0.00896936374768464	0.0513644026784717	1	1	0.968979198463978	0.998790808935051	0.482035028131052
down	SLC22A5; PDZK1; SLC25A29;	GO:0015879~carnitine transport	3	5	60	0.00896936374768464	0.0513644026784717	1	1	0.968979198463978	0.998790808935051	0.482035028131052
down	ACACA; NECAB3; NUMBL;	GO:0019538~protein metabolic process	3	5	60	0.00896936374768464	0.0513644026784717	1	1	0.968979198463978	0.998790808935051	0.482035028131052
down	NRP1; PLXNA3; SEMA3F;	GO:0021637~trigeminal nerve structural organization	3	5	60	0.00896936374768464	0.0513644026784717	1	1	0.968979198463978	0.998790808935051	0.482035028131052
down	NRP1; PLXNA3; SEMA3F;	GO:0021785~branchiomotor neuron axon guidance	3	5	60	0.00896936374768464	0.0513644026784717	1	1	0.968979198463978	0.998790808935051	0.482035028131052
down	CPE; EXOC3L1; SMPD3;	GO:0030072~peptide hormone secretion	3	5	60	0.00896936374768464	0.0513644026784717	1	1	0.968979198463978	0.998790808935051	0.482035028131052
down	MTOR; TYSND1; LONP2;	GO:0031998~regulation of fatty acid beta-oxidation	3	5	60	0.00896936374768464	0.0513644026784717	1	1	0.968979198463978	0.998790808935051	0.482035028131052
down	PARP1; LONP1; TOP3A;	GO:0032042~mitochondrial DNA metabolic process	3	5	60	0.00896936374768464	0.0513644026784717	1	1	0.968979198463978	0.998790808935051	0.482035028131052
down	ABL1; PDGFRB; PTPN1;	GO:0035791~platelet-derived growth factor receptor-beta signaling pathway	3	5	60	0.00896936374768464	0.0513644026784717	1	1	0.968979198463978	0.998790808935051	0.482035028131052
down	STC1; RAB11B; PDZK1;	GO:0044070~regulation of anion transport	3	5	60	0.00896936374768464	0.0513644026784717	1	1	0.968979198463978	0.998790808935051	0.482035028131052
down	UCK2; UCK1; UCKL1;	GO:0044206~UMP salvage	3	5	60	0.00896936374768464	0.0513644026784717	1	1	0.968979198463978	0.998790808935051	0.482035028131052
down	SOX15; BMP4; SIRT2;	GO:0045843~negative regulation of striated muscle tissue development	3	5	60	0.00896936374768464	0.0513644026784717	1	1	0.968979198463978	0.998790808935051	0.482035028131052
down	ACVR1B; LHFPL2; DACH1;	GO:0046545~development of primary female sexual characteristics	3	5	60	0.00896936374768464	0.0513644026784717	1	1	0.968979198463978	0.998790808935051	0.482035028131052
down	CDK9; CAMK1; SUPT6H;	GO:0051147~regulation of muscle cell differentiation	3	5	60	0.00896936374768464	0.0513644026784717	1	1	0.968979198463978	0.998790808935051	0.482035028131052
down	SORBS3; PLXNA3; P2RX7;	GO:0051495~positive regulation of cytoskeleton organization	3	5	60	0.00896936374768464	0.0513644026784717	1	1	0.968979198463978	0.998790808935051	0.482035028131052
down	NRP1; PLXNA1; PLXND1;	GO:0060666~dichotomous subdivision of terminal units involved in salivary gland branching	3	5	60	0.00896936374768464	0.0513644026784717	1	1	0.968979198463978	0.998790808935051	0.482035028131052
down	WNT7B; TRIM28; SETD2;	GO:0060669~embryonic placenta morphogenesis	3	5	60	0.00896936374768464	0.0513644026784717	1	1	0.968979198463978	0.998790808935051	0.482035028131052
down	KHK; TKFC; GLYCTK;	GO:0061624~fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate	3	5	60	0.00896936374768464	0.0513644026784717	1	1	0.968979198463978	0.998790808935051	0.482035028131052
down	CDH1; JUP; BRCA1;	GO:0071681~cellular response to indole-3-methanol	3	5	60	0.00896936374768464	0.0513644026784717	1	1	0.968979198463978	0.998790808935051	0.482035028131052
down	EIF3D; EIF3B; EIF3L;	GO:0075525~viral translational termination-reinitiation	3	5	60	0.00896936374768464	0.0513644026784717	1	1	0.968979198463978	0.998790808935051	0.482035028131052
down	MECP2; CKAP5; DCTN1;	GO:0090063~positive regulation of microtubule nucleation	3	5	60	0.00896936374768464	0.0513644026784717	1	1	0.968979198463978	0.998790808935051	0.482035028131052
down	DYNC1H1; NUMA1; SPAG5;	GO:0090235~regulation of metaphase plate congression	3	5	60	0.00896936374768464	0.0513644026784717	1	1	0.968979198463978	0.998790808935051	0.482035028131052
down	RIPK1; IRF3; RIPK3;	GO:0097300~programmed necrotic cell death	3	5	60	0.00896936374768464	0.0513644026784717	1	1	0.968979198463978	0.998790808935051	0.482035028131052
down	RAB32; HPS1; HPS4;	GO:1903232~melanosome assembly	3	5	60	0.00896936374768464	0.0513644026784717	1	1	0.968979198463978	0.998790808935051	0.482035028131052
down	ARL3; RABEP1; GGA1;	GO:1903441~protein localization to ciliary membrane	3	5	60	0.00896936374768464	0.0513644026784717	1	1	0.968979198463978	0.998790808935051	0.482035028131052
down	AXIN1; GSK3B; AMER1;	GO:1904885~beta-catenin destruction complex assembly	3	5	60	0.00896936374768464	0.0513644026784717	1	1	0.968979198463978	0.998790808935051	0.482035028131052
down	DYNC1H1; NUMA1; SPAG5;	GO:1905832~positive regulation of spindle assembly	3	5	60	0.00896936374768464	0.0513644026784717	1	1	0.968979198463978	0.998790808935051	0.482035028131052
down	ADCY6; ADCY3; PRKACA; PRKAR1B; ADCY7; ADCY1; AQP3;	GO:0003091~renal water homeostasis	7	34	20.5882352941176	0.00907211563988275	0.0516870833941487	1	1	0.970035402513534	0.998790808935051	0.485063261688685
down	EGFR; AKT1; MPV17; PXN; PKD2; AGAP3; CAMKK2;	GO:0034614~cellular response to reactive oxygen species	7	34	20.5882352941176	0.00907211563988275	0.0516870833941487	1	1	0.970035402513534	0.998790808935051	0.485063261688685
down	PLA2G6; HLA-DRB1; LRP1; STX4; TRPM4; PHPT1; SYBU;	GO:0035774~positive regulation of insulin secretion involved in cellular response to glucose stimulus	7	34	20.5882352941176	0.00907211563988275	0.0516870833941487	1	1	0.970035402513534	0.998790808935051	0.485063261688685
down	COL5A3; ITGA3; LTB; DHCR24; WNT10A; SUFU; DSP;	GO:0043588~skin development	7	34	20.5882352941176	0.00907211563988275	0.0516870833941487	1	1	0.970035402513534	0.998790808935051	0.485063261688685
down	GJA5; ACVR1; ZFPM1; ROBO2; HEYL; HEY1; ROBO1;	GO:0060412~ventricular septum morphogenesis	7	34	20.5882352941176	0.00907211563988275	0.0516870833941487	1	1	0.970035402513534	0.998790808935051	0.485063261688685
down	DLX3; ALDH1A2; GJA4; FOXF1; RAPGEF1; MAP3K3; ANTXR1; SPHK2;	GO:0001568~blood vessel development	8	43	18.6046511627907	0.00911273603507179	0.0518742886902766	1	1	0.970035402513534	0.998790808935051	0.486820110897079
down	CALM3; DGKQ; PPP2R5D; SIRT2; INPP5K;	GO:0010801~negative regulation of peptidyl-threonine phosphorylation	5	18	27.7777777777778	0.00948259987742972	0.052647374024548	1	1	0.972278475031149	0.998790808935051	0.494075217379791
down	SKI; CNTNAP1; DAG1; SIRT2; LGI4;	GO:0022011~myelination in peripheral nervous system	5	18	27.7777777777778	0.00948259987742972	0.052647374024548	1	1	0.972278475031149	0.998790808935051	0.494075217379791
down	ITGA6; AXL; CDKN1A; ADNP; ARHGAP35;	GO:0031668~cellular response to extracellular stimulus	5	18	27.7777777777778	0.00948259987742972	0.052647374024548	1	1	0.972278475031149	0.998790808935051	0.494075217379791
down	TTI1; ARAF; GNA12; FLCN; TELO2;	GO:0032006~regulation of TOR signaling	5	18	27.7777777777778	0.00948259987742972	0.052647374024548	1	1	0.972278475031149	0.998790808935051	0.494075217379791
down	SOX15; DYSF; LARGE1; DAG1; TARBP2;	GO:0043403~skeletal muscle tissue regeneration	5	18	27.7777777777778	0.00948259987742972	0.052647374024548	1	1	0.972278475031149	0.998790808935051	0.494075217379791
down	MAPK12; PLEKHM3; MAML1; DDX17; HINFP;	GO:0045445~myoblast differentiation	5	18	27.7777777777778	0.00948259987742972	0.052647374024548	1	1	0.972278475031149	0.998790808935051	0.494075217379791
down	DLG4; KCTD13; CLSTN1; CLSTN3; RIMS3;	GO:0050806~positive regulation of synaptic transmission	5	18	27.7777777777778	0.00948259987742972	0.052647374024548	1	1	0.972278475031149	0.998790808935051	0.494075217379791
down	RAB11B; MICALL1; VPS39; SNX27; ANKRD27;	GO:1990126~retrograde transport, endosome to plasma membrane	5	18	27.7777777777778	0.00948259987742972	0.052647374024548	1	1	0.972278475031149	0.998790808935051	0.494075217379791
down	MPV17; FOXM1; PARL; RNF41; COQ7;	GO:2000377~regulation of reactive oxygen species metabolic process	5	18	27.7777777777778	0.00948259987742972	0.052647374024548	1	1	0.972278475031149	0.998790808935051	0.494075217379791
down	SLC26A6; SLC26A1; SLC13A4; SLC25A10;	GO:0008272~sulfate transport	4	11	36.3636363636364	0.00948487779822771	0.052647374024548	1	1	0.972278475031149	0.998790808935051	0.494075217379791
down	MAN2B1; GM2A; NEU3; MAN2B2;	GO:0009313~oligosaccharide catabolic process	4	11	36.3636363636364	0.00948487779822771	0.052647374024548	1	1	0.972278475031149	0.998790808935051	0.494075217379791
down	DCTN1; ODF2; CEP250; CNTLN;	GO:0010457~centriole-centriole cohesion	4	11	36.3636363636364	0.00948487779822771	0.052647374024548	1	1	0.972278475031149	0.998790808935051	0.494075217379791
down	SETD7; SETD2; EHMT1; KMT5A;	GO:0018026~peptidyl-lysine monomethylation	4	11	36.3636363636364	0.00948487779822771	0.052647374024548	1	1	0.972278475031149	0.998790808935051	0.494075217379791
down	ITPKB; IP6K1; IP6K2; PPIP5K1;	GO:0032958~inositol phosphate biosynthetic process	4	11	36.3636363636364	0.00948487779822771	0.052647374024548	1	1	0.972278475031149	0.998790808935051	0.494075217379791
down	EIF2AK2; ADAR; BST2; LAMP3;	GO:0035455~response to interferon-alpha	4	11	36.3636363636364	0.00948487779822771	0.052647374024548	1	1	0.972278475031149	0.998790808935051	0.494075217379791
down	IFIT3; TPR; AXL; GAS6;	GO:0035457~cellular response to interferon-alpha	4	11	36.3636363636364	0.00948487779822771	0.052647374024548	1	1	0.972278475031149	0.998790808935051	0.494075217379791
down	TMCC2; LDLRAP1; NCSTN; APH1A;	GO:0042982~amyloid precursor protein metabolic process	4	11	36.3636363636364	0.00948487779822771	0.052647374024548	1	1	0.972278475031149	0.998790808935051	0.494075217379791
down	PKD2; TONSL; KEAP1; SUFU;	GO:0042994~cytoplasmic sequestering of transcription factor	4	11	36.3636363636364	0.00948487779822771	0.052647374024548	1	1	0.972278475031149	0.998790808935051	0.494075217379791
down	SRC; CDH5; TEK; ABR;	GO:0043114~regulation of vascular permeability	4	11	36.3636363636364	0.00948487779822771	0.052647374024548	1	1	0.972278475031149	0.998790808935051	0.494075217379791
down	"NASP; VPS72; DMAP1; SRCAP;"	GO:0043486~histone exchange	4	11	36.3636363636364	0.00948487779822771	0.052647374024548	1	1	0.972278475031149	0.998790808935051	0.494075217379791
down	EGFR; GLI3; BNC2; WNT10A;	GO:0043586~tongue development	4	11	36.3636363636364	0.00948487779822771	0.052647374024548	1	1	0.972278475031149	0.998790808935051	0.494075217379791
down	BMP4; ACVRL1; VEZF1; TMEM100;	GO:0045603~positive regulation of endothelial cell differentiation	4	11	36.3636363636364	0.00948487779822771	0.052647374024548	1	1	0.972278475031149	0.998790808935051	0.494075217379791
down	BMP7; FGFR2; DAG1; ESRP2;	GO:0060445~branching involved in salivary gland morphogenesis	4	11	36.3636363636364	0.00948487779822771	0.052647374024548	1	1	0.972278475031149	0.998790808935051	0.494075217379791
down	NOTCH2; HEYL; DLL4; HEY1;	GO:0061314~Notch signaling involved in heart development	4	11	36.3636363636364	0.00948487779822771	0.052647374024548	1	1	0.972278475031149	0.998790808935051	0.494075217379791
down	PARP1; PARP6; PARP16; PARP3;	GO:0070213~protein auto-ADP-ribosylation	4	11	36.3636363636364	0.00948487779822771	0.052647374024548	1	1	0.972278475031149	0.998790808935051	0.494075217379791
down	HDAC4; SIRT2; SIRT7; HDAC3;	GO:0070933~histone H4 deacetylation	4	11	36.3636363636364	0.00948487779822771	0.052647374024548	1	1	0.972278475031149	0.998790808935051	0.494075217379791
down	BRCA1; UIMC1; BABAM1; DTL;	GO:0072425~signal transduction involved in G2 DNA damage checkpoint	4	11	36.3636363636364	0.00948487779822771	0.052647374024548	1	1	0.972278475031149	0.998790808935051	0.494075217379791
down	RAB8A; GRIP1; SCRIB; GRIPAP1;	GO:0098887~neurotransmitter receptor transport, endosome to postsynaptic membrane	4	11	36.3636363636364	0.00948487779822771	0.052647374024548	1	1	0.972278475031149	0.998790808935051	0.494075217379791
down	JUP; DSP; CAV1; TRPM4;	GO:0098911~regulation of ventricular cardiac muscle cell action potential	4	11	36.3636363636364	0.00948487779822771	0.052647374024548	1	1	0.972278475031149	0.998790808935051	0.494075217379791
down	TLR4; CYBA; CD36; HDAC4;	GO:1903428~positive regulation of reactive oxygen species biosynthetic process	4	11	36.3636363636364	0.00948487779822771	0.052647374024548	1	1	0.972278475031149	0.998790808935051	0.494075217379791
down	U2AF2; AKT1; ARRB2; MTOR; CAV1; NXN; SH3RF2; RASD2; SIRT7;	GO:0031397~negative regulation of protein ubiquitination	9	53	16.9811320754717	0.0097062144826181	0.0533189743095924	1	1	0.973470845158934	0.998790808935051	0.500377925975872
down	ATRN; NFASC; ERBB2; EIF2B5; TSC1; EIF2B4; MYO5A; AFG3L2; ZNF18;	GO:0042552~myelination	9	53	16.9811320754717	0.0097062144826181	0.0533189743095924	1	1	0.973470845158934	0.998790808935051	0.500377925975872
down	UBR5; ARIH2; IFI27; SYVN1; RNF126; RNF216; BFAR; UBE2D4; RNF115;	GO:0070936~protein K48-linked ubiquitination	9	53	16.9811320754717	0.0097062144826181	0.0533189743095924	1	1	0.973470845158934	0.998790808935051	0.500377925975872
down	EGFR; ATP2B4; ITGA3; AKT1; WNT3A; LRP1; STX4; NKD2; PPP1R9B;	GO:1903078~positive regulation of protein localization to plasma membrane	9	53	16.9811320754717	0.0097062144826181	0.0533189743095924	1	1	0.973470845158934	0.998790808935051	0.500377925975872
down	DNASE2; POLG; TOPBP1; MYO18A; TATDN2; MMS19;	GO:0006259~DNA metabolic process	6	26	23.0769230769231	0.00971756856338224	0.0533189743095924	1	1	0.973470845158934	0.998790808935051	0.500377925975872
down	SMC1A; KIF22; DDX11; PHB2; REC8; STAG1;	GO:0007062~sister chromatid cohesion	6	26	23.0769230769231	0.00971756856338224	0.0533189743095924	1	1	0.973470845158934	0.998790808935051	0.500377925975872
down	CETP; PLTP; PRELID3A; PITPNM2; OSBPL5; PRELID2;	GO:0015914~phospholipid transport	6	26	23.0769230769231	0.00971756856338224	0.0533189743095924	1	1	0.973470845158934	0.998790808935051	0.500377925975872
down	AXIN1; APP; ITGA3; FOXP3; TCF7L1; VANGL2;	GO:0030111~regulation of Wnt signaling pathway	6	26	23.0769230769231	0.00971756856338224	0.0533189743095924	1	1	0.973470845158934	0.998790808935051	0.500377925975872
down	TLR4; POLR3A; POLR3D; IRF1; IRF3; MAVS;	GO:0032728~positive regulation of interferon-beta production	6	26	23.0769230769231	0.00971756856338224	0.0533189743095924	1	1	0.973470845158934	0.998790808935051	0.500377925975872
down	ABL1; TCF3; MAPK12; CAMK1; TARBP2; CDON;	GO:0051149~positive regulation of muscle cell differentiation	6	26	23.0769230769231	0.00971756856338224	0.0533189743095924	1	1	0.973470845158934	0.998790808935051	0.500377925975872
down	ARHGAP6; WAS; ARAP1; DLC1; INPP5K; WASF2;	GO:0051497~negative regulation of stress fiber assembly	6	26	23.0769230769231	0.00971756856338224	0.0533189743095924	1	1	0.973470845158934	0.998790808935051	0.500377925975872
down	EMD; AMER1; KREMEN1; ZNF703; MKS1; BTRC;	GO:0060828~regulation of canonical Wnt signaling pathway	6	26	23.0769230769231	0.00971756856338224	0.0533189743095924	1	1	0.973470845158934	0.998790808935051	0.500377925975872
down	ERCC1; PARP1; ERCC3; XPC; DDB1; DDB2;	GO:0070911~global genome nucleotide-excision repair	6	26	23.0769230769231	0.00971756856338224	0.0533189743095924	1	1	0.973470845158934	0.998790808935051	0.500377925975872
down	ADCY6; ADCY3; PRKACA; PRKAR1B; ADCY7; ADCY1;	GO:0071377~cellular response to glucagon stimulus	6	26	23.0769230769231	0.00971756856338224	0.0533189743095924	1	1	0.973470845158934	0.998790808935051	0.500377925975872
down	KCNN4; IDO1; YTHDF1; IRF1; IRF2; IRF9; IRF3;	GO:0002376~immune system process	7	35	20	0.0103488107969668	0.0565041687550075	1	1	0.977369493554275	0.998790808935051	0.530269742370772
down	COPE; GOSR2; GOLGA3; COG2; COG1; COPZ2; COPG1;	GO:0006891~intra-Golgi vesicle-mediated transport	7	35	20	0.0103488107969668	0.0565041687550075	1	1	0.977369493554275	0.998790808935051	0.530269742370772
down	PARN; PAN2; TOE1; USB1; ISG20L2; NOCT; EXOSC1;	GO:0090503~RNA phosphodiester bond hydrolysis, exonucleolytic	7	35	20	0.0103488107969668	0.0565041687550075	1	1	0.977369493554275	0.998790808935051	0.530269742370772
down	APP; CBL; AKT1; E2F1; RAPGEF1; MICALL1; KAT2A;	GO:1990090~cellular response to nerve growth factor stimulus	7	35	20	0.0103488107969668	0.0565041687550075	1	1	0.977369493554275	0.998790808935051	0.530269742370772
down	DLL1; LRP4; ALDH1A2; GLI3; PBX2; CHSY1;	GO:0009954~proximal/distal pattern formation	6	27	22.2222222222222	0.0113012784407766	0.0612927589884053	1	1	0.98321122434756	0.998790808935051	0.575208807316454
down	CDH5; MMP24; CDH24; CDH13; CDH6; CDH1;	GO:0044331~cell-cell adhesion mediated by cadherin	6	27	22.2222222222222	0.0113012784407766	0.0612927589884053	1	1	0.98321122434756	0.998790808935051	0.575208807316454
down	F2R; ARRB2; ORAI1; P2RX4; STIM2; CAMK2A;	GO:0051928~positive regulation of calcium ion transport	6	27	22.2222222222222	0.0113012784407766	0.0612927589884053	1	1	0.98321122434756	0.998790808935051	0.575208807316454
down	GYS1; PHKG2; AKT1; AKT2; PHKG1;	GO:0005978~glycogen biosynthetic process	5	19	26.3157894736842	0.0114113387181854	0.0612927589884053	1	1	0.98346614536592	0.998790808935051	0.575208807316454
down	NR1H2; PLTP; CAV1; LRP1; GPS2;	GO:0010875~positive regulation of cholesterol efflux	5	19	26.3157894736842	0.0114113387181854	0.0612927589884053	1	1	0.98346614536592	0.998790808935051	0.575208807316454
down	NFE2L1; GIGYF2; SCYL3; SCYL1; IFT172;	GO:0021522~spinal cord motor neuron differentiation	5	19	26.3157894736842	0.0114113387181854	0.0612927589884053	1	1	0.98346614536592	0.998790808935051	0.575208807316454
down	MECP2; TTC21B; MBOAT7; CCDC134; CELSR2;	GO:0021591~ventricular system development	5	19	26.3157894736842	0.0114113387181854	0.0612927589884053	1	1	0.98346614536592	0.998790808935051	0.575208807316454
down	TAL1; EP300; ZFPM1; VPS33A; ZNF385A;	GO:0030220~platelet formation	5	19	26.3157894736842	0.0114113387181854	0.0612927589884053	1	1	0.98346614536592	0.998790808935051	0.575208807316454
down	SMAD6; LRP4; CHSY1; KREMEN2; KREMEN1;	GO:0030279~negative regulation of ossification	5	19	26.3157894736842	0.0114113387181854	0.0612927589884053	1	1	0.98346614536592	0.998790808935051	0.575208807316454
down	SLC25A12; TNFRSF1B; ITGAX; SOX10; DAG1;	GO:0031643~positive regulation of myelination	5	19	26.3157894736842	0.0114113387181854	0.0612927589884053	1	1	0.98346614536592	0.998790808935051	0.575208807316454
down	B4GAT1; LARGE1; LARGE2; POMGNT2; POMT2;	GO:0035269~protein O-linked mannosylation	5	19	26.3157894736842	0.0114113387181854	0.0612927589884053	1	1	0.98346614536592	0.998790808935051	0.575208807316454
down	JAK1; STAT5A; STAT5B; JAK3; CISH;	GO:0038111~interleukin-7-mediated signaling pathway	5	19	26.3157894736842	0.0114113387181854	0.0612927589884053	1	1	0.98346614536592	0.998790808935051	0.575208807316454
down	WDR91; SOCS7; SOCS3; WDR81; CISH;	GO:0043551~regulation of phosphatidylinositol 3-kinase activity	5	19	26.3157894736842	0.0114113387181854	0.0612927589884053	1	1	0.98346614536592	0.998790808935051	0.575208807316454
down	RHBDF2; RSAD2; RHBDF1; FRMD4A; SERGEF;	GO:0050709~negative regulation of protein secretion	5	19	26.3157894736842	0.0114113387181854	0.0612927589884053	1	1	0.98346614536592	0.998790808935051	0.575208807316454
down	EGFR; APP; PDGFRB; EFNA1; PPP2R5B;	GO:0050730~regulation of peptidyl-tyrosine phosphorylation	5	19	26.3157894736842	0.0114113387181854	0.0612927589884053	1	1	0.98346614536592	0.998790808935051	0.575208807316454
down	GBP1; MMP14; LDLRAP1; ZDHHC7; VPS4A;	GO:1903076~regulation of protein localization to plasma membrane	5	19	26.3157894736842	0.0114113387181854	0.0612927589884053	1	1	0.98346614536592	0.998790808935051	0.575208807316454
down	ABL1; CSF1R; ARHGDIA; NOTCH2; PHPT1;	GO:2000249~regulation of actin cytoskeleton reorganization	5	19	26.3157894736842	0.0114113387181854	0.0612927589884053	1	1	0.98346614536592	0.998790808935051	0.575208807316454
down	HLA-G; PLCG1; CD40; COL18A1; ANO6;	GO:2000353~positive regulation of endothelial cell apoptotic process	5	19	26.3157894736842	0.0114113387181854	0.0612927589884053	1	1	0.98346614536592	0.998790808935051	0.575208807316454
down	ABL1; RBL1; TERF2; MAP3K3; ZKSCAN3;	GO:2000773~negative regulation of cellular senescence	5	19	26.3157894736842	0.0114113387181854	0.0612927589884053	1	1	0.98346614536592	0.998790808935051	0.575208807316454
down	KDM6B; COL4A2; CYBA; CBL; MTOR; HSF1; BNIP1; DNMT3B;	GO:0014823~response to activity	8	45	17.7777777777778	0.0114459618760332	0.0612927589884053	1	1	0.984313961008477	0.998790808935051	0.575208807316454
down	ADAMTS3; TNXB; COL5A3; FMOD; ADAMTS14; VIPAS39; DPT; LOXL4;	GO:0030199~collagen fibril organization	8	45	17.7777777777778	0.0114459618760332	0.0612927589884053	1	1	0.984313961008477	0.998790808935051	0.575208807316454
down	LCP1; ADD1; SHROOM2; NEDD9; RHOB; ESPN; RHOBTB1; MICAL1;	GO:0051017~actin filament bundle assembly	8	45	17.7777777777778	0.0114459618760332	0.0612927589884053	1	1	0.984313961008477	0.998790808935051	0.575208807316454
down	HSF1; MVP; SUPT6H; ZC3H3; BICD2; KHSRP; IWS1; XPO7;	GO:0051028~mRNA transport	8	45	17.7777777777778	0.0114459618760332	0.0612927589884053	1	1	0.984313961008477	0.998790808935051	0.575208807316454
down	SEC16A; BNIP1; MIA3; SMPD4; LMAN2L; SEC31B; RNF112;	GO:0007029~endoplasmic reticulum organization	7	36	19.4444444444444	0.0117512467952989	0.0627766445507456	1	1	0.986074808881479	0.998790808935051	0.589134498680246
down	ARID1A; BRCA1; FHL2; DDX17; KAT5; DAXX; GRIP1;	GO:0030521~androgen receptor signaling pathway	7	36	19.4444444444444	0.0117512467952989	0.0627766445507456	1	1	0.986074808881479	0.998790808935051	0.589134498680246
down	RRP8; SUV39H1; SIRT2; BAZ2A;	GO:0000183~chromatin silencing at rDNA	4	12	33.3333333333333	0.0120690683730277	0.0628663943390054	1	1	0.987928332958324	0.998790808935051	0.589976765687212
down	PIK3CD; KAT7; STAT5B; AXL;	GO:0001779~natural killer cell differentiation	4	12	33.3333333333333	0.0120690683730277	0.0628663943390054	1	1	0.987928332958324	0.998790808935051	0.589976765687212
down	PECAM1; STC1; NOTCH4; COL18A1;	GO:0001886~endothelial cell morphogenesis	4	12	33.3333333333333	0.0120690683730277	0.0628663943390054	1	1	0.987928332958324	0.998790808935051	0.589976765687212
down	SOX18; FLT4; ACVRL1; PTPN14;	GO:0001946~lymphangiogenesis	4	12	33.3333333333333	0.0120690683730277	0.0628663943390054	1	1	0.987928332958324	0.998790808935051	0.589976765687212
down	DDR1; MINK1; TSC1; EMP2;	GO:0001952~regulation of cell-matrix adhesion	4	12	33.3333333333333	0.0120690683730277	0.0628663943390054	1	1	0.987928332958324	0.998790808935051	0.589976765687212
down	MEIS1; SKI; SHROOM2; NECTIN1;	GO:0002089~lens morphogenesis in camera-type eye	4	12	33.3333333333333	0.0120690683730277	0.0628663943390054	1	1	0.987928332958324	0.998790808935051	0.589976765687212
down	DLL1; BMP4; SIDT2; SMO;	GO:0003323~type B pancreatic cell development	4	12	33.3333333333333	0.0120690683730277	0.0628663943390054	1	1	0.987928332958324	0.998790808935051	0.589976765687212
down	PFKM; HK1; HK3; NFE2L1;	GO:0006002~fructose 6-phosphate metabolic process	4	12	33.3333333333333	0.0120690683730277	0.0628663943390054	1	1	0.987928332958324	0.998790808935051	0.589976765687212
down	"NASP; RBBP4; ASF1B; CABIN1;"	GO:0006336~DNA replication-independent nucleosome assembly	4	12	33.3333333333333	0.0120690683730277	0.0628663943390054	1	1	0.987928332958324	0.998790808935051	0.589976765687212
down	TLR4; IKBKB; DAB2IP; ERC1;	GO:0007252~I-kappaB phosphorylation	4	12	33.3333333333333	0.0120690683730277	0.0628663943390054	1	1	0.987928332958324	0.998790808935051	0.589976765687212
down	CD4; CAV1; P2RX4; P2RX7;	GO:0010524~positive regulation of calcium ion transport into cytosol	4	12	33.3333333333333	0.0120690683730277	0.0628663943390054	1	1	0.987928332958324	0.998790808935051	0.589976765687212
down	TTLL1; TTLL4; TTLL5; TTLL11;	GO:0018095~protein polyglutamylation	4	12	33.3333333333333	0.0120690683730277	0.0628663943390054	1	1	0.987928332958324	0.998790808935051	0.589976765687212
down	C2CD3; LTBP4; PARL; SPOP;	GO:0030162~regulation of proteolysis	4	12	33.3333333333333	0.0120690683730277	0.0628663943390054	1	1	0.987928332958324	0.998790808935051	0.589976765687212
down	GFRA2; ENG; MVP; TESK1;	GO:0031953~negative regulation of protein autophosphorylation	4	12	33.3333333333333	0.0120690683730277	0.0628663943390054	1	1	0.987928332958324	0.998790808935051	0.589976765687212
down	PTPRS; NLRC3; CACTIN; TRAIP;	GO:0032688~negative regulation of interferon-beta production	4	12	33.3333333333333	0.0120690683730277	0.0628663943390054	1	1	0.987928332958324	0.998790808935051	0.589976765687212
down	KMT2D; PARP1; MED1; PAGR1;	GO:0033148~positive regulation of intracellular estrogen receptor signaling pathway	4	12	33.3333333333333	0.0120690683730277	0.0628663943390054	1	1	0.987928332958324	0.998790808935051	0.589976765687212
down	SPPL3; SPPL2B; PARL; AFG3L2;	GO:0033619~membrane protein proteolysis	4	12	33.3333333333333	0.0120690683730277	0.0628663943390054	1	1	0.987928332958324	0.998790808935051	0.589976765687212
down	RING1; DDB1; KDM2B; DDB2;	GO:0035518~histone H2A monoubiquitination	4	12	33.3333333333333	0.0120690683730277	0.0628663943390054	1	1	0.987928332958324	0.998790808935051	0.589976765687212
down	SOCS3; NF2; CAV1; INPP5F;	GO:0042532~negative regulation of tyrosine phosphorylation of STAT protein	4	12	33.3333333333333	0.0120690683730277	0.0628663943390054	1	1	0.987928332958324	0.998790808935051	0.589976765687212
down	ABCC5; EBP; SLC47A2; ABCC1;	GO:0042908~xenobiotic transport	4	12	33.3333333333333	0.0120690683730277	0.0628663943390054	1	1	0.987928332958324	0.998790808935051	0.589976765687212
down	CD36; LRP1; UNC119; MIA3;	GO:0042953~lipoprotein transport	4	12	33.3333333333333	0.0120690683730277	0.0628663943390054	1	1	0.987928332958324	0.998790808935051	0.589976765687212
down	IGF1R; SRC; LRP1; AGER;	GO:0045056~transcytosis	4	12	33.3333333333333	0.0120690683730277	0.0628663943390054	1	1	0.987928332958324	0.998790808935051	0.589976765687212
down	NCOR1; NAGLU; MTA1; CIART;	GO:0045475~locomotor rhythm	4	12	33.3333333333333	0.0120690683730277	0.0628663943390054	1	1	0.987928332958324	0.998790808935051	0.589976765687212
down	PRKACA; FGFR2; RASSF2; TCIRG1;	GO:0045667~regulation of osteoblast differentiation	4	12	33.3333333333333	0.0120690683730277	0.0628663943390054	1	1	0.987928332958324	0.998790808935051	0.589976765687212
down	RAB4B; TSC1; SLC2A8; SLC2A6;	GO:0046323~glucose import	4	12	33.3333333333333	0.0120690683730277	0.0628663943390054	1	1	0.987928332958324	0.998790808935051	0.589976765687212
down	KDR; CASR; F2RL1; CDH13;	GO:0050927~positive regulation of positive chemotaxis	4	12	33.3333333333333	0.0120690683730277	0.0628663943390054	1	1	0.987928332958324	0.998790808935051	0.589976765687212
down	ARID1A; SOCS3; NOTCH2; PKD2;	GO:0060674~placenta blood vessel development	4	12	33.3333333333333	0.0120690683730277	0.0628663943390054	1	1	0.987928332958324	0.998790808935051	0.589976765687212
down	TCIRG1; STIM1; NECTIN1; FAM20C;	GO:0070166~enamel mineralization	4	12	33.3333333333333	0.0120690683730277	0.0628663943390054	1	1	0.987928332958324	0.998790808935051	0.589976765687212
down	NRP1; DAG1; ROBO3; SMO;	GO:0071679~commissural neuron axon guidance	4	12	33.3333333333333	0.0120690683730277	0.0628663943390054	1	1	0.987928332958324	0.998790808935051	0.589976765687212
down	TYROBP; ABL1; APP; AGER;	GO:1900272~negative regulation of long-term synaptic potentiation	4	12	33.3333333333333	0.0120690683730277	0.0628663943390054	1	1	0.987928332958324	0.998790808935051	0.589976765687212
down	USP19; F8A1; PSMF1; LAMP3;	GO:1901799~negative regulation of proteasomal protein catabolic process	4	12	33.3333333333333	0.0120690683730277	0.0628663943390054	1	1	0.987928332958324	0.998790808935051	0.589976765687212
down	CD34; KDR; TMEM100; HIF1AN;	GO:2001214~positive regulation of vasculogenesis	4	12	33.3333333333333	0.0120690683730277	0.0628663943390054	1	1	0.987928332958324	0.998790808935051	0.589976765687212
down	DLL1; TP53; EP300; FOXF1; LFNG; KAT2A; POFUT1; NLE1;	GO:0001756~somitogenesis	8	46	17.3913043478261	0.0127649215450345	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	CLDN5; DVL2; SOX18; GJA5; TBX2; ZFPM1; HEYL; PLXND1;	GO:0003151~outflow tract morphogenesis	8	46	17.3913043478261	0.0127649215450345	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	RPN2; MGAT3; MGAT5; DOLPP1; GORASP1; MGAT4B; ALG12; MOGS;	GO:0006487~protein N-linked glycosylation	8	46	17.3913043478261	0.0127649215450345	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	P4HB; LCP1; LMNB1; JAK1; MSN; TYK2; IL12RB1; IL12RB2;	GO:0035722~interleukin-12-mediated signaling pathway	8	46	17.3913043478261	0.0127649215450345	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	NRP1; CXCL10; BMP4; TSC2; CX3CL1; PTPRJ; SCRIB; GPNMB;	GO:0050918~positive chemotaxis	8	46	17.3913043478261	0.0127649215450345	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	WAS; WIPF3; WIPF2;	GO:0000147~actin cortical patch assembly	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	SF3A2; SF3A1; SF1;	GO:0000389~mRNA 3'-splice site recognition	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	HLA-DRB1; BCL3; CD81;	GO:0002455~humoral immune response mediated by circulating immunoglobulin	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	BMP7; ROBO2; ROBO1;	GO:0003272~endocardial cushion formation	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	ERCC1; RAD52; RAD51;	GO:0006312~mitotic recombination	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	"NAA10; KAT6A; ASH1L;"	GO:0006323~DNA packaging	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	EZH2; SIRT2; DOT1L;	GO:0006348~chromatin silencing at telomere	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	KIF3B; NUP62; NDE1;	GO:0007100~mitotic centrosome separation	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	CDON; FUZ; IFT122;	GO:0010172~embryonic body morphogenesis	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	WIZ; DBF4B; INO80;	GO:0010571~positive regulation of nuclear cell cycle DNA replication	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	SLC26A5; SLC2A8; SLC2A6;	GO:0015755~fructose transmembrane transport	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	GPAA1; PIGT; PIGS;	GO:0016255~attachment of GPI anchor to protein	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	BGN; EGFLAM; NDNF;	GO:0019800~peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	KAT7; TICRR; CDT1;	GO:0030174~regulation of DNA-dependent DNA replication initiation	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	SKI; FOXP3; SPHK2;	GO:0031064~negative regulation of histone deacetylation	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	SLC9A3R1; CASR; STARD10;	GO:0032782~bile acid secretion	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	PODXL; CD3E; SKAP1;	GO:0033634~positive regulation of cell-cell adhesion mediated by integrin	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	CYBA; F2RL1; TIRAP;	GO:0034137~positive regulation of toll-like receptor 2 signaling pathway	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	PIK3CD; GAS6; HSD3B7;	GO:0035754~B cell chemotaxis	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	HLA-B; HLA-A; HLA-G;	GO:0042270~protection from natural killer cell mediated cytotoxicity	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	GTF3C2; GTF3C4; GTF3C5;	GO:0042791~5S class rRNA transcription by RNA polymerase III	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	MMP14; SCRIB; APCDD1;	GO:0043615~astrocyte cell migration	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	UBE2L3; UPF1; TIMELESS;	GO:0044770~cell cycle phase transition	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	PEX5; PEX26; PEX16;	GO:0045046~protein import into peroxisome membrane	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	GSK3A; GSK3B; INPP5K;	GO:0045719~negative regulation of glycogen biosynthetic process	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	NUP62; FOXM1; FLCN;	GO:0046578~regulation of Ras protein signal transduction	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	AXL; PPT1; ANKFY1;	GO:0048549~positive regulation of pinocytosis	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	TOP3A; NCAPD3; NCAPD2;	GO:0051304~chromosome separation	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	TUBGCP6; TUBGCP3; TUBGCP4;	GO:0051415~microtubule nucleation by interphase microtubule organizing center	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	KDM1A; BRCA1; WDR5;	GO:0051572~negative regulation of histone H3-K4 methylation	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	HMBOX1; SMG6; NABP2;	GO:0051972~regulation of telomerase activity	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	KDM6B; KDM1A; EHMT1;	GO:0060992~response to fungicide	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	LRP5; COL4A1; FZD4;	GO:0061304~retinal blood vessel morphogenesis	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	PHGDH; EZH2; SMPD3;	GO:0070314~G1 to G0 transition	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	EZH2; EHMT2; EHMT1;	GO:0070734~histone H3-K27 methylation	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	SLC2A8; SLC2A6; SLC23A1;	GO:0070837~dehydroascorbic acid transport	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	EXOSC10; EXOSC2; EXOSC7;	GO:0071035~nuclear polyadenylation-dependent rRNA catabolic process	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	EXOSC7; EXOSC10; EXOSC2;	GO:0071038~nuclear polyadenylation-dependent tRNA catabolic process	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	ADCY6; GNG2; GNB1;	GO:0071870~cellular response to catecholamine stimulus	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	PIK3CD; PECAM1; JAML;	GO:0072672~neutrophil extravasation	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	RAD51; DDX11; TIMELESS;	GO:0072719~cellular response to cisplatin	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	ATG13; GPS2; BECN1;	GO:0098780~response to mitochondrial depolarisation	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	ABCC5; ABCB1; ABCC1;	GO:0140115~export across plasma membrane	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	NRP1; NRP2; SEMA3F;	GO:1901166~neural crest cell migration involved in autonomic nervous system development	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	TULP3; PRKACA; SUFU;	GO:1901621~negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	TAPBP; TAP1; STX4;	GO:1990668~vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	TAL1; MED1; NCAPG2;	GO:2000273~positive regulation of signaling receptor activity	3	6	50	0.0128732698307293	0.0643952561966798	1	1	0.991944301791488	0.998790808935051	0.604324542165521
down	PHKG2; PHKA1; GSK3A; GSK3B; PPP1R3E; PCDH12;	GO:0005977~glycogen metabolic process	6	28	21.4285714285714	0.0130587050034217	0.0648857438943249	1	1	0.993018997676419	0.998790808935051	0.608927579265208
down	ZFP36L2; METTL3; METTL16; KHSRP; NUDT16; ZHX2;	GO:0006402~mRNA catabolic process	6	28	21.4285714285714	0.0130587050034217	0.0648857438943249	1	1	0.993018997676419	0.998790808935051	0.608927579265208
down	F2R; DGKQ; LRP1; DGKZ; DGKD; CISH;	GO:0007205~protein kinase C-activating G protein-coupled receptor signaling pathway	6	28	21.4285714285714	0.0130587050034217	0.0648857438943249	1	1	0.993018997676419	0.998790808935051	0.608927579265208
down	C5; ATF4; ARNT; FLT4; BRCA1; C3AR1;	GO:0010575~positive regulation of vascular endothelial growth factor production	6	28	21.4285714285714	0.0130587050034217	0.0648857438943249	1	1	0.993018997676419	0.998790808935051	0.608927579265208
down	COL4A2; ITGB5; MMP14; MMP15; LAMB3; SETD2;	GO:0035987~endodermal cell differentiation	6	28	21.4285714285714	0.0130587050034217	0.0648857438943249	1	1	0.993018997676419	0.998790808935051	0.608927579265208
down	STAU1; RAD23A; ADAR; TARBP2; DDB1; LARP1;	GO:0045070~positive regulation of viral genome replication	6	28	21.4285714285714	0.0130587050034217	0.0648857438943249	1	1	0.993018997676419	0.998790808935051	0.608927579265208
down	HAP1; SNW1; SPEN; SRRT; ZNF335; NUMBL;	GO:0050769~positive regulation of neurogenesis	6	28	21.4285714285714	0.0130587050034217	0.0648857438943249	1	1	0.993018997676419	0.998790808935051	0.608927579265208
down	CSNK2A2; PCGF2; WNT4; CX3CL1; MNT; AATF;	GO:2001234~negative regulation of apoptotic signaling pathway	6	28	21.4285714285714	0.0130587050034217	0.0648857438943249	1	1	0.993018997676419	0.998790808935051	0.608927579265208
down	FOXN3; CDKN1A; CDK5RAP3; TAOK2; TOPBP1;	GO:0007095~mitotic G2 DNA damage checkpoint	5	20	25	0.0135905379028706	0.0670794422488065	1	1	0.995842755152507	0.998790808935051	0.629514588806289
down	TP53; THBD; ERCC1; CDKN1A; RAD51;	GO:0010165~response to X-ray	5	20	25	0.0135905379028706	0.0670794422488065	1	1	0.995842755152507	0.998790808935051	0.629514588806289
down	EP300; STOX1; PARL; SIRT7; RHOT2;	GO:0010821~regulation of mitochondrion organization	5	20	25	0.0135905379028706	0.0670794422488065	1	1	0.995842755152507	0.998790808935051	0.629514588806289
down	SRC; HAP1; GRB2; ZFYVE27; AKT1S1;	GO:0048011~neurotrophin TRK receptor signaling pathway	5	20	25	0.0135905379028706	0.0670794422488065	1	1	0.995842755152507	0.998790808935051	0.629514588806289
down	HRAS; APP; RAB8A; DLG4; SYNGAP1;	GO:0048169~regulation of long-term neuronal synaptic plasticity	5	20	25	0.0135905379028706	0.0670794422488065	1	1	0.995842755152507	0.998790808935051	0.629514588806289
down	EGFR; AKT1; CAV1; NOSTRIN; CYGB;	GO:0050999~regulation of nitric-oxide synthase activity	5	20	25	0.0135905379028706	0.0670794422488065	1	1	0.995842755152507	0.998790808935051	0.629514588806289
down	HLA-DRB1; TP53; SHMT2; PKD2; CPSF7;	GO:0051262~protein tetramerization	5	20	25	0.0135905379028706	0.0670794422488065	1	1	0.995842755152507	0.998790808935051	0.629514588806289
down	HDAC4; SIRT2; SIRT7; HDAC6; HDAC3;	GO:0070932~histone H3 deacetylation	5	20	25	0.0135905379028706	0.0670794422488065	1	1	0.995842755152507	0.998790808935051	0.629514588806289
down	CSF1R; AKT2; SLC26A5; DUOX1; PHPT1;	GO:2000147~positive regulation of cell motility	5	20	25	0.0135905379028706	0.0670794422488065	1	1	0.995842755152507	0.998790808935051	0.629514588806289
down	CTSK; BECN1; USP30; MARK2; FBXO7; ATG13; ATG2A;	GO:0000422~autophagy of mitochondrion	7	38	18.4210526315789	0.0149589343144823	0.0721135616596006	1	1	0.998790808935051	0.998790808935051	0.676757849999984
down	TAF4; FANCG; MMP14; EIF2B5; LFNG; EIF2B4; KMT2B;	GO:0001541~ovarian follicle development	7	38	18.4210526315789	0.0149589343144823	0.0721135616596006	1	1	0.998790808935051	0.998790808935051	0.676757849999984
down	CIT; KIF3B; SVIL; CDC25B; PKP4; CDC6; AURKC;	GO:0032467~positive regulation of cytokinesis	7	38	18.4210526315789	0.0149589343144823	0.0721135616596006	1	1	0.998790808935051	0.998790808935051	0.676757849999984
down	PARP1; ERCC3; RPA1; XPC; DDB1; DDB2;	GO:0006294~nucleotide-excision repair, preincision complex assembly	6	29	20.6896551724138	0.014998712190482	0.0721135616596006	1	1	0.998790808935051	0.998790808935051	0.676757849999984
down	POLR1A; UBTF; POLR2E; ERCC3; POLR2H; TAF1C;	GO:0006362~transcription elongation from RNA polymerase I promoter	6	29	20.6896551724138	0.014998712190482	0.0721135616596006	1	1	0.998790808935051	0.998790808935051	0.676757849999984
down	TPR; XPO6; XPO5; XPO7; RANBP3; CCHCR1;	GO:0006611~protein export from nucleus	6	29	20.6896551724138	0.014998712190482	0.0721135616596006	1	1	0.998790808935051	0.998790808935051	0.676757849999984
down	BMP4; AKT1; MTOR; FANCC; ACVR1; CELF1;	GO:0007281~germ cell development	6	29	20.6896551724138	0.014998712190482	0.0721135616596006	1	1	0.998790808935051	0.998790808935051	0.676757849999984
down	AKT1; NCS1; ACAP3; FBXO7; GSK3B; GSK3A;	GO:0010975~regulation of neuron projection development	6	29	20.6896551724138	0.014998712190482	0.0721135616596006	1	1	0.998790808935051	0.998790808935051	0.676757849999984
down	PHGDH; ALDH1A2; PKD2; C2CD3; ZNF358; GRHL2;	GO:0021915~neural tube development	6	29	20.6896551724138	0.014998712190482	0.0721135616596006	1	1	0.998790808935051	0.998790808935051	0.676757849999984
down	ARHGAP6; HCLS1; WAS; CORO7; CTTN; PREX1;	GO:0030041~actin filament polymerization	6	29	20.6896551724138	0.014998712190482	0.0721135616596006	1	1	0.998790808935051	0.998790808935051	0.676757849999984
down	TLR4; ARRB2; CX3CL1; GAS6; NLRC3; FOXP3;	GO:0032715~negative regulation of interleukin-6 production	6	29	20.6896551724138	0.014998712190482	0.0721135616596006	1	1	0.998790808935051	0.998790808935051	0.676757849999984
down	MEN1; CDKN1A; CDKN2C; CDKN2D; CDK5RAP1; FBXO7;	GO:0045736~negative regulation of cyclin-dependent protein serine/threonine kinase activity	6	29	20.6896551724138	0.014998712190482	0.0721135616596006	1	1	0.998790808935051	0.998790808935051	0.676757849999984
down	SLC9A3R1; ABL1; EGFR; SCRIB; NLE1; BTG2;	GO:0045930~negative regulation of mitotic cell cycle	6	29	20.6896551724138	0.014998712190482	0.0721135616596006	1	1	0.998790808935051	0.998790808935051	0.676757849999984
down	MELTF; STEAP3; NEO1; SLC25A28; EIF2AK1; TFR2;	GO:0055072~iron ion homeostasis	6	29	20.6896551724138	0.014998712190482	0.0721135616596006	1	1	0.998790808935051	0.998790808935051	0.676757849999984
down	UBE2L3; CDC26; RNF26; ANAPC5; ANAPC2; UBE2D4;	GO:0070979~protein K11-linked ubiquitination	6	29	20.6896551724138	0.014998712190482	0.0721135616596006	1	1	0.998790808935051	0.998790808935051	0.676757849999984
down	GINS1; NCAPG2; GINS4; PRPF19;	GO:0001833~inner cell mass cell proliferation	4	13	30.7692307692308	0.0150636738106842	0.0721135616596006	1	1	0.998790808935051	0.998790808935051	0.676757849999984
down	OGG1; NUPR1; ACVR1; EIF2AK1;	GO:0002526~acute inflammatory response	4	13	30.7692307692308	0.0150636738106842	0.0721135616596006	1	1	0.998790808935051	0.998790808935051	0.676757849999984
down	CD34; MCAM; ADGRF5; TMEM63C;	GO:0003094~glomerular filtration	4	13	30.7692307692308	0.0150636738106842	0.0721135616596006	1	1	0.998790808935051	0.998790808935051	0.676757849999984
down	BMP2; ACVR1; ZFPM1; HEYL;	GO:0003181~atrioventricular valve morphogenesis	4	13	30.7692307692308	0.0150636738106842	0.0721135616596006	1	1	0.998790808935051	0.998790808935051	0.676757849999984
down	BMP4; ENG; HEYL; TMEM100;	GO:0003198~epithelial to mesenchymal transition involved in endocardial cushion formation	4	13	30.7692307692308	0.0150636738106842	0.0721135616596006	1	1	0.998790808935051	0.998790808935051	0.676757849999984
down	ZER1; LONP2; HDAC6; LONP1;	GO:0006515~protein quality control for misfolded or incompletely synthesized proteins	4	13	30.7692307692308	0.0150636738106842	0.0721135616596006	1	1	0.998790808935051	0.998790808935051	0.676757849999984
down	ERCC1; ERCC3; SCARA3; SDF4;	GO:0009650~UV protection	4	13	30.7692307692308	0.0150636738106842	0.0721135616596006	1	1	0.998790808935051	0.998790808935051	0.676757849999984
down	CTDNEP1; SREBF1; NR1H2; SLC27A1;	GO:0010867~positive regulation of triglyceride biosynthetic process	4	13	30.7692307692308	0.0150636738106842	0.0721135616596006	1	1	0.998790808935051	0.998790808935051	0.676757849999984
down	ACACB; NFKB1; NR1H2; ASXL2;	GO:0010884~positive regulation of lipid storage	4	13	30.7692307692308	0.0150636738106842	0.0721135616596006	1	1	0.998790808935051	0.998790808935051	0.676757849999984
down	RPS6KA4; MAP3K12; BAZ1B; INCENP;	GO:0016572~histone phosphorylation	4	13	30.7692307692308	0.0150636738106842	0.0721135616596006	1	1	0.998790808935051	0.998790808935051	0.676757849999984
down	EPHB3; PTPRS; HERC1; RTN4RL1;	GO:0022038~corpus callosum development	4	13	30.7692307692308	0.0150636738106842	0.0721135616596006	1	1	0.998790808935051	0.998790808935051	0.676757849999984
down	CDH5; MAPRE1; INPP5J; TBCD;	GO:0031115~negative regulation of microtubule polymerization	4	13	30.7692307692308	0.0150636738106842	0.0721135616596006	1	1	0.998790808935051	0.998790808935051	0.676757849999984
down	PLEK; FLNA; LIMK1; CX3CL1;	GO:0032233~positive regulation of actin filament bundle assembly	4	13	30.7692307692308	0.0150636738106842	0.0721135616596006	1	1	0.998790808935051	0.998790808935051	0.676757849999984
down	CDK4; TSC2; FUT7; SIK2;	GO:0046626~regulation of insulin receptor signaling pathway	4	13	30.7692307692308	0.0150636738106842	0.0721135616596006	1	1	0.998790808935051	0.998790808935051	0.676757849999984
down	KIF22; TRAPPC12; KIF2C; INCENP;	GO:0051310~metaphase plate congression	4	13	30.7692307692308	0.0150636738106842	0.0721135616596006	1	1	0.998790808935051	0.998790808935051	0.676757849999984
down	BMP2; ADAM15; HEYL; HEY1;	GO:0060317~cardiac epithelial to mesenchymal transition	4	13	30.7692307692308	0.0150636738106842	0.0721135616596006	1	1	0.998790808935051	0.998790808935051	0.676757849999984
down	IRF3; MAVS; NLRC5; ZBP1;	GO:0060340~positive regulation of type I interferon-mediated signaling pathway	4	13	30.7692307692308	0.0150636738106842	0.0721135616596006	1	1	0.998790808935051	0.998790808935051	0.676757849999984
down	TP53; BMP7; MKS1; HEY1;	GO:0060411~cardiac septum morphogenesis	4	13	30.7692307692308	0.0150636738106842	0.0721135616596006	1	1	0.998790808935051	0.998790808935051	0.676757849999984
down	GJA5; NOTCH2; ZFPM1; SMO;	GO:0060413~atrial septum morphogenesis	4	13	30.7692307692308	0.0150636738106842	0.0721135616596006	1	1	0.998790808935051	0.998790808935051	0.676757849999984
down	COL4A1; CAV1; DAG1; RIC8A;	GO:0071711~basement membrane organization	4	13	30.7692307692308	0.0150636738106842	0.0721135616596006	1	1	0.998790808935051	0.998790808935051	0.676757849999984
down	CYTH3; SIPA1L3; FBF1; FRMD4A;	GO:0090162~establishment of epithelial cell polarity	4	13	30.7692307692308	0.0150636738106842	0.0721135616596006	1	1	0.998790808935051	0.998790808935051	0.676757849999984
down	PTK7; VANGL2; DVL3; DVL2;	GO:0090179~planar cell polarity pathway involved in neural tube closure	4	13	30.7692307692308	0.0150636738106842	0.0721135616596006	1	1	0.998790808935051	0.998790808935051	0.676757849999984
down	CHEK2; TP53; CDKN1A; CTC1;	GO:0090399~replicative senescence	4	13	30.7692307692308	0.0150636738106842	0.0721135616596006	1	1	0.998790808935051	0.998790808935051	0.676757849999984
down	DLG4; RELN; CEP112; SCRIB;	GO:0097120~receptor localization to synapse	4	13	30.7692307692308	0.0150636738106842	0.0721135616596006	1	1	0.998790808935051	0.998790808935051	0.676757849999984
down	SLC3A2; SLC7A5; SLC43A2; SLC7A7;	GO:1902475~L-alpha-amino acid transmembrane transport	4	13	30.7692307692308	0.0150636738106842	0.0721135616596006	1	1	0.998790808935051	0.998790808935051	0.676757849999984
down	APP; CNP; PPT1; MECP2; GIGYF2; LGI4; TSC1; INPP5F;	GO:0008344~adult locomotory behavior	8	48	16.6666666666667	0.0157311702080563	0.0752551256266571	1	1	0.998790808935051	0.998790808935051	0.706240211251511
down	PDGFRB; CD34; ACACA; ANKRD11; P2RX4;	GO:0001894~tissue homeostasis	5	21	23.8095238095238	0.0160331779782354	0.0760466489911622	1	1	0.998790808935051	0.998790808935051	0.713668351507788
down	NUBP1; MMS19; NDOR1; NUBP2; IBA57;	GO:0016226~iron-sulfur cluster assembly	5	21	23.8095238095238	0.0160331779782354	0.0760466489911622	1	1	0.998790808935051	0.998790808935051	0.713668351507788
down	GLI3; SOX10; HPS4; MYO5A; HPS6;	GO:0030318~melanocyte differentiation	5	21	23.8095238095238	0.0160331779782354	0.0760466489911622	1	1	0.998790808935051	0.998790808935051	0.713668351507788
down	DVL2; DVL3; CCDC88C; FZD4; FZD5;	GO:0035567~non-canonical Wnt signaling pathway	5	21	23.8095238095238	0.0160331779782354	0.0760466489911622	1	1	0.998790808935051	0.998790808935051	0.713668351507788
down	TLR4; TYROBP; APP; SPN; AGER;	GO:0042535~positive regulation of tumor necrosis factor biosynthetic process	5	21	23.8095238095238	0.0160331779782354	0.0760466489911622	1	1	0.998790808935051	0.998790808935051	0.713668351507788
down	JUP; ATP2B4; ACVRL1; MECP2; VASH1;	GO:0043537~negative regulation of blood vessel endothelial cell migration	5	21	23.8095238095238	0.0160331779782354	0.0760466489911622	1	1	0.998790808935051	0.998790808935051	0.713668351507788
down	IRF1; TIRAP; TKFC; SAMHD1; TREML2;	GO:0045088~regulation of innate immune response	5	21	23.8095238095238	0.0160331779782354	0.0760466489911622	1	1	0.998790808935051	0.998790808935051	0.713668351507788
down	CRTAM; LAMP1; PVR; STAT5B; CADM1;	GO:0045954~positive regulation of natural killer cell mediated cytotoxicity	5	21	23.8095238095238	0.0160331779782354	0.0760466489911622	1	1	0.998790808935051	0.998790808935051	0.713668351507788
down	LRP4; GDI1; ARHGDIA; LINGO1; SYNGAP1;	GO:0050771~negative regulation of axonogenesis	5	21	23.8095238095238	0.0160331779782354	0.0760466489911622	1	1	0.998790808935051	0.998790808935051	0.713668351507788
down	CUL7; PARP6; FBXO31; ANKRD27; ANAPC2;	GO:0050775~positive regulation of dendrite morphogenesis	5	21	23.8095238095238	0.0160331779782354	0.0760466489911622	1	1	0.998790808935051	0.998790808935051	0.713668351507788
down	CALM3; S100A1; AKT1; TERF2; NOD1;	GO:0051000~positive regulation of nitric-oxide synthase activity	5	21	23.8095238095238	0.0160331779782354	0.0760466489911622	1	1	0.998790808935051	0.998790808935051	0.713668351507788
down	NRP1; ABL1; KDR; MAP3K3; RHOJ;	GO:0090050~positive regulation of cell migration involved in sprouting angiogenesis	5	21	23.8095238095238	0.0160331779782354	0.0760466489911622	1	1	0.998790808935051	0.998790808935051	0.713668351507788
down	RAB11FIP3; VPS53; VPS52; DENND1A; PTPN23; GGA3; EHD2;	GO:0032456~endocytic recycling	7	39	17.9487179487179	0.0167765891087261	0.07945991850717	1	1	0.998790808935051	0.998790808935051	0.745700564117501
down	POLR1A; UBTF; POLR2E; ERCC3; POLR2H; TAF1C;	GO:0006363~termination of RNA polymerase I transcription	6	30	20	0.0171297685864682	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	REC8; PSMC3IP; MSH5; RAD51; RAD54L; RAD51D;	GO:0007131~reciprocal meiotic recombination	6	30	20	0.0171297685864682	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	ERBB2; LAMC2; EGFLAM; RNF165; RAC2; AGRN;	GO:0008045~motor neuron axon guidance	6	30	20	0.0171297685864682	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	HAP1; VAMP2; STX4; RAB3D; RAB15; RAB8A;	GO:0017157~regulation of exocytosis	6	30	20	0.0171297685864682	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	KDR; MAP2K2; ZFP36L2; CCL11; MED1; IQGAP3;	GO:0070371~ERK1 and ERK2 cascade	6	30	20	0.0171297685864682	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	ATG13; TCIRG1; BECN1; ATG2A; KIAA1324; PACS2; RAB1B; ATG16L2; ULK2;	GO:0000045~autophagosome assembly	9	59	15.2542372881356	0.0172762696446456	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	CTNS; APP; SLC1A4; DGCR2; MGAT3; RP9; C12orf57; SETD5;	GO:0050890~cognition	8	49	16.3265306122449	0.0173876766800148	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	SMAD6; EFNA1; ACVR1;	GO:0003183~mitral valve morphogenesis	3	7	42.8571428571429	0.0175990992108043	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	BMP7; DLL4; LRP6;	GO:0003344~pericardium morphogenesis	3	7	42.8571428571429	0.0175990992108043	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	ADAR; METTL3; NUDT16;	GO:0006382~adenosine to inosine editing	3	7	42.8571428571429	0.0175990992108043	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	MDH2; NAA10; EP300;	GO:0006475~internal protein amino acid acetylation	3	7	42.8571428571429	0.0175990992108043	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	GMPS; MTHFD1; MTHFD1L;	GO:0009113~purine nucleobase biosynthetic process	3	7	42.8571428571429	0.0175990992108043	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	ERBB3; LAMA2; GPC1;	GO:0014037~Schwann cell differentiation	3	7	42.8571428571429	0.0175990992108043	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	ABCC5; HYAL1; CEMIP;	GO:0030213~hyaluronan biosynthetic process	3	7	42.8571428571429	0.0175990992108043	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	NFASC; CNTNAP1; UGT8;	GO:0030913~paranodal junction assembly	3	7	42.8571428571429	0.0175990992108043	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	TERF2; ACD; TFIP11;	GO:0031848~protection from non-homologous end joining at telomere	3	7	42.8571428571429	0.0175990992108043	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	TERF2; SMG6; SMG5;	GO:0032210~regulation of telomere maintenance via telomerase	3	7	42.8571428571429	0.0175990992108043	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	PLEK; SRC; SKAP1;	GO:0033625~positive regulation of integrin activation	3	7	42.8571428571429	0.0175990992108043	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	F2RL1; TIRAP; CAV1;	GO:0034141~positive regulation of toll-like receptor 3 signaling pathway	3	7	42.8571428571429	0.0175990992108043	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	ADAR; TARBP2; AGO1;	GO:0035280~miRNA loading onto RISC involved in gene silencing by miRNA	3	7	42.8571428571429	0.0175990992108043	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	VPS18; VPS16; VPS11;	GO:0035542~regulation of SNARE complex assembly	3	7	42.8571428571429	0.0175990992108043	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	IL18BP; ALOX5; AKT1;	GO:0035655~interleukin-18-mediated signaling pathway	3	7	42.8571428571429	0.0175990992108043	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	TP53; ATF4; MAPK7;	GO:0036003~positive regulation of transcription from RNA polymerase II promoter in response to stress	3	7	42.8571428571429	0.0175990992108043	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	STAT5A; RELN; DAB2IP;	GO:0038026~reelin-mediated signaling pathway	3	7	42.8571428571429	0.0175990992108043	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	GTF3C2; GTF3C4; GTF3C5;	GO:0042797~tRNA transcription by RNA polymerase III	3	7	42.8571428571429	0.0175990992108043	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	KAT7; KAT2A; JADE2;	GO:0043983~histone H4-K12 acetylation	3	7	42.8571428571429	0.0175990992108043	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	SRC; RELN; CDON;	GO:0051057~positive regulation of small GTPase mediated signal transduction	3	7	42.8571428571429	0.0175990992108043	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	FGFR2; FOXF1; GRHL2;	GO:0060463~lung lobe morphogenesis	3	7	42.8571428571429	0.0175990992108043	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	TULP3; GLI3; IFT122;	GO:0060831~smoothened signaling pathway involved in dorsal/ventral neural tube patterning	3	7	42.8571428571429	0.0175990992108043	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	GLI3; ACVRL1; LUZP1;	GO:0060840~artery development	3	7	42.8571428571429	0.0175990992108043	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	CSF1R; CSF1; CX3CL1;	GO:0061518~microglial cell proliferation	3	7	42.8571428571429	0.0175990992108043	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	BMP4; EFNA1; JAK3;	GO:0070244~negative regulation of thymocyte apoptotic process	3	7	42.8571428571429	0.0175990992108043	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	PARN; EXOSC2; EXOSC10;	GO:0071051~polyadenylation-dependent snoRNA 3'-end processing	3	7	42.8571428571429	0.0175990992108043	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	DNAJB12; HDAC6; DNAJC18;	GO:0071218~cellular response to misfolded protein	3	7	42.8571428571429	0.0175990992108043	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	ATP2A2; SLC9A1; SLC8B1;	GO:0086036~regulation of cardiac muscle cell membrane potential	3	7	42.8571428571429	0.0175990992108043	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	UNC13B; RAB32; RAB34;	GO:0090382~phagosome maturation	3	7	42.8571428571429	0.0175990992108043	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	DLG4; CACNG4; GPHN;	GO:0098970~postsynaptic neurotransmitter receptor diffusion trapping	3	7	42.8571428571429	0.0175990992108043	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	LRPAP1; LRP1; RAB11B;	GO:0150093~amyloid-beta clearance by transcytosis	3	7	42.8571428571429	0.0175990992108043	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	LRP4; CD36; LRP1;	GO:0150094~amyloid-beta clearance by cellular catabolic process	3	7	42.8571428571429	0.0175990992108043	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	LRPAP1; LRP1; ROCK1;	GO:1900223~positive regulation of amyloid-beta clearance	3	7	42.8571428571429	0.0175990992108043	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	CLEC16A; FYCO1; UVRAG;	GO:1901098~positive regulation of autophagosome maturation	3	7	42.8571428571429	0.0175990992108043	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	TAF1; ATP2B4; CDKN1A;	GO:1902806~regulation of cell cycle G1/S phase transition	3	7	42.8571428571429	0.0175990992108043	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	EFNA1; EFNA3; AGER;	GO:1902961~positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process	3	7	42.8571428571429	0.0175990992108043	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	HAX1; SREBF1; PARL;	GO:1903214~regulation of protein targeting to mitochondrion	3	7	42.8571428571429	0.0175990992108043	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	DAB2IP; RGP1; CDK5RAP3;	GO:1903363~negative regulation of cellular protein catabolic process	3	7	42.8571428571429	0.0175990992108043	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	HTT; CAMKK2; FBXO7;	GO:1903599~positive regulation of autophagy of mitochondrion	3	7	42.8571428571429	0.0175990992108043	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	CSF1; CX3CL1; P2RX4;	GO:1904141~positive regulation of microglial cell migration	3	7	42.8571428571429	0.0175990992108043	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	AXL; GAS6; LILRB1;	GO:2000669~negative regulation of dendritic cell apoptotic process	3	7	42.8571428571429	0.0175990992108043	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	ECE1; SCRIB; ARAP1; INPP5F;	GO:0001921~positive regulation of receptor recycling	4	14	28.5714285714286	0.0184873959876199	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	DGKQ; USP7; SLC35B4; SIRT7;	GO:0006111~regulation of gluconeogenesis	4	14	28.5714285714286	0.0184873959876199	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	PRKCSH; GANAB; MGAT4B; MAN1B1;	GO:0006491~N-glycan processing	4	14	28.5714285714286	0.0184873959876199	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	FGFR2; EPPK1; MED1; KDF1;	GO:0010839~negative regulation of keratinocyte proliferation	4	14	28.5714285714286	0.0184873959876199	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	SRC; MMP14; RHBDD1; NKD2;	GO:0010954~positive regulation of protein processing	4	14	28.5714285714286	0.0184873959876199	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	EXTL3; B3GAT3; XYLT2; VANGL2;	GO:0015012~heparan sulfate proteoglycan biosynthetic process	4	14	28.5714285714286	0.0184873959876199	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	AKT1; MTOR; TSC1; USP36;	GO:0016242~negative regulation of macroautophagy	4	14	28.5714285714286	0.0184873959876199	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	ADAR; TARBP2; AGO1; DROSHA;	GO:0031054~pre-miRNA processing	4	14	28.5714285714286	0.0184873959876199	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	BRCA1; LBH; CNOT9; PHB2;	GO:0033147~negative regulation of intracellular estrogen receptor signaling pathway	4	14	28.5714285714286	0.0184873959876199	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	PDGFRB; LRP1; NPRL3; TBX2;	GO:0035909~aorta morphogenesis	4	14	28.5714285714286	0.0184873959876199	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	PIK3CD; LAT; CBL; MILR1;	GO:0043303~mast cell degranulation	4	14	28.5714285714286	0.0184873959876199	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	ATP2B4; CD34; CAV1; KHSRP;	GO:0045019~negative regulation of nitric oxide biosynthetic process	4	14	28.5714285714286	0.0184873959876199	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	NUPR1; NCOR1; PFKFB1; HDAC4;	GO:0045820~negative regulation of glycolytic process	4	14	28.5714285714286	0.0184873959876199	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	CKAP5; MAPRE1; MAP7D3; CENPJ;	GO:0046785~microtubule polymerization	4	14	28.5714285714286	0.0184873959876199	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	DGKQ; DGKZ; DGKD; SPHK2;	GO:0046834~lipid phosphorylation	4	14	28.5714285714286	0.0184873959876199	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	EGFR; EPHB3; SOX10; VANGL2;	GO:0048546~digestive tract morphogenesis	4	14	28.5714285714286	0.0184873959876199	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	WNT10B; CD36; SCNN1D; GNB1;	GO:0050909~sensory perception of taste	4	14	28.5714285714286	0.0184873959876199	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	STC1; LILRB1; INPP5K; PACSIN3;	GO:0051926~negative regulation of calcium ion transport	4	14	28.5714285714286	0.0184873959876199	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	SRGAP2; PAK4; EPHB3; CAMK2A;	GO:0060996~dendritic spine development	4	14	28.5714285714286	0.0184873959876199	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	CDH1; GSK3A; ADCY7; NFATC4;	GO:0071285~cellular response to lithium ion	4	14	28.5714285714286	0.0184873959876199	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	ABL1; ATF4; SIN3A; HCN3;	GO:1903351~cellular response to dopamine	4	14	28.5714285714286	0.0184873959876199	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	OS9; SYVN1; UGGT1; MAN1B1;	GO:1904380~endoplasmic reticulum mannose trimming	4	14	28.5714285714286	0.0184873959876199	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	PARP1; ERCC3; XPC; DDB1; DDB2;	GO:0000717~nucleotide-excision repair, DNA duplex unwinding	5	22	22.7272727272727	0.0187511911856793	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	MTHFD1; SHMT2; FPGS; SFXN3; MTHFR;	GO:0006730~one-carbon metabolic process	5	22	22.7272727272727	0.0187511911856793	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	ACVRL1; STC1; DAB2IP; VASH1; DLL4;	GO:0010596~negative regulation of endothelial cell migration	5	22	22.7272727272727	0.0187511911856793	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	WNT3A; CAV1; NOTCH4; PYGO2; ARHGAP35;	GO:0030879~mammary gland development	5	22	22.7272727272727	0.0187511911856793	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	SHROOM2; BLOC1S3; DTNBP1; AP1M1; RAB32;	GO:0032438~melanosome organization	5	22	22.7272727272727	0.0187511911856793	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	AXIN1; HSF1; PDE4DIP; AP2M1; DNAJB12;	GO:0034622~cellular protein-containing complex assembly	5	22	22.7272727272727	0.0187511911856793	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	BRD1; TFF1; ERCC1; LRP11; PPP1R9B;	GO:0035902~response to immobilization stress	5	22	22.7272727272727	0.0187511911856793	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	DST; FAM83H; MACF1; DSP; EPPK1;	GO:0045104~intermediate filament cytoskeleton organization	5	22	22.7272727272727	0.0187511911856793	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	TNFSF14; FLT3LG; CXCL9; CDON; HIF1AN;	GO:0045663~positive regulation of myoblast differentiation	5	22	22.7272727272727	0.0187511911856793	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	TP53; AKT1; BAG6; NR1H2; HDAC6;	GO:0045861~negative regulation of proteolysis	5	22	22.7272727272727	0.0187511911856793	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	STX16-NPEPL1; STX1B; TSNARE1; STX2; STX4;	GO:0048278~vesicle docking	5	22	22.7272727272727	0.0187511911856793	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	STAU1; APP; RELN; ADCY1; EIF2AK4;	GO:1900273~positive regulation of long-term synaptic potentiation	5	22	22.7272727272727	0.0187511911856793	0.080383387352044	1	1	0.998790808935051	0.998790808935051	0.754366961610789
down	FOXP2; FLNB; SVIL; CAV1; EP300; HLX; TAZ; IGSF8;	GO:0007519~skeletal muscle tissue development	8	50	16	0.0191657428691682	0.0811689858014264	1	1	0.998790808935051	0.998790808935051	0.76173949883308
down	HTT; DCTN1; NUMA1; CDK5RAP2; NDE1; ACTR1B;	GO:0000132~establishment of mitotic spindle orientation	6	31	19.3548387096774	0.0194598985546227	0.0820507899309423	1	1	0.998790808935051	0.998790808935051	0.77001488910751
down	BTN2A1; ERMAP; CD276; BTN3A3; BTN3A1; BTN2A2;	GO:0001817~regulation of cytokine production	6	31	19.3548387096774	0.0194598985546227	0.0820507899309423	1	1	0.998790808935051	0.998790808935051	0.77001488910751
down	PFKM; PFKFB1; DHTKD1; HK3; GPI; HK1;	GO:0006096~glycolytic process	6	31	19.3548387096774	0.0194598985546227	0.0820507899309423	1	1	0.998790808935051	0.998790808935051	0.77001488910751
down	EGFR; PLCG1; EDNRA; PLCB2; GPR55; ARHGAP6;	GO:0007202~activation of phospholipase C activity	6	31	19.3548387096774	0.0194598985546227	0.0820507899309423	1	1	0.998790808935051	0.998790808935051	0.77001488910751
down	EGFR; ERBB2; SRC; ERBB3; SHC1; GRB2;	GO:0038128~ERBB2 signaling pathway	6	31	19.3548387096774	0.0194598985546227	0.0820507899309423	1	1	0.998790808935051	0.998790808935051	0.77001488910751
down	CLDN5; MYH3; SKI; EP300; ANKRD11; LRP6;	GO:0060325~face morphogenesis	6	31	19.3548387096774	0.0194598985546227	0.0820507899309423	1	1	0.998790808935051	0.998790808935051	0.77001488910751
down	EGFR; TYMS; GLI3; CSNK2A2; RPL10; EZH2;	GO:0097421~liver regeneration	6	31	19.3548387096774	0.0194598985546227	0.0820507899309423	1	1	0.998790808935051	0.998790808935051	0.77001488910751
down	ADCY3; MST1R; MFGE8; TARBP2; LHFPL2; IGSF8; TUBGCP3; SPAG8; ASH1L;	GO:0007338~single fertilization	9	61	14.7540983606557	0.0205620092069979	0.0865884735541065	1	1	0.998790808935051	0.998790808935051	0.812599292680425
down	PSMD3; OAZ2; PSMB9; PSMB10; PSMD4; PSMD2; PSME4; PSMF1;	GO:0006521~regulation of cellular amino acid metabolic process	8	51	15.6862745098039	0.0210696916347174	0.0886146942698655	1	1	0.998790808935051	0.998790808935051	0.83161458943827
down	ARID1A; NOTCH2; SMC1A; METTL3; RTF1; MED12; MED15; ZNF358;	GO:0019827~stem cell population maintenance	8	51	15.6862745098039	0.0210696916347174	0.0886146942698655	1	1	0.998790808935051	0.998790808935051	0.83161458943827
down	LAT; LTB; TCIRG1; EDA; FOXP3;	GO:0010467~gene expression	5	23	21.7391304347826	0.0217553887483569	0.0909263683585174	1	1	0.998790808935051	0.998790808935051	0.85330875555811
down	EGFR; PIP4K2A; PIP4K2B; PPP2R5B; PIP4K2C;	GO:0014066~regulation of phosphatidylinositol 3-kinase signaling	5	23	21.7391304347826	0.0217553887483569	0.0909263683585174	1	1	0.998790808935051	0.998790808935051	0.85330875555811
down	EEF2K; DLL1; AP2B1; LRP1; TFR2;	GO:0045807~positive regulation of endocytosis	5	23	21.7391304347826	0.0217553887483569	0.0909263683585174	1	1	0.998790808935051	0.998790808935051	0.85330875555811
down	SLC9A1; ROCK1; LDB1; PEAK1; MACF1;	GO:0051893~regulation of focal adhesion assembly	5	23	21.7391304347826	0.0217553887483569	0.0909263683585174	1	1	0.998790808935051	0.998790808935051	0.85330875555811
down	KPNA6; PLA2G6; ITGA3; MTOR; APOL2;	GO:0060135~maternal process involved in female pregnancy	5	23	21.7391304347826	0.0217553887483569	0.0909263683585174	1	1	0.998790808935051	0.998790808935051	0.85330875555811
down	DLL1; FANCC; FUT10; SRRT; MMP24;	GO:0097150~neuronal stem cell population maintenance	5	23	21.7391304347826	0.0217553887483569	0.0909263683585174	1	1	0.998790808935051	0.998790808935051	0.85330875555811
down	BMP7; RASSF2; RELA; NLRC3; CPNE1;	GO:1901223~negative regulation of NIK/NF-kappaB signaling	5	23	21.7391304347826	0.0217553887483569	0.0909263683585174	1	1	0.998790808935051	0.998790808935051	0.85330875555811
down	NUMA1; MAPRE1; PSRC1; MARK4; CDK5RAP2; AAAS;	GO:0001578~microtubule bundle formation	6	32	18.75	0.021996638033342	0.0917052601227849	1	1	0.998790808935051	0.998790808935051	0.860618353137781
down	CNNM3; SLC6A6; SLC6A9; TMEM184B; CNNM1; SLC6A11;	GO:0006810~transport	6	32	18.75	0.021996638033342	0.0917052601227849	1	1	0.998790808935051	0.998790808935051	0.860618353137781
down	TYROBP; FARP2; CSF1R; CSF1; TCIRG1; SNX10;	GO:0030316~osteoclast differentiation	6	32	18.75	0.021996638033342	0.0917052601227849	1	1	0.998790808935051	0.998790808935051	0.860618353137781
down	FGF1; SRC; AKT1; MTOR; GAS6; MAPKAP1;	GO:0032148~activation of protein kinase B activity	6	32	18.75	0.021996638033342	0.0917052601227849	1	1	0.998790808935051	0.998790808935051	0.860618353137781
down	GGT5; GSS; HAGH; GGT7;	GO:0006750~glutathione biosynthetic process	4	15	26.6666666666667	0.0223556711966748	0.0923133091759074	1	1	0.998790808935051	0.998790808935051	0.866324658032664
down	AGRN; GRK2; GNA11; GNB1;	GO:0007213~G protein-coupled acetylcholine receptor signaling pathway	4	15	26.6666666666667	0.0223556711966748	0.0923133091759074	1	1	0.998790808935051	0.998790808935051	0.866324658032664
down	NRP1; NRP2; SEMA3F; AFG3L2;	GO:0021675~nerve development	4	15	26.6666666666667	0.0223556711966748	0.0923133091759074	1	1	0.998790808935051	0.998790808935051	0.866324658032664
down	RHOJ; RAC2; RTKN; RAC3;	GO:0030865~cortical cytoskeleton organization	4	15	26.6666666666667	0.0223556711966748	0.0923133091759074	1	1	0.998790808935051	0.998790808935051	0.866324658032664
down	ENTPD6; ENTPD1; NUDT16; ENTPD2;	GO:0034656~nucleobase-containing small molecule catabolic process	4	15	26.6666666666667	0.0223556711966748	0.0923133091759074	1	1	0.998790808935051	0.998790808935051	0.866324658032664
down	HTT; MARK4; FUZ; ARHGAP35;	GO:0045724~positive regulation of cilium assembly	4	15	26.6666666666667	0.0223556711966748	0.0923133091759074	1	1	0.998790808935051	0.998790808935051	0.866324658032664
down	NUBP1; BICD2; SYNE2; NDE1;	GO:0051642~centrosome localization	4	15	26.6666666666667	0.0223556711966748	0.0923133091759074	1	1	0.998790808935051	0.998790808935051	0.866324658032664
down	BMP2; ZFPM1; MYOM1; MYOM3;	GO:0055008~cardiac muscle tissue morphogenesis	4	15	26.6666666666667	0.0223556711966748	0.0923133091759074	1	1	0.998790808935051	0.998790808935051	0.866324658032664
down	CHD2; TP53; ACE; TAL1;	GO:0060218~hematopoietic stem cell differentiation	4	15	26.6666666666667	0.0223556711966748	0.0923133091759074	1	1	0.998790808935051	0.998790808935051	0.866324658032664
down	TEK; FHL2; ADAMTS1; HEY1;	GO:0060347~heart trabecula formation	4	15	26.6666666666667	0.0223556711966748	0.0923133091759074	1	1	0.998790808935051	0.998790808935051	0.866324658032664
down	PLEK; DGKQ; PLVAP; ADGRG1;	GO:0070528~protein kinase C signaling	4	15	26.6666666666667	0.0223556711966748	0.0923133091759074	1	1	0.998790808935051	0.998790808935051	0.866324658032664
down	GSK3B; AGER; NCSTN; YTHDF1;	GO:1900271~regulation of long-term synaptic potentiation	4	15	26.6666666666667	0.0223556711966748	0.0923133091759074	1	1	0.998790808935051	0.998790808935051	0.866324658032664
down	TRIM21; PML; TRIM26; TRIM28;	GO:1902187~negative regulation of viral release from host cell	4	15	26.6666666666667	0.0223556711966748	0.0923133091759074	1	1	0.998790808935051	0.998790808935051	0.866324658032664
down	KDM1A; PARP1; PPM1F; DVL3;	GO:1903827~regulation of cellular protein localization	4	15	26.6666666666667	0.0223556711966748	0.0923133091759074	1	1	0.998790808935051	0.998790808935051	0.866324658032664
down	ZFP36L2; LBH; NELFB; CDK12;	GO:2000737~negative regulation of stem cell differentiation	4	15	26.6666666666667	0.0223556711966748	0.0923133091759074	1	1	0.998790808935051	0.998790808935051	0.866324658032664
down	AKT1; ARRB2; GSK3A; GSK3B; MECP2; MPP2; P2RX4; P2RX7; GRIN2C;	GO:0060079~excitatory postsynaptic potential	9	62	14.5161290322581	0.0223634965667805	0.0923133091759074	1	1	0.998790808935051	0.998790808935051	0.866324658032664
down	THRA; BMP4; RARG; BMP7; RXRB; NR2C2; NR1H2; NR1I3;	GO:0043401~steroid hormone mediated signaling pathway	8	52	15.3846153846154	0.023103701349684	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	MAP2K7; AKT1; EIF2B5; MICA; LRP11; EIF2B4; TRPV2;	GO:0009408~response to heat	7	42	16.6666666666667	0.0231549342962952	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	BMP2; BMP4; BMP7; MTOR; EZH2; BCL9L; ZNF703;	GO:0010718~positive regulation of epithelial to mesenchymal transition	7	42	16.6666666666667	0.0231549342962952	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	FGFR2; FGFR3; BNC2;	GO:0003416~endochondral bone growth	3	8	37.5	0.0231609820890784	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	TRAM2; ZFAND2B; SEC61A2;	GO:0006616~SRP-dependent cotranslational protein targeting to membrane, translocation	3	8	37.5	0.0231609820890784	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	CHEK2; ABL1; MAPK12;	GO:0006975~DNA damage induced protein phosphorylation	3	8	37.5	0.0231609820890784	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	CD3E; SRC; PXN;	GO:0007172~signal complex assembly	3	8	37.5	0.0231609820890784	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	GRK2; GRK5; TAC4;	GO:0007217~tachykinin receptor signaling pathway	3	8	37.5	0.0231609820890784	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	ZBTB48; RAD51; CTC1;	GO:0010833~telomere maintenance via telomere lengthening	3	8	37.5	0.0231609820890784	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	SLC9A1; HDAC4; ATP2A2;	GO:0010882~regulation of cardiac muscle contraction by calcium ion signaling	3	8	37.5	0.0231609820890784	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	TCN2; ABCC1; CD320;	GO:0015889~cobalamin transport	3	8	37.5	0.0231609820890784	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	SETD7; EHMT2; EHMT1;	GO:0018027~peptidyl-lysine dimethylation	3	8	37.5	0.0231609820890784	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	SREBF1; CAV1; NFE2L1;	GO:0019217~regulation of fatty acid metabolic process	3	8	37.5	0.0231609820890784	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	SLC9A3R1; FGFR2; MSN;	GO:0022612~gland morphogenesis	3	8	37.5	0.0231609820890784	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	EEF2K; PPP2R5D; PPP2R5B;	GO:0031952~regulation of protein autophosphorylation	3	8	37.5	0.0231609820890784	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	MT-ND1; XRCC1; RNF112;	GO:0033194~response to hydroperoxide	3	8	37.5	0.0231609820890784	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	IQGAP3; RREB1; ZNF703;	GO:0033601~positive regulation of mammary gland epithelial cell proliferation	3	8	37.5	0.0231609820890784	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	MX1; SHMT2; SETD2;	GO:0034340~response to type I interferon	3	8	37.5	0.0231609820890784	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	ANO6; P2RX4; P2RX7;	GO:0035590~purinergic nucleotide receptor signaling pathway	3	8	37.5	0.0231609820890784	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	JAK1; STAT1; JAK3;	GO:0038114~interleukin-21-mediated signaling pathway	3	8	37.5	0.0231609820890784	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	TPR; BMP4; NUP62;	GO:0042306~regulation of protein import into nucleus	3	8	37.5	0.0231609820890784	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	MAPKAPK3; SNX33; RAB34;	GO:0044351~macropinocytosis	3	8	37.5	0.0231609820890784	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	PPM1F; ADAR; CDK5RAP3;	GO:0044387~negative regulation of protein kinase activity by regulation of protein phosphorylation	3	8	37.5	0.0231609820890784	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	CSF1R; PC; IGF2R;	GO:0044794~positive regulation by host of viral process	3	8	37.5	0.0231609820890784	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	CSF1R; F2R; F2RL1;	GO:0045217~cell-cell junction maintenance	3	8	37.5	0.0231609820890784	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	TOM1L1; BMP4; BMP7;	GO:0045839~negative regulation of mitotic nuclear division	3	8	37.5	0.0231609820890784	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	JAK3; ELP2; DOT1L;	GO:0046425~regulation of receptor signaling pathway via JAK-STAT	3	8	37.5	0.0231609820890784	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	THOC5; DDX39B; THOC6;	GO:0046784~viral mRNA export from host cell nucleus	3	8	37.5	0.0231609820890784	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	BMP2; BMP7; FGFR2;	GO:0048762~mesenchymal cell differentiation	3	8	37.5	0.0231609820890784	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	NRP1; NRP2; SEMA3F;	GO:0048846~axon extension involved in axon guidance	3	8	37.5	0.0231609820890784	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	STK25; SLC9A3R1; COPG1;	GO:0051683~establishment of Golgi localization	3	8	37.5	0.0231609820890784	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	MTOR; DDX39B; PARP2;	GO:0061051~positive regulation of cell growth involved in cardiac muscle cell development	3	8	37.5	0.0231609820890784	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	SHMT2; TSFM; MTG2;	GO:0070129~regulation of mitochondrial translation	3	8	37.5	0.0231609820890784	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	CDKN1A; CRIP1; HYAL1;	GO:0071493~cellular response to UV-B	3	8	37.5	0.0231609820890784	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	DLL1; ITGA3; NUP85;	GO:0072006~nephron development	3	8	37.5	0.0231609820890784	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	MYO1G; ITGB7; MSN;	GO:0072678~T cell migration	3	8	37.5	0.0231609820890784	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	IL17RC; IL17RE; IL17RA;	GO:0097400~interleukin-17-mediated signaling pathway	3	8	37.5	0.0231609820890784	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	AP2B1; MX1; DNM1;	GO:0098884~postsynaptic neurotransmitter receptor internalization	3	8	37.5	0.0231609820890784	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	CLSTN1; RAB8A; GRIP1;	GO:0099003~vesicle-mediated transport in synapse	3	8	37.5	0.0231609820890784	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	TP53; SIRT2; DLC1;	GO:1900119~positive regulation of execution phase of apoptosis	3	8	37.5	0.0231609820890784	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	CALM3; DGKQ; ROCK1;	GO:1900242~regulation of synaptic vesicle endocytosis	3	8	37.5	0.0231609820890784	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	SUPT5H; RNF40; CDK9;	GO:1900364~negative regulation of mRNA polyadenylation	3	8	37.5	0.0231609820890784	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	CDK10; EVI5L; TCHP;	GO:1902018~negative regulation of cilium assembly	3	8	37.5	0.0231609820890784	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	HAP1; CENPJ; WRAP73;	GO:1902857~positive regulation of non-motile cilium assembly	3	8	37.5	0.0231609820890784	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	SLC22A5; RALBP1; PDZK1;	GO:1990961~xenobiotic detoxification by transmembrane export across the plasma membrane	3	8	37.5	0.0231609820890784	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	BRCA1; SMARCB1; SPHK2;	GO:2000617~positive regulation of histone H3-K9 acetylation	3	8	37.5	0.0231609820890784	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	DNAJC13; SRC; MAP2K2;	GO:2000641~regulation of early endosome to late endosome transport	3	8	37.5	0.0231609820890784	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	MSN; VPS11; PTPN23;	GO:2000643~positive regulation of early endosome to late endosome transport	3	8	37.5	0.0231609820890784	0.0927966686458697	1	1	0.998790808935051	0.998790808935051	0.870860799475974
down	CXCL10; FGF1; TPR; ATP2A2; PRKACA; CDKN1A; HSF1; CLPB; DAXX;	GO:0034605~cellular response to heat	9	63	14.2857142857143	0.0242751108128846	0.0972022561788542	1	1	0.998790808935051	0.998790808935051	0.912205532397128
down	POLR1A; UBTF; POLR2E; ERCC3; POLR2H; TAF1C;	GO:0006361~transcription initiation from RNA polymerase I promoter	6	33	18.1818181818182	0.0247469951132664	0.0985602910261974	1	1	0.998790808935051	0.998790808935051	0.924950163536709
down	APP; PABPC1L; SYMPK; TUT1; SCAF8; WDR33;	GO:0006378~mRNA polyadenylation	6	33	18.1818181818182	0.0247469951132664	0.0985602910261974	1	1	0.998790808935051	0.998790808935051	0.924950163536709
down	LCAT; CSNK2A2; SLC27A1; GPAT4; SLC44A2; STARD10;	GO:0006656~phosphatidylcholine biosynthetic process	6	33	18.1818181818182	0.0247469951132664	0.0985602910261974	1	1	0.998790808935051	0.998790808935051	0.924950163536709
down	SH3PXD2B; CSF1; GHR; STAT5B; HSF1; SMO;	GO:0040018~positive regulation of multicellular organism growth	6	33	18.1818181818182	0.0247469951132664	0.0985602910261974	1	1	0.998790808935051	0.998790808935051	0.924950163536709
down	BMP4; SRC; FGFR2; AQP3; WNT10A; MYO5A;	GO:0042476~odontogenesis	6	33	18.1818181818182	0.0247469951132664	0.0985602910261974	1	1	0.998790808935051	0.998790808935051	0.924950163536709
down	SH3PXD2B; PDGFRB; FGFR2; ANKRD11; P2RX7; NLE1;	GO:0048705~skeletal system morphogenesis	6	33	18.1818181818182	0.0247469951132664	0.0985602910261974	1	1	0.998790808935051	0.998790808935051	0.924950163536709
down	APP; SRC; CYBA; MTHFR; HDAC4; RELA;	GO:0070555~response to interleukin-1	6	33	18.1818181818182	0.0247469951132664	0.0985602910261974	1	1	0.998790808935051	0.998790808935051	0.924950163536709
down	MFN2; DNMT1; DDX39B; LDLRAP1; FOXJ2; ADAMTS1;	GO:1904707~positive regulation of vascular smooth muscle cell proliferation	6	33	18.1818181818182	0.0247469951132664	0.0985602910261974	1	1	0.998790808935051	0.998790808935051	0.924950163536709
down	ACE; CAV1; METTL16; EPB41L5; ZC3H7B;	GO:0010608~posttranscriptional regulation of gene expression	5	24	20.8333333333333	0.0250554033281016	0.0994921333581124	1	1	0.998790808935051	0.998790808935051	0.933695142963222
down	ZDHHC1; ZDHHC16; ZDHHC7; ZDHHC3; ZDHHC9;	GO:0018345~protein palmitoylation	5	24	20.8333333333333	0.0250554033281016	0.0994921333581124	1	1	0.998790808935051	0.998790808935051	0.933695142963222
down	TRIM21; CD40; CIITA; BST2; NUB1;	GO:0034341~response to interferon-gamma	5	24	20.8333333333333	0.0250554033281016	0.0994921333581124	1	1	0.998790808935051	0.998790808935051	0.933695142963222
down	APP; PFKFB1; ARNT; PFKFB4; P2RX7;	GO:0045821~positive regulation of glycolytic process	5	24	20.8333333333333	0.0250554033281016	0.0994921333581124	1	1	0.998790808935051	0.998790808935051	0.933695142963222
down	RRP8; TP53; E2F1; E2F2; PPP1R13B;	GO:0072332~intrinsic apoptotic signaling pathway by p53 class mediator	5	24	20.8333333333333	0.0250554033281016	0.0994921333581124	1	1	0.998790808935051	0.998790808935051	0.933695142963222
down	AP4M1; OS9; FUT10; KATNB1; HPS4; TRAK1; HAP1;	GO:0006605~protein targeting	7	43	16.2790697674419	0.0256075516868309	0.101624268362881	1	1	0.998790808935051	0.998790808935051	0.95370440430782
down	NDUFS5; NDUFA3; MT-ND1; MT-ND4; NDUFV3; TAZ; NDUFA11; ECSIT; COA1;	GO:0032981~mitochondrial respiratory chain complex I assembly	9	64	14.0625	0.026300010912497	0.104310369690337	1	1	0.998790808935051	0.998790808935051	0.978912425065858
down	CD34; MMP14; PRKX; TEK;	GO:0001935~endothelial cell proliferation	4	16	25	0.0266806916562956	0.104763256368404	1	1	0.998790808935051	0.998790808935051	0.983162591157905
down	UBE4B; ENG; MED1; DLL4;	GO:0003222~ventricular trabecula myocardium morphogenesis	4	16	25	0.0266806916562956	0.104763256368404	1	1	0.998790808935051	0.998790808935051	0.983162591157905
down	CHD3; CKAP5; SPAG5; UVRAG;	GO:0007051~spindle organization	4	16	25	0.0266806916562956	0.104763256368404	1	1	0.998790808935051	0.998790808935051	0.983162591157905
down	MFN2; USP30; MIEF1; AFG3L2;	GO:0008053~mitochondrial fusion	4	16	25	0.0266806916562956	0.104763256368404	1	1	0.998790808935051	0.998790808935051	0.983162591157905
down	BMP4; SKI; WNT3; WLS;	GO:0009948~anterior/posterior axis specification	4	16	25	0.0266806916562956	0.104763256368404	1	1	0.998790808935051	0.998790808935051	0.983162591157905
down	AKT1; MLLT6; SCN4B; SCN3B;	GO:0010765~positive regulation of sodium ion transport	4	16	25	0.0266806916562956	0.104763256368404	1	1	0.998790808935051	0.998790808935051	0.983162591157905
down	OSBP; GRAMD1A; OSBPL7; OSBPL6;	GO:0015918~sterol transport	4	16	25	0.0266806916562956	0.104763256368404	1	1	0.998790808935051	0.998790808935051	0.983162591157905
down	SLFN13; SLFN11; DROSHA; EXOSC7;	GO:0016075~rRNA catabolic process	4	16	25	0.0266806916562956	0.104763256368404	1	1	0.998790808935051	0.998790808935051	0.983162591157905
down	SLC9A1; HYAL1; CEMIP; STAB2;	GO:0030214~hyaluronan catabolic process	4	16	25	0.0266806916562956	0.104763256368404	1	1	0.998790808935051	0.998790808935051	0.983162591157905
down	ARHGAP35; RHOBTB1; RHOB; MAPKAP1;	GO:0030950~establishment or maintenance of actin cytoskeleton polarity	4	16	25	0.0266806916562956	0.104763256368404	1	1	0.998790808935051	0.998790808935051	0.983162591157905
down	DAG1; RTN4RL1; MTR; MAPK8IP3;	GO:0031103~axon regeneration	4	16	25	0.0266806916562956	0.104763256368404	1	1	0.998790808935051	0.998790808935051	0.983162591157905
down	LCK; BMP7; AGER; SKAP1;	GO:0034116~positive regulation of heterotypic cell-cell adhesion	4	16	25	0.0266806916562956	0.104763256368404	1	1	0.998790808935051	0.998790808935051	0.983162591157905
down	EP400; BRD8; DMAP1; TRRAP;	GO:0043968~histone H2A acetylation	4	16	25	0.0266806916562956	0.104763256368404	1	1	0.998790808935051	0.998790808935051	0.983162591157905
down	INPP5K; INPP5E; INPP5B; INPP5J;	GO:0046855~inositol phosphate dephosphorylation	4	16	25	0.0266806916562956	0.104763256368404	1	1	0.998790808935051	0.998790808935051	0.983162591157905
down	RASSF2; SART3; ASXL1; CARD11;	GO:0048872~homeostasis of number of cells	4	16	25	0.0266806916562956	0.104763256368404	1	1	0.998790808935051	0.998790808935051	0.983162591157905
down	NUPR1; RNF40; DAB2IP; OSBPL7;	GO:1901800~positive regulation of proteasomal protein catabolic process	4	16	25	0.0266806916562956	0.104763256368404	1	1	0.998790808935051	0.998790808935051	0.983162591157905
down	SEC13; CLEC16A; TELO2; FLCN;	GO:1904263~positive regulation of TORC1 signaling	4	16	25	0.0266806916562956	0.104763256368404	1	1	0.998790808935051	0.998790808935051	0.983162591157905
down	MAP2K7; PARN; HMBOX1; MAPKAPK5; ACD; PNKP;	GO:0032212~positive regulation of telomere maintenance via telomerase	6	34	17.6470588235294	0.0277174154574718	0.108578832064645	1	1	0.998790808935051	0.998790808935051	1
down	CTDNEP1; LMNA; BMP4; BMP7; GBP2; SMO;	GO:0034504~protein localization to nucleus	6	34	17.6470588235294	0.0277174154574718	0.108578832064645	1	1	0.998790808935051	0.998790808935051	1
down	USP19; OTUD3; USP7; OTUB1; OTUD5; USP20;	GO:0071108~protein K48-linked deubiquitination	6	34	17.6470588235294	0.0277174154574718	0.108578832064645	1	1	0.998790808935051	0.998790808935051	1
down	TECPR1; VPS33A; VPS16; RUBCNL; VIPAS39; UVRAG;	GO:0097352~autophagosome maturation	6	34	17.6470588235294	0.0277174154574718	0.108578832064645	1	1	0.998790808935051	0.998790808935051	1
down	BMP2; FGFR2; FGFR3; GPNMB; ZBTB40; SMPD3; SNX10;	GO:0030282~bone mineralization	7	44	15.9090909090909	0.0282317269041734	0.108853835213611	1	1	0.998790808935051	0.998790808935051	1
down	PEX14; MPV17; PEX5; TYSND1; PAOX; PEX26; LONP2; DECR2; PEX16;	GO:0006625~protein targeting to peroxisome	9	65	13.8461538461538	0.0284412418365287	0.108853835213611	1	1	0.998790808935051	0.998790808935051	1
down	TP53; NUP62; MTOR; TBX2; MNT;	GO:0007569~cell aging	5	25	20	0.0286596458698909	0.108853835213611	1	1	0.998790808935051	0.998790808935051	1
down	RAC2; MTOR; HDAC4; CARMIL2; WASF2;	GO:0010592~positive regulation of lamellipodium assembly	5	25	20	0.0286596458698909	0.108853835213611	1	1	0.998790808935051	0.998790808935051	1
down	PCDH17; PTPRF; PTPRS; GPC4; LRFN3;	GO:0099560~synaptic membrane adhesion	5	25	20	0.0286596458698909	0.108853835213611	1	1	0.998790808935051	0.998790808935051	1
down	ACVR1; TEAD2; MEGF8;	GO:0003143~embryonic heart tube morphogenesis	3	9	33.3333333333333	0.0295613565612405	0.108853835213611	1	1	0.998790808935051	0.998790808935051	1
down	FLNB; KDF1; BCL11B;	GO:0003334~keratinocyte development	3	9	33.3333333333333	0.0295613565612405	0.108853835213611	1	1	0.998790808935051	0.998790808935051	1
down	ERCC3; TOP3A; TOP1MT;	GO:0006265~DNA topological change	3	9	33.3333333333333	0.0295613565612405	0.108853835213611	1	1	0.998790808935051	0.998790808935051	1
down	CDK9; SIRT7; POLH;	GO:0006282~regulation of DNA repair	3	9	33.3333333333333	0.0295613565612405	0.108853835213611	1	1	0.998790808935051	0.998790808935051	1
down	GPAA1; OS9; KDELR1;	GO:0006621~protein retention in ER lumen	3	9	33.3333333333333	0.0295613565612405	0.108853835213611	1	1	0.998790808935051	0.998790808935051	1
down	GNA11; PDE6B; PDE6C;	GO:0007603~phototransduction, visible light	3	9	33.3333333333333	0.0295613565612405	0.108853835213611	1	1	0.998790808935051	0.998790808935051	1
down	CRTAM; PECAM1; CADM1;	GO:0008037~cell recognition	3	9	33.3333333333333	0.0295613565612405	0.108853835213611	1	1	0.998790808935051	0.998790808935051	1
down	CYB5R3; SLC23A2; SLC23A1;	GO:0019852~L-ascorbic acid metabolic process	3	9	33.3333333333333	0.0295613565612405	0.108853835213611	1	1	0.998790808935051	0.998790808935051	1
down	TAPBP; HLA-A; TAP1;	GO:0019885~antigen processing and presentation of endogenous peptide antigen via MHC class I	3	9	33.3333333333333	0.0295613565612405	0.108853835213611	1	1	0.998790808935051	0.998790808935051	1
down	CDC26; CDC6; NEK6;	GO:0030071~regulation of mitotic metaphase/anaphase transition	3	9	33.3333333333333	0.0295613565612405	0.108853835213611	1	1	0.998790808935051	0.998790808935051	1
down	DLL1; CAV1; SMO;	GO:0030857~negative regulation of epithelial cell differentiation	3	9	33.3333333333333	0.0295613565612405	0.108853835213611	1	1	0.998790808935051	0.998790808935051	1
down	SEC16A; TECPR2; SEC13;	GO:0032527~protein exit from endoplasmic reticulum	3	9	33.3333333333333	0.0295613565612405	0.108853835213611	1	1	0.998790808935051	0.998790808935051	1
down	SREBF1; SCAP; SREBF2;	GO:0032933~SREBP signaling pathway	3	9	33.3333333333333	0.0295613565612405	0.108853835213611	1	1	0.998790808935051	0.998790808935051	1
down	CTBP1; FOXP3; BRCA1;	GO:0035067~negative regulation of histone acetylation	3	9	33.3333333333333	0.0295613565612405	0.108853835213611	1	1	0.998790808935051	0.998790808935051	1
down	VGLL4; LIMD1; WWC3;	GO:0035331~negative regulation of hippo signaling	3	9	33.3333333333333	0.0295613565612405	0.108853835213611	1	1	0.998790808935051	0.998790808935051	1
down	GPS2; ASXL2; STARD10;	GO:0035360~positive regulation of peroxisome proliferator activated receptor signaling pathway	3	9	33.3333333333333	0.0295613565612405	0.108853835213611	1	1	0.998790808935051	0.998790808935051	1
down	P4HB; TYK2; IL12RB1;	GO:0038155~interleukin-23-mediated signaling pathway	3	9	33.3333333333333	0.0295613565612405	0.108853835213611	1	1	0.998790808935051	0.998790808935051	1
down	LRP5; MEGF8; RIC8A;	GO:0042074~cell migration involved in gastrulation	3	9	33.3333333333333	0.0295613565612405	0.108853835213611	1	1	0.998790808935051	0.998790808935051	1
down	KDM1A; CDK4; SLC26A5;	GO:0045793~positive regulation of cell size	3	9	33.3333333333333	0.0295613565612405	0.108853835213611	1	1	0.998790808935051	0.998790808935051	1
down	ZFP36L2; WNT3A; VANGL2;	GO:0048103~somatic stem cell division	3	9	33.3333333333333	0.0295613565612405	0.108853835213611	1	1	0.998790808935051	0.998790808935051	1
down	TYROBP; APP; AGER;	GO:0050725~positive regulation of interleukin-1 beta biosynthetic process	3	9	33.3333333333333	0.0295613565612405	0.108853835213611	1	1	0.998790808935051	0.998790808935051	1
down	DLL1; RBL1; KIF18B;	GO:0051302~regulation of cell division	3	9	33.3333333333333	0.0295613565612405	0.108853835213611	1	1	0.998790808935051	0.998790808935051	1
down	ROCK1; PLEKHO1; SMO;	GO:0051451~myoblast migration	3	9	33.3333333333333	0.0295613565612405	0.108853835213611	1	1	0.998790808935051	0.998790808935051	1
down	BUB1; MKI67; KIF2C;	GO:0051983~regulation of chromosome segregation	3	9	33.3333333333333	0.0295613565612405	0.108853835213611	1	1	0.998790808935051	0.998790808935051	1
down	BMP2; CCM2; SETD2;	GO:0060039~pericardium development	3	9	33.3333333333333	0.0295613565612405	0.108853835213611	1	1	0.998790808935051	0.998790808935051	1
down	F2R; BLOC1S3; DTNBP1;	GO:0060155~platelet dense granule organization	3	9	33.3333333333333	0.0295613565612405	0.108853835213611	1	1	0.998790808935051	0.998790808935051	1
down	PTPN1; RNASEL; USP18;	GO:0060338~regulation of type I interferon-mediated signaling pathway	3	9	33.3333333333333	0.0295613565612405	0.108853835213611	1	1	0.998790808935051	0.998790808935051	1
down	NRP1; NRP2; SEMA3F;	GO:0061549~sympathetic ganglion development	3	9	33.3333333333333	0.0295613565612405	0.108853835213611	1	1	0.998790808935051	0.998790808935051	1
down	ROCK1; GAS6; HEY1;	GO:0070168~negative regulation of biomineral tissue development	3	9	33.3333333333333	0.0295613565612405	0.108853835213611	1	1	0.998790808935051	0.998790808935051	1
down	WNT10B; PRKACA; HDAC4;	GO:0071374~cellular response to parathyroid hormone stimulus	3	9	33.3333333333333	0.0295613565612405	0.108853835213611	1	1	0.998790808935051	0.998790808935051	1
down	LAMP1; IFT122; LAMP3;	GO:0072594~establishment of protein localization to organelle	3	9	33.3333333333333	0.0295613565612405	0.108853835213611	1	1	0.998790808935051	0.998790808935051	1
down	GJC1; KCNQ1; SCN3B;	GO:0086014~atrial cardiac muscle cell action potential	3	9	33.3333333333333	0.0295613565612405	0.108853835213611	1	1	0.998790808935051	0.998790808935051	1
down	STAT2; INF2; MYO19;	GO:0090140~regulation of mitochondrial fission	3	9	33.3333333333333	0.0295613565612405	0.108853835213611	1	1	0.998790808935051	0.998790808935051	1
down	GDPD2; NEDD9; EFS;	GO:0090527~actin filament reorganization	3	9	33.3333333333333	0.0295613565612405	0.108853835213611	1	1	0.998790808935051	0.998790808935051	1
down	APP; CCL11; AGER;	GO:0090647~modulation of age-related behavioral decline	3	9	33.3333333333333	0.0295613565612405	0.108853835213611	1	1	0.998790808935051	0.998790808935051	1
down	PDLIM4; GRIN2C; SSH1;	GO:0098976~excitatory chemical synaptic transmission	3	9	33.3333333333333	0.0295613565612405	0.108853835213611	1	1	0.998790808935051	0.998790808935051	1
down	RFC4; RFC2; RFC5;	GO:1900264~positive regulation of DNA-directed DNA polymerase activity	3	9	33.3333333333333	0.0295613565612405	0.108853835213611	1	1	0.998790808935051	0.998790808935051	1
down	PARP1; TERF2; SLX4;	GO:1904357~negative regulation of telomere maintenance via telomere lengthening	3	9	33.3333333333333	0.0295613565612405	0.108853835213611	1	1	0.998790808935051	0.998790808935051	1
down	FGF1; WNT3A; MED1;	GO:2000347~positive regulation of hepatocyte proliferation	3	9	33.3333333333333	0.0295613565612405	0.108853835213611	1	1	0.998790808935051	0.998790808935051	1
down	ARRB2; WNT3A; KAT2A;	GO:2000727~positive regulation of cardiac muscle cell differentiation	3	9	33.3333333333333	0.0295613565612405	0.108853835213611	1	1	0.998790808935051	0.998790808935051	1
down	SLC6A6; SLC6A9; SLC38A10; SLC7A5; SLC7A7; SLC38A7;	GO:0003333~amino acid transmembrane transport	6	35	17.1428571428571	0.0309137525690127	0.11053858128342	1	1	0.998790808935051	0.998790808935051	1
down	SMPD1; MTOR; EFTUD2; DNMT3B; CACNG4; MBD1;	GO:0042220~response to cocaine	6	35	17.1428571428571	0.0309137525690127	0.11053858128342	1	1	0.998790808935051	0.998790808935051	1
down	TLR4; HK1; FZD5; P2RX7; NLRP1; CARD8;	GO:0050718~positive regulation of interleukin-1 beta secretion	6	35	17.1428571428571	0.0309137525690127	0.11053858128342	1	1	0.998790808935051	0.998790808935051	1
down	CDH13; PCDH12; PCDHGC3; CDH1; CDH6; CDH24; CDH5;	GO:0016339~calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules	7	45	15.5555555555556	0.0310319702344694	0.110783470660769	1	1	0.998790808935051	0.998790808935051	1
down	"NAV2; PCSK9; LEMD2; CDK5RAP2; TRAK1; HAP1; BTBD2;"	GO:0022008~neurogenesis	7	45	15.5555555555556	0.0310319702344694	0.110783470660769	1	1	0.998790808935051	0.998790808935051	1
down	CYBA; IL2RB; LRP1; MFGE8; ABR; GAS6; SIRPG;	GO:0050766~positive regulation of phagocytosis	7	45	15.5555555555556	0.0310319702344694	0.110783470660769	1	1	0.998790808935051	0.998790808935051	1
down	ACVR1; ZBTB17; LRP5; LRP6;	GO:0001702~gastrulation with mouth forming second	4	17	23.5294117647059	0.0314714691986484	0.111047428011915	1	1	0.998790808935051	0.998790808935051	1
down	CTNS; GGT5; GSS; PHGDH;	GO:0006520~cellular amino acid metabolic process	4	17	23.5294117647059	0.0314714691986484	0.111047428011915	1	1	0.998790808935051	0.998790808935051	1
down	A2M; VWF; SERPING1; GP1BA;	GO:0007597~blood coagulation, intrinsic pathway	4	17	23.5294117647059	0.0314714691986484	0.111047428011915	1	1	0.998790808935051	0.998790808935051	1
down	TSPAN15; LFNG; POFUT1; LLGL2;	GO:0008593~regulation of Notch signaling pathway	4	17	23.5294117647059	0.0314714691986484	0.111047428011915	1	1	0.998790808935051	0.998790808935051	1
down	MEN1; CX3CL1; TBCD; FZD4;	GO:0010812~negative regulation of cell-substrate adhesion	4	17	23.5294117647059	0.0314714691986484	0.111047428011915	1	1	0.998790808935051	0.998790808935051	1
down	KCNN4; KCNK10; KCNK6; KCNK3;	GO:0030322~stabilization of membrane potential	4	17	23.5294117647059	0.0314714691986484	0.111047428011915	1	1	0.998790808935051	0.998790808935051	1
down	FBL; NSUN4; RRNAD1; FTSJ3;	GO:0031167~rRNA methylation	4	17	23.5294117647059	0.0314714691986484	0.111047428011915	1	1	0.998790808935051	0.998790808935051	1
down	APOM; LCAT; CETP; PLTP;	GO:0034375~high-density lipoprotein particle remodeling	4	17	23.5294117647059	0.0314714691986484	0.111047428011915	1	1	0.998790808935051	0.998790808935051	1
down	G6PD; NSMF; PCSK9; AKT1S1;	GO:0043523~regulation of neuron apoptotic process	4	17	23.5294117647059	0.0314714691986484	0.111047428011915	1	1	0.998790808935051	0.998790808935051	1
down	EP300; SMARCB1; SNW1; RRP1B;	GO:0043923~positive regulation by host of viral transcription	4	17	23.5294117647059	0.0314714691986484	0.111047428011915	1	1	0.998790808935051	0.998790808935051	1
down	ERCC1; UNG; MLH1; MSH6;	GO:0045190~isotype switching	4	17	23.5294117647059	0.0314714691986484	0.111047428011915	1	1	0.998790808935051	0.998790808935051	1
down	SLC9A3R1; MSN; FOXF1; PTK7;	GO:0045198~establishment of epithelial cell apical/basal polarity	4	17	23.5294117647059	0.0314714691986484	0.111047428011915	1	1	0.998790808935051	0.998790808935051	1
down	SON; METTL16; KHDRBS3; KHDRBS1;	GO:0048024~regulation of mRNA splicing, via spliceosome	4	17	23.5294117647059	0.0314714691986484	0.111047428011915	1	1	0.998790808935051	0.998790808935051	1
down	EGFR; APP; AGER; SMO;	GO:0048143~astrocyte activation	4	17	23.5294117647059	0.0314714691986484	0.111047428011915	1	1	0.998790808935051	0.998790808935051	1
down	CD4; CD3E; CDH13; P2RX4;	GO:0050850~positive regulation of calcium-mediated signaling	4	17	23.5294117647059	0.0314714691986484	0.111047428011915	1	1	0.998790808935051	0.998790808935051	1
down	PDGFRB; PPM1F; F2RL1; STX4;	GO:0050921~positive regulation of chemotaxis	4	17	23.5294117647059	0.0314714691986484	0.111047428011915	1	1	0.998790808935051	0.998790808935051	1
down	RPUSD3; NSUN4; CDK5RAP1; UQCC1;	GO:0070131~positive regulation of mitochondrial translation	4	17	23.5294117647059	0.0314714691986484	0.111047428011915	1	1	0.998790808935051	0.998790808935051	1
down	CD36; CASR; CD81; SREBF2;	GO:0071404~cellular response to low-density lipoprotein particle stimulus	4	17	23.5294117647059	0.0314714691986484	0.111047428011915	1	1	0.998790808935051	0.998790808935051	1
down	ZBTB7B; BMP7; RREB1; SOX13;	GO:0090336~positive regulation of brown fat cell differentiation	4	17	23.5294117647059	0.0314714691986484	0.111047428011915	1	1	0.998790808935051	0.998790808935051	1
down	MAP2K7; MAPKAPK5; PNKP; NABP2;	GO:1904355~positive regulation of telomere capping	4	17	23.5294117647059	0.0314714691986484	0.111047428011915	1	1	0.998790808935051	0.998790808935051	1
down	CSNK2A2; TAF1; PML; SUFU;	GO:2000059~negative regulation of ubiquitin-dependent protein catabolic process	4	17	23.5294117647059	0.0314714691986484	0.111047428011915	1	1	0.998790808935051	0.998790808935051	1
down	TLR4; F2R; F2RL1; CD244;	GO:2000484~positive regulation of interleukin-8 secretion	4	17	23.5294117647059	0.0314714691986484	0.111047428011915	1	1	0.998790808935051	0.998790808935051	1
down	ACACB; GNB3; FOXK1; FOXK2; NFE2L1;	GO:0010906~regulation of glucose metabolic process	5	26	19.2307692307692	0.032575275956139	0.114458764045676	1	1	0.998790808935051	0.998790808935051	1
down	SOX10; EIF2B5; MED12; HDAC10; EIF2B4;	GO:0014003~oligodendrocyte development	5	26	19.2307692307692	0.032575275956139	0.114458764045676	1	1	0.998790808935051	0.998790808935051	1
down	NMT2; NMT1; GRK4; PDE6B; FNTB;	GO:0022400~regulation of rhodopsin mediated signaling pathway	5	26	19.2307692307692	0.032575275956139	0.114458764045676	1	1	0.998790808935051	0.998790808935051	1
down	PTPN1; HSF1; DAB2IP; RHBDD1; DAXX;	GO:0034620~cellular response to unfolded protein	5	26	19.2307692307692	0.032575275956139	0.114458764045676	1	1	0.998790808935051	0.998790808935051	1
down	NRP1; EGFR; APP; ITGA6; APLN;	GO:0042327~positive regulation of phosphorylation	5	26	19.2307692307692	0.032575275956139	0.114458764045676	1	1	0.998790808935051	0.998790808935051	1
down	ATRN; SZT2; BLOC1S3; VANGL1; EDA;	GO:0043473~pigmentation	5	26	19.2307692307692	0.032575275956139	0.114458764045676	1	1	0.998790808935051	0.998790808935051	1
down	DYSF; CD74; RAC2; TIRAP; C3AR1;	GO:0090023~positive regulation of neutrophil chemotaxis	5	26	19.2307692307692	0.032575275956139	0.114458764045676	1	1	0.998790808935051	0.998790808935051	1
down	CACNB3; STX1B; DLG4; RELN; SSH1;	GO:2000463~positive regulation of excitatory postsynaptic potential	5	26	19.2307692307692	0.032575275956139	0.114458764045676	1	1	0.998790808935051	0.998790808935051	1
down	ZBTB7B; PFKFB1; MTOR; HSD11B2; RELA; SCAP; TSC1; KHK; SLC27A1;	GO:0032868~response to insulin	9	67	13.4328358208955	0.0330842490610455	0.116186041237502	1	1	0.998790808935051	0.998790808935051	1
down	GRK2; MTOR; KCNQ1; TAZ; SCN4B; PPP1R13L; SCN3B;	GO:0060048~cardiac muscle contraction	7	46	15.2173913043478	0.0340124497671812	0.119382984135542	1	1	0.998790808935051	0.998790808935051	1
down	MT-CO2; CXCL10; THRA; LRP11; ZNF516; SLC27A1;	GO:0009409~response to cold	6	36	16.6666666666667	0.0343412428643858	0.120284342800152	1	1	0.998790808935051	0.998790808935051	1
down	BAG6; DDB1; RNF41; PRPF19; PSMB10; PSMB9;	GO:0010498~proteasomal protein catabolic process	6	36	16.6666666666667	0.0343412428643858	0.120284342800152	1	1	0.998790808935051	0.998790808935051	1
down	BMP2; SKI; FGFR2; WNT3; WLS; MACF1;	GO:0030177~positive regulation of Wnt signaling pathway	6	36	16.6666666666667	0.0343412428643858	0.120284342800152	1	1	0.998790808935051	0.998790808935051	1
down	VAMP2; RABEP1; BET1L; MX1; DNM1; DYSF;	GO:0061025~membrane fusion	6	36	16.6666666666667	0.0343412428643858	0.120284342800152	1	1	0.998790808935051	0.998790808935051	1
down	SMPD2; SRC; STAT1; MMP14; CLCN6; BTG2; LRP11; P2RX7;	GO:0009612~response to mechanical stimulus	8	57	14.0350877192982	0.0353588870237468	0.123719079570523	1	1	0.998790808935051	0.998790808935051	1
down	ENTPD6; SLC25A12; EGFR; CALM3; GDI1; CAV1; AQP3; P2RX7;	GO:0051592~response to calcium ion	8	57	14.0350877192982	0.0353588870237468	0.123719079570523	1	1	0.998790808935051	0.998790808935051	1
down	CEP152; CNTROB; CDK5RAP2; CENPJ;	GO:0007099~centriole replication	4	18	22.2222222222222	0.0367339332267944	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	TP53; SLFN11; CDAN1; CDC6;	GO:0008156~negative regulation of DNA replication	4	18	22.2222222222222	0.0367339332267944	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	SCG5; PCSK6; ECE1; PCSK7;	GO:0016486~peptide hormone processing	4	18	22.2222222222222	0.0367339332267944	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	BMP2; BMP4; KAT2A; ZDHHC16;	GO:0021537~telencephalon development	4	18	22.2222222222222	0.0367339332267944	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	ALDH1A2; BMP7; WLS; KDM2B;	GO:0030902~hindbrain development	4	18	22.2222222222222	0.0367339332267944	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	STK25; EIF2AK2; SEMA4C; TAOK2;	GO:0032874~positive regulation of stress-activated MAPK cascade	4	18	22.2222222222222	0.0367339332267944	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	SPI1; LTBR; NOTCH2; BATF2;	GO:0043011~myeloid dendritic cell differentiation	4	18	22.2222222222222	0.0367339332267944	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	SRC; ITGB5; TNFAIP1; KCTD13;	GO:0043149~stress fiber assembly	4	18	22.2222222222222	0.0367339332267944	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	GLI3; FGFR2; FOXF1; HLX;	GO:0048557~embryonic digestive tract morphogenesis	4	18	22.2222222222222	0.0367339332267944	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	BMP7; ECE1; RIPPLY3; ACVR1;	GO:0060037~pharyngeal system development	4	18	22.2222222222222	0.0367339332267944	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	PRKACA; NFE2L1; RHBDF1; BTRC;	GO:0061136~regulation of proteasomal protein catabolic process	4	18	22.2222222222222	0.0367339332267944	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	DHCR24; RILPL1; TSC1; CTSZ;	GO:1901214~regulation of neuron death	4	18	22.2222222222222	0.0367339332267944	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	DLL1; FGF1; S100A1; JAK1;	GO:1903672~positive regulation of sprouting angiogenesis	4	18	22.2222222222222	0.0367339332267944	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	FOXF1; NOTCH4; SETD2;	GO:0001763~morphogenesis of a branching structure	3	10	30	0.0367927098703245	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	BMP4; FGFR2; VANGL2;	GO:0003149~membranous septum morphogenesis	3	10	30	0.0367927098703245	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	CPE; GSK3A; FOXF1;	GO:0003214~cardiac left ventricle morphogenesis	3	10	30	0.0367927098703245	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	PFKFB1; PFKFB4; KHK;	GO:0006000~fructose metabolic process	3	10	30	0.0367927098703245	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	HK1; MAN2B2; MAN2B1;	GO:0006013~mannose metabolic process	3	10	30	0.0367927098703245	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	ALKBH5; ALKBH3; FTO;	GO:0006307~DNA dealkylation involved in DNA repair	3	10	30	0.0367927098703245	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	AP2M1; P2RX7; VPS4A;	GO:0006900~vesicle budding from membrane	3	10	30	0.0367927098703245	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	LMNA; EMD; REEP4;	GO:0007084~mitotic nuclear envelope reassembly	3	10	30	0.0367927098703245	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	HAP1; DST; DYNC1H1;	GO:0008090~retrograde axonal transport	3	10	30	0.0367927098703245	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	PLCG2; PLCG1; ENPP2;	GO:0009395~phospholipid catabolic process	3	10	30	0.0367927098703245	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	DAG1; PHLDB1; TGIF2;	GO:0010470~regulation of gastrulation	3	10	30	0.0367927098703245	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	TFAP2A; DACH1; KDM2A;	GO:0010944~negative regulation of transcription by competitive promoter binding	3	10	30	0.0367927098703245	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	HDAC4; DAG1; MTMR4;	GO:0014894~response to denervation involved in regulation of muscle adaptation	3	10	30	0.0367927098703245	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	SLC26A5; SLC26A6; SLC26A1;	GO:0019532~oxalate transport	3	10	30	0.0367927098703245	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	BMP4; WNT3A; SMO;	GO:0021904~dorsal/ventral neural tube patterning	3	10	30	0.0367927098703245	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	B3GAT3; XYLT2; CLN6;	GO:0030203~glycosaminoglycan metabolic process	3	10	30	0.0367927098703245	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	PCSK6; AXL; CKLF;	GO:0032940~secretion by cell	3	10	30	0.0367927098703245	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	RELA; HMG20B; PIAS3;	GO:0033234~negative regulation of protein sumoylation	3	10	30	0.0367927098703245	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	AGO1; TNRC6B; MOV10;	GO:0035194~posttranscriptional gene silencing by RNA	3	10	30	0.0367927098703245	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	IFT140; IFT122; TTC21B;	GO:0035721~intraciliary retrograde transport	3	10	30	0.0367927098703245	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	FGFR3; MMP14; STC1;	GO:0035988~chondrocyte proliferation	3	10	30	0.0367927098703245	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	ECE1; DDR1; SHROOM2;	GO:0043583~ear development	3	10	30	0.0367927098703245	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	ZFP36L2; CARD11; SLAMF8;	GO:0045577~regulation of B cell differentiation	3	10	30	0.0367927098703245	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	RARG; CREBBP; RNF41;	GO:0045637~regulation of myeloid cell differentiation	3	10	30	0.0367927098703245	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	DGKQ; DGKZ; DGKD;	GO:0046486~glycerolipid metabolic process	3	10	30	0.0367927098703245	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	PARP1; KDR; P2RX7;	GO:0051901~positive regulation of mitochondrial depolarization	3	10	30	0.0367927098703245	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	BMP4; BMP7; HYAL1;	GO:0060272~embryonic skeletal joint morphogenesis	3	10	30	0.0367927098703245	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	NLRC4; GSDMC; GSDMB;	GO:0070269~pyroptosis	3	10	30	0.0367927098703245	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	ABCB1; ABCC1; SLC26A6;	GO:0070633~transepithelial transport	3	10	30	0.0367927098703245	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	IGF1R; ITGA3; CTTN;	GO:0097062~dendritic spine maintenance	3	10	30	0.0367927098703245	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	KCNAB2; RAB11B; GBF1;	GO:2000008~regulation of protein localization to cell surface	3	10	30	0.0367927098703245	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	NFASC; ERBB2; ERBB3; UGT8; SOX10;	GO:0007422~peripheral nervous system development	5	27	18.5185185185185	0.0368081847325789	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	DCTN1; NUMA1; MAPRE1; PSRC1; CDK5RAP2;	GO:0031116~positive regulation of microtubule polymerization	5	27	18.5185185185185	0.0368081847325789	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	FLNA; EMP2; GGA3; GGA2; GGA1;	GO:0034394~protein localization to cell surface	5	27	18.5185185185185	0.0368081847325789	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	DVL2; NPHP4; TEAD4; TEAD2; AMOTL1;	GO:0035329~hippo signaling	5	27	18.5185185185185	0.0368081847325789	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	PLA2G6; DBI; TMEM86B; PLA2G2F; PLA2G4C;	GO:0036151~phosphatidylcholine acyl-chain remodeling	5	27	18.5185185185185	0.0368081847325789	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	BRD1; MT-CO1; SRC; BTG2; P2RX7;	GO:0051602~response to electrical stimulus	5	27	18.5185185185185	0.0368081847325789	0.125504642126441	1	1	0.998790808935051	0.998790808935051	1
down	CTNS; APP; MTOR; MECP2; PDE1B; SYNGAP1; RIC8A;	GO:0008542~visual learning	7	47	14.8936170212766	0.0371769752470021	0.126503933592523	1	1	0.998790808935051	0.998790808935051	1
down	HS6ST1; PPT1; ATAT1; SCYL3; SCYL1; SECISBP2; TENM3;	GO:0048666~neuron development	7	47	14.8936170212766	0.0371769752470021	0.126503933592523	1	1	0.998790808935051	0.998790808935051	1
down	KCNK3; KCNQ1; CACNB3; KCNJ2; CACNB1; CACNG4; KCNK6;	GO:0061337~cardiac conduction	7	47	14.8936170212766	0.0371769752470021	0.126503933592523	1	1	0.998790808935051	0.998790808935051	1
down	TLR4; WNT10B; ATF4; NR1H2; FLCN; IP6K1; NOVA2;	GO:0120163~negative regulation of cold-induced thermogenesis	7	47	14.8936170212766	0.0371769752470021	0.126503933592523	1	1	0.998790808935051	0.998790808935051	1
down	SMAD6; GDF11; BMP4; BMP7; FGFR2; ROBO2;	GO:0001657~ureteric bud development	6	37	16.2162162162162	0.038004485470168	0.129122509607083	1	1	0.998790808935051	0.998790808935051	1
down	ITGA6; ITGA3; PPM1F; FOXF1; EGFLAM; NDNF;	GO:0010811~positive regulation of cell-substrate adhesion	6	37	16.2162162162162	0.038004485470168	0.129122509607083	1	1	0.998790808935051	0.998790808935051	1
down	TLR4; F2R; F2RL1; IL16; MAVS; IL17RC;	GO:2000778~positive regulation of interleukin-6 secretion	6	37	16.2162162162162	0.038004485470168	0.129122509607083	1	1	0.998790808935051	0.998790808935051	1
down	SOCS3; CSF1R; IL6R; GHR; HCLS1; PECAM1; FGFR3; CD40; HSF1;	GO:0042531~positive regulation of tyrosine phosphorylation of STAT protein	9	69	13.0434782608696	0.0382258599997941	0.129808649582634	1	1	0.998790808935051	0.998790808935051	1
down	DVL2; WNT3A; DUOXA1; SCYL3; SCYL1; SIN3A; PRPF19; GAS8;	GO:0034613~cellular protein localization	8	59	13.5593220338983	0.0412972603074472	0.136462613542477	1	1	0.998790808935051	0.998790808935051	1
down	GDF11; BMP2; BMP4; SKI; BMP7; ZMIZ2; RBM14; BMP8A;	GO:0060395~SMAD protein signal transduction	8	59	13.5593220338983	0.0412972603074472	0.136462613542477	1	1	0.998790808935051	0.998790808935051	1
down	SNRPGP15; GEMIN4; SNRPD3; SART3; PRMT7;	GO:0000387~spliceosomal snRNP assembly	5	28	17.8571428571429	0.0413629894275713	0.136462613542477	1	1	0.998790808935051	0.998790808935051	1
down	EIF4B; EIF3B; EIF4H; EIF2AK4; GLE1;	GO:0006446~regulation of translational initiation	5	28	17.8571428571429	0.0413629894275713	0.136462613542477	1	1	0.998790808935051	0.998790808935051	1
down	TLR4; TIRAP; RIPK1; MAVS; PRKD2;	GO:0032757~positive regulation of interleukin-8 production	5	28	17.8571428571429	0.0413629894275713	0.136462613542477	1	1	0.998790808935051	0.998790808935051	1
down	LRP5; PDGFRB; NUP62; SH2B1; SMPD3;	GO:0045840~positive regulation of mitotic nuclear division	5	28	17.8571428571429	0.0413629894275713	0.136462613542477	1	1	0.998790808935051	0.998790808935051	1
down	SLC9A1; TM9SF4; SLC26A6; SLC4A2; SLC9A8;	GO:0051453~regulation of intracellular pH	5	28	17.8571428571429	0.0413629894275713	0.136462613542477	1	1	0.998790808935051	0.998790808935051	1
down	CD4; STIM1; IL16; ORAI1; CASR;	GO:0051924~regulation of calcium ion transport	5	28	17.8571428571429	0.0413629894275713	0.136462613542477	1	1	0.998790808935051	0.998790808935051	1
down	TCIRG1; ATP6V0E2; ATP6V0A1; ATP6V1E2; SLAMF8;	GO:0090383~phagosome acidification	5	28	17.8571428571429	0.0413629894275713	0.136462613542477	1	1	0.998790808935051	0.998790808935051	1
down	SLC1A4; CNIH2; ALS2; CLSTN3; UNC13B; GRIN2C;	GO:0035249~synaptic transmission, glutamatergic	6	38	15.7894736842105	0.0419074266222929	0.136462613542477	1	1	0.998790808935051	0.998790808935051	1
down	RBP1; CETP; USF1; ACACA; NR1I3; NR1H2;	GO:0055088~lipid homeostasis	6	38	15.7894736842105	0.0419074266222929	0.136462613542477	1	1	0.998790808935051	0.998790808935051	1
down	COX10; MIEF1; DNM1; MX1;	GO:0000266~mitochondrial fission	4	19	21.0526315789474	0.0424710560371715	0.136462613542477	1	1	0.998790808935051	0.998790808935051	1
down	MEN1; HDAC4; LIMD1; LRP5;	GO:0002076~osteoblast development	4	19	21.0526315789474	0.0424710560371715	0.136462613542477	1	1	0.998790808935051	0.998790808935051	1
down	DIAPH2; PARN; C17orf53; MCM8;	GO:0007292~female gamete generation	4	19	21.0526315789474	0.0424710560371715	0.136462613542477	1	1	0.998790808935051	0.998790808935051	1
down	APP; CDK4; PPP5C; BACE1;	GO:0010288~response to lead ion	4	19	21.0526315789474	0.0424710560371715	0.136462613542477	1	1	0.998790808935051	0.998790808935051	1
down	NRP1; PDGFRB; SRC; HDAC4;	GO:0014911~positive regulation of smooth muscle cell migration	4	19	21.0526315789474	0.0424710560371715	0.136462613542477	1	1	0.998790808935051	0.998790808935051	1
down	MCM3AP; GLE1; NXF1; DDX19B;	GO:0016973~poly(A)+ mRNA export from nucleus	4	19	21.0526315789474	0.0424710560371715	0.136462613542477	1	1	0.998790808935051	0.998790808935051	1
down	MYO5A; MYO1G; MYO5C; MYO19;	GO:0030050~vesicle transport along actin filament	4	19	21.0526315789474	0.0424710560371715	0.136462613542477	1	1	0.998790808935051	0.998790808935051	1
down	TYROBP; EGFR; CYBA; F2RL1;	GO:0032930~positive regulation of superoxide anion generation	4	19	21.0526315789474	0.0424710560371715	0.136462613542477	1	1	0.998790808935051	0.998790808935051	1
down	WNT3A; SCRIB; MED12; VANGL2;	GO:0036342~post-anal tail morphogenesis	4	19	21.0526315789474	0.0424710560371715	0.136462613542477	1	1	0.998790808935051	0.998790808935051	1
down	SLC9A3R1; PKD2; ODF2; MARK4;	GO:0044782~cilium organization	4	19	21.0526315789474	0.0424710560371715	0.136462613542477	1	1	0.998790808935051	0.998790808935051	1
down	LAMA2; BAG6; EHMT1; NOCT;	GO:0045995~regulation of embryonic development	4	19	21.0526315789474	0.0424710560371715	0.136462613542477	1	1	0.998790808935051	0.998790808935051	1
down	SPN; ITGB7; JAM2; ROCK1;	GO:0050901~leukocyte tethering or rolling	4	19	21.0526315789474	0.0424710560371715	0.136462613542477	1	1	0.998790808935051	0.998790808935051	1
down	CALM3; PRKACA; GJA5; P2RX4;	GO:0055117~regulation of cardiac muscle contraction	4	19	21.0526315789474	0.0424710560371715	0.136462613542477	1	1	0.998790808935051	0.998790808935051	1
down	ADCY6; ACE; P2RY2; ROCK1;	GO:0097746~regulation of blood vessel diameter	4	19	21.0526315789474	0.0424710560371715	0.136462613542477	1	1	0.998790808935051	0.998790808935051	1
down	DEPDC5; SZT2; ITFG2; KPTN;	GO:1904262~negative regulation of TORC1 signaling	4	19	21.0526315789474	0.0424710560371715	0.136462613542477	1	1	0.998790808935051	0.998790808935051	1
down	POLQ; TP53BP1; UBQLN4; RMI2;	GO:2000042~negative regulation of double-strand break repair via homologous recombination	4	19	21.0526315789474	0.0424710560371715	0.136462613542477	1	1	0.998790808935051	0.998790808935051	1
down	NDUFS5; COQ9; NDUFA3; MT-ND1; MT-ND4; NDUFV3; NDUFA11;	GO:0006120~mitochondrial electron transport, NADH to ubiquinone	7	49	14.2857142857143	0.0440715288057738	0.136956085476382	1	1	0.998790808935051	0.998790808935051	1
down	XRCC1; APTX; TDP1;	GO:0000012~single strand break repair	3	11	27.2727272727273	0.0448391313814641	0.136956085476382	1	1	0.998790808935051	0.998790808935051	1
down	SETMAR; REXO4; EXOG;	GO:0000737~DNA catabolic process, endonucleolytic	3	11	27.2727272727273	0.0448391313814641	0.136956085476382	1	1	0.998790808935051	0.998790808935051	1
down	ALOX5; CX3CL1; FUT7;	GO:0002523~leukocyte migration involved in inflammatory response	3	11	27.2727272727273	0.0448391313814641	0.136956085476382	1	1	0.998790808935051	0.998790808935051	1
down	GSTZ1; FAH; IL4I1;	GO:0006559~L-phenylalanine catabolic process	3	11	27.2727272727273	0.0448391313814641	0.136956085476382	1	1	0.998790808935051	0.998790808935051	1
down	KIF4A; ATP2A2; HPS6;	GO:0006996~organelle organization	3	11	27.2727272727273	0.0448391313814641	0.136956085476382	1	1	0.998790808935051	0.998790808935051	1
down	SLC9A3R1; GNG2; GNB1;	GO:0007191~adenylate cyclase-activating dopamine receptor signaling pathway	3	11	27.2727272727273	0.0448391313814641	0.136956085476382	1	1	0.998790808935051	0.998790808935051	1
down	E4F1; SND1; RPRD1B;	GO:0010564~regulation of cell cycle process	3	11	27.2727272727273	0.0448391313814641	0.136956085476382	1	1	0.998790808935051	0.998790808935051	1
down	PIK3CD; CXCL11; CXCL10;	GO:0010818~T cell chemotaxis	3	11	27.2727272727273	0.0448391313814641	0.136956085476382	1	1	0.998790808935051	0.998790808935051	1
down	CTNS; AKT1; AKT2;	GO:0010918~positive regulation of mitochondrial membrane potential	3	11	27.2727272727273	0.0448391313814641	0.136956085476382	1	1	0.998790808935051	0.998790808935051	1
down	PPFIA3; STX1B; UNC13B;	GO:0016081~synaptic vesicle docking	3	11	27.2727272727273	0.0448391313814641	0.136956085476382	1	1	0.998790808935051	0.998790808935051	1
down	ALDH1A2; FGFR2; KDF1;	GO:0016331~morphogenesis of embryonic epithelium	3	11	27.2727272727273	0.0448391313814641	0.136956085476382	1	1	0.998790808935051	0.998790808935051	1
down	P4HB; P4HA2; P4HTM;	GO:0018401~peptidyl-proline hydroxylation to 4-hydroxy-L-proline	3	11	27.2727272727273	0.0448391313814641	0.136956085476382	1	1	0.998790808935051	0.998790808935051	1
down	MICAL3; MICAL1; PPP1R9B;	GO:0030042~actin filament depolymerization	3	11	27.2727272727273	0.0448391313814641	0.136956085476382	1	1	0.998790808935051	0.998790808935051	1
down	STAT1; BST2; XAF1;	GO:0035456~response to interferon-beta	3	11	27.2727272727273	0.0448391313814641	0.136956085476382	1	1	0.998790808935051	0.998790808935051	1
down	COL4A1; DDR1; COL4A2;	GO:0038063~collagen-activated tyrosine kinase receptor signaling pathway	3	11	27.2727272727273	0.0448391313814641	0.136956085476382	1	1	0.998790808935051	0.998790808935051	1
down	DIEXF; RBM19; NR2C2;	GO:0040019~positive regulation of embryonic development	3	11	27.2727272727273	0.0448391313814641	0.136956085476382	1	1	0.998790808935051	0.998790808935051	1
down	UCK2; UCK1; UCKL1;	GO:0043097~pyrimidine nucleoside salvage	3	11	27.2727272727273	0.0448391313814641	0.136956085476382	1	1	0.998790808935051	0.998790808935051	1
down	CD74; CD3E; GLI3;	GO:0045060~negative thymic T cell selection	3	11	27.2727272727273	0.0448391313814641	0.136956085476382	1	1	0.998790808935051	0.998790808935051	1
down	CD74; APP; AGER;	GO:0045080~positive regulation of chemokine biosynthetic process	3	11	27.2727272727273	0.0448391313814641	0.136956085476382	1	1	0.998790808935051	0.998790808935051	1
down	KDM6B; SCUBE1; KDR;	GO:0045446~endothelial cell differentiation	3	11	27.2727272727273	0.0448391313814641	0.136956085476382	1	1	0.998790808935051	0.998790808935051	1
down	SOX12; HLA-G; BTN2A2;	GO:0045591~positive regulation of regulatory T cell differentiation	3	11	27.2727272727273	0.0448391313814641	0.136956085476382	1	1	0.998790808935051	0.998790808935051	1
down	AKT1; HLX; SMO;	GO:0046622~positive regulation of organ growth	3	11	27.2727272727273	0.0448391313814641	0.136956085476382	1	1	0.998790808935051	0.998790808935051	1
down	ANO6; TSPAN33; P2RX7;	GO:0046931~pore complex assembly	3	11	27.2727272727273	0.0448391313814641	0.136956085476382	1	1	0.998790808935051	0.998790808935051	1
down	KDM6B; FGFR2; ITGA3;	GO:0048333~mesodermal cell differentiation	3	11	27.2727272727273	0.0448391313814641	0.136956085476382	1	1	0.998790808935051	0.998790808935051	1
down	MTHFD1; NDST1; MTHFD1L;	GO:0048703~embryonic viscerocranium morphogenesis	3	11	27.2727272727273	0.0448391313814641	0.136956085476382	1	1	0.998790808935051	0.998790808935051	1
down	FGL2; PCBP2; RNF26;	GO:0050687~negative regulation of defense response to virus	3	11	27.2727272727273	0.0448391313814641	0.136956085476382	1	1	0.998790808935051	0.998790808935051	1
down	TTLL11; LZTS2; KATNB1;	GO:0051013~microtubule severing	3	11	27.2727272727273	0.0448391313814641	0.136956085476382	1	1	0.998790808935051	0.998790808935051	1
down	MEN1; TP53; SRC;	GO:0051974~negative regulation of telomerase activity	3	11	27.2727272727273	0.0448391313814641	0.136956085476382	1	1	0.998790808935051	0.998790808935051	1
down	SLC12A9; SLC12A4; SLC12A7;	GO:0055064~chloride ion homeostasis	3	11	27.2727272727273	0.0448391313814641	0.136956085476382	1	1	0.998790808935051	0.998790808935051	1
down	JAK1; TYK2; STAT1;	GO:0070106~interleukin-27-mediated signaling pathway	3	11	27.2727272727273	0.0448391313814641	0.136956085476382	1	1	0.998790808935051	0.998790808935051	1
down	TPP1; TERF2; ACD;	GO:0070198~protein localization to chromosome, telomeric region	3	11	27.2727272727273	0.0448391313814641	0.136956085476382	1	1	0.998790808935051	0.998790808935051	1
down	SLC9A1; NFE2L1; EIF2AK4;	GO:0070417~cellular response to cold	3	11	27.2727272727273	0.0448391313814641	0.136956085476382	1	1	0.998790808935051	0.998790808935051	1
down	JAK1; STAT1; IL12RB2;	GO:0070757~interleukin-35-mediated signaling pathway	3	11	27.2727272727273	0.0448391313814641	0.136956085476382	1	1	0.998790808935051	0.998790808935051	1
down	CD81; TM9SF4; SEC16A;	GO:0070863~positive regulation of protein exit from endoplasmic reticulum	3	11	27.2727272727273	0.0448391313814641	0.136956085476382	1	1	0.998790808935051	0.998790808935051	1
down	BAG6; UGGT1; POMT2;	GO:0071712~ER-associated misfolded protein catabolic process	3	11	27.2727272727273	0.0448391313814641	0.136956085476382	1	1	0.998790808935051	0.998790808935051	1
down	PARP6; PARP16; PARP3;	GO:0140289~protein mono-ADP-ribosylation	3	11	27.2727272727273	0.0448391313814641	0.136956085476382	1	1	0.998790808935051	0.998790808935051	1
down	FLNA; KCNQ1; KCNJ2;	GO:1901381~positive regulation of potassium ion transmembrane transport	3	11	27.2727272727273	0.0448391313814641	0.136956085476382	1	1	0.998790808935051	0.998790808935051	1
down	ADCY6; ADCY3; ADCY1;	GO:1904322~cellular response to forskolin	3	11	27.2727272727273	0.0448391313814641	0.136956085476382	1	1	0.998790808935051	0.998790808935051	1
down	TP53; ATF4; ATF6B;	GO:1990440~positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress	3	11	27.2727272727273	0.0448391313814641	0.136956085476382	1	1	0.998790808935051	0.998790808935051	1
down	BTG2; RAPGEF1; KDM2B;	GO:2000178~negative regulation of neural precursor cell proliferation	3	11	27.2727272727273	0.0448391313814641	0.136956085476382	1	1	0.998790808935051	0.998790808935051	1
down	TLR4; CD36; AKT1; MTOR; PKD2; P2RX4;	GO:0045429~positive regulation of nitric oxide biosynthetic process	6	39	15.3846153846154	0.0460533485158903	0.140472171671244	1	1	0.998790808935051	0.998790808935051	1
down	OGG1; EGFR; AKT1; PPP5C; HSF1; DAXX;	GO:0071276~cellular response to cadmium ion	6	39	15.3846153846154	0.0460533485158903	0.140472171671244	1	1	0.998790808935051	0.998790808935051	1
down	GDF11; GLI3; BMP7; APH1A; ROBO2;	GO:0001656~metanephros development	5	29	17.2413793103448	0.0462430384662258	0.14053761985893	1	1	0.998790808935051	0.998790808935051	1
down	BMP4; FGFR3; MMP14; TEK; SMPD3;	GO:0001958~endochondral ossification	5	29	17.2413793103448	0.0462430384662258	0.14053761985893	1	1	0.998790808935051	0.998790808935051	1
down	MEN1; EP300; SNW1; FLCN; CREBBP;	GO:0030511~positive regulation of transforming growth factor beta receptor signaling pathway	5	29	17.2413793103448	0.0462430384662258	0.14053761985893	1	1	0.998790808935051	0.998790808935051	1
down	MAP2K7; GSS; RIPK1; NUB1; GGT5;	GO:0034612~response to tumor necrosis factor	5	29	17.2413793103448	0.0462430384662258	0.14053761985893	1	1	0.998790808935051	0.998790808935051	1
down	ERBB2; CNP; GLI3; CDKN2C; SOX10;	GO:0048709~oligodendrocyte differentiation	5	29	17.2413793103448	0.0462430384662258	0.14053761985893	1	1	0.998790808935051	0.998790808935051	1
down	EGFR; ERBB2; FGFR2; ARHGEF5; TRAF7;	GO:0070372~regulation of ERK1 and ERK2 cascade	5	29	17.2413793103448	0.0462430384662258	0.14053761985893	1	1	0.998790808935051	0.998790808935051	1
down	APP; BACE1; HSF1; NFE2L1; DAXX;	GO:0071280~cellular response to copper ion	5	29	17.2413793103448	0.0462430384662258	0.14053761985893	1	1	0.998790808935051	0.998790808935051	1
down	APP; WNT3A; CLSTN3; LRFN3; GPC4;	GO:1905606~regulation of presynapse assembly	5	29	17.2413793103448	0.0462430384662258	0.14053761985893	1	1	0.998790808935051	0.998790808935051	1
down	SIPA1L1; CX3CL1; GRIN2C; AGER; KAT2A; SYNGAP1; RIMS3;	GO:0048167~regulation of synaptic plasticity	7	50	14	0.0478072681033929	0.145159460579271	1	1	0.998790808935051	0.998790808935051	1
down	RXRB; ROR1; NR2C2; IGF1R; ATXN1L; TFAP2C; TFAP2A;	GO:0048856~anatomical structure development	7	50	14	0.0478072681033929	0.145159460579271	1	1	0.998790808935051	0.998790808935051	1
down	FOXK1; FOXK2; HK3; HK1;	GO:0001678~cellular glucose homeostasis	4	20	20	0.0486829995009828	0.147083402199398	1	1	0.998790808935051	0.998790808935051	1
down	ATP2A2; KCNQ1; TRPM4; SCN3B;	GO:0010460~positive regulation of heart rate	4	20	20	0.0486829995009828	0.147083402199398	1	1	0.998790808935051	0.998790808935051	1
down	PARP1; SLC9A1; CDK9; ROCK1;	GO:0010613~positive regulation of cardiac muscle hypertrophy	4	20	20	0.0486829995009828	0.147083402199398	1	1	0.998790808935051	0.998790808935051	1
down	RAC3; PARVB; RHOJ; RAC2;	GO:0030031~cell projection assembly	4	20	20	0.0486829995009828	0.147083402199398	1	1	0.998790808935051	0.998790808935051	1
down	BMP4; RARG; ADAMTS12; LTBP3;	GO:0032331~negative regulation of chondrocyte differentiation	4	20	20	0.0486829995009828	0.147083402199398	1	1	0.998790808935051	0.998790808935051	1
down	PDGFRB; SRC; CBL; HYAL1;	GO:0036120~cellular response to platelet-derived growth factor stimulus	4	20	20	0.0486829995009828	0.147083402199398	1	1	0.998790808935051	0.998790808935051	1
down	GBP1; PTPRJ; BTN2A2; PHPT1;	GO:0050860~negative regulation of T cell receptor signaling pathway	4	20	20	0.0486829995009828	0.147083402199398	1	1	0.998790808935051	0.998790808935051	1
down	TLR4; TP53; RIPK1; RIPK3;	GO:0070266~necroptotic process	4	20	20	0.0486829995009828	0.147083402199398	1	1	0.998790808935051	0.998790808935051	1
down	TET3; APOBEC3F; FTO; APOBEC3C;	GO:0080111~DNA demethylation	4	20	20	0.0486829995009828	0.147083402199398	1	1	0.998790808935051	0.998790808935051	1
down	PLA2G6; EGFR; GJA5; F2RL1;	GO:0097755~positive regulation of blood vessel diameter	4	20	20	0.0486829995009828	0.147083402199398	1	1	0.998790808935051	0.998790808935051	1
